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ABSTRACT

Efficacy of a Cognitive-Behavioral Treatment for Weight Loss
in Adults with Type 2 Diabetes

by

Kathy Wickersham, Master of Science
Utah State University, 2007

Major Professor : Dr. David M. Stein
Department: Psychology

The prevalence of type 2 diabetes is increasing across all sociodemographic
groups. Obesity and overweight are major risk factors in the development of the disease
and in the development of complications. Conversely, weight loss improves glycemic
control, which reduces likelihood of complications. Interventions combining cognitive
and behavioral components show promise in addressing the problem of weight loss
maintenance. The objective of this study was to test the efficacy of a cognitivebehavioral intervention. Participants were 54 adults diagnosed with type 2 diabetes
randomly assigned to either a treatment group or a control. The assessment measures
utilized in this study were the Diabetes Care Profile, the Short Form 36, and the Diabetes
Empowerment Scale. Specific outcomes measured included Body Mass Index (BMI),
weight, and glycosolated hemoglobin .
A repeated measures analysis of variance revealed significant weight loss and
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reduction in BMI. Treatment effects on BMI and weight were sustained at 2-month
follow-up.
(209 pages)
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CHAPTER I
INTRODUCTION

The prevalence of type 2 diabetes among Americans of all ages is increasing at an
epidemic rate . Between 1990 and 1998 the prevalence of type 2 diabetes in the U.S.
increased in men and women, across all sociodemographic groups and in nearly all states
by about one third (Mokdad et al., 2000). According to the Center for Disease Control
(CDC), 1 in 3 children born in the year 2000 may develop diabetes sometime during the
course of their lives (Center for Disease Control, 2004).
Type 1 diabetes accounts for 5% of the diabetic population and most often occurs
in childhood and adolescence. It develops when the body's immune system destroys
pancreatic beta cells that results in dependence on insulin replacement therapy for
survival. Type 2, which most often occurs in adulthood, is due to insulin resistance in
nonnally insulin-responsive cells. This resistance leads to an inability to uptake glucose
into the cell. Individuals diagnosed with type 2 diabetes are typically initially treated with
diet, exercise, weight loss and oral medications (American Diabetes Association, 2002).
An uncontrolled glucose level in diabetic patients is the primary predictor of
developing diabetic complications such as cardiovascular disease, retinopathy,
neuropathy, and nephropathy (Klein et al., 2004). Many of these complications lead to
disability and early death in diabetic patients. Indeed, diabetes is now the sixth largest
killer in the United States (CDC, 2004).
Standards of care for individuals with diabetes direct physicians to focus on
glycemic control, suggesting it is best achieved by a combination of patient education to
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increase knowledge about diabetes and self-care behaviors, medication management, and
reduction of Body Mass Index (BMI) if overweight. Unfortunately, less than 50% of
individuals with type 2 diabetes achieve glycemic control (HbA

1c

< 7%) (Norris et al.,

2002) . The HbA 1c test , a measure of a 2-3 month average blood glucose level, is often
the preferred standard for assessing glycemic control (Goldstein, 1995).
Further, obesity, overweight , and weight gain are major risk factors in the
development of type 2 diabetes. Every 1 kg increase in weight is associated with a 9%
relative increase in the prevalence of diabetes (Mokdad et al., 2000) . Obesity is also
associated with greater risk of developing complications associated with diabetes , such as
hypertension (Mokdad et al) . Conversely , weight loss improves insulin sens itiv ity and
glycemic control (Sjostrom , Peltonen, Wedel, & Sjostrom, 2000) .
A weight classification system has been put forth by the National Heart , Lung and
Blood Institute (NHLBI; 1998) and is widely accepted as the nomenclature for describing
overweight and obesity . This classification system, described in Table 1, is based on BMI
that describes relative weight for height and is calculated as weight (kg)/height squared
(m 2 ) . For purposes of simplicity, unless specified, the classes of obesity, including
overweight will be referred to as obesity.
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Table 1

Classification of Overweight and Obesity by BM!
Classification
Underweight
Normal
Overweight
Obesity
Extreme Obesity

Obesity class

I
II
III

BMI (kg/m)
< 18.5
18.5 - 24.9
25.0- 29.9
30.0- 34.9
35.0 - 39.9
~40

Management of BMI and Obesity in Diabetes Treatment

If patients with diabetes need to reduce BMI, physicians will typically refer
patients to education programs for assistance with weight loss. Unfortunately, educa tion
programs have not demonstrated outcomes oflong-term weight loss (Norris et al., 2004).

It is possible that the obesity problem in type 2 diabetes represents a key obstacle to
improving overall health of patients. Yet, were clinicians to attempt to address the BMIdiabetes association by embracing weight regulation as a goal, a number of key obstacles
to effective BMI intervention would still have to be overcome.
First, the obese problem among type 2 diabetics is pervasive with proximately
85% of type 2 diabetics classified as overweight or obese. Second, there is very little
research on effective methods for helping patients successfully decrease their weight and
maintain this loss over time. Overall, studies incorporating appropriate follow-up periods
tend to show a clear trend toward return to baseline weight (Avenell et al., 2004; Cooper
& Fairburn, 2001,). In fact, longitudinal studies within the broader obesity literature
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show that 95% of those who successfully lose weight regain it within 5 years (Perri,
Nezu, & Viegener, 1992). Wing (2002) stated that "data from a variety of weight loss
interventions suggest that weight loss and maintenance may be an even greater problem
for diabetic than for non-diabetic individuals" (p. 41 ).
This weight-rebound phenomenon after a weight loss is more distressing when the
broader, co morbid relationships between obesity and other chronic diseases is
considered, for example, heart disease, cancer and type 2 diabetes (Anderson , Kendall , &
Jenkins, 2003 ; Orzano & Scott , 2004) . Given the high failure rate observed in weight
loss treatment programs , it is perhaps not surprising that only 25 % of obese patients
receive any type of weight-loss treatment servic es from their ph ysicians (Or zano & Scot;
Stafford , Farhat, Misra , & Schoenfeld , 2000) .

Empirically Support ed Treatments for Obesity in Diab etes
Presently, health professionals can recommend three evidence-based approaches
for treating obesity identified in clinical guidelines put forth by the NHLBI (NHLBI,
1998): lifestyle therapy (includes dietary therapy with a low-calorie diet, physical activity
and behavior therapy); pharmacotherapy (only as part of a comprehensive weight-loss
program including dietary therapy /low-calorie diet and physical activity); and bariatric
(weight-loss) surgery (Cooper & Fairburn, 2001; NHLBI) .
Lifestyle therapy was found to achieve the greatest likelihood of success of weight
loss and maintenance oflost weight for > 1 year (NHLBI, 1998). Treatments for obesity
produce an average weight loss of 10% of initial body weight. Unfortunately this is
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almost always followed by a regain of the weight lost, with 40% being regained over the ·
first year following treatment. The rest is regained over the following 3 years (Cooper &
Fairburn, 2001 ; NHLBI) . Without the addition of behavior therapy, long-term
effectiveness of weight-loss therapy has not been demonstrated (NHLBI) . Cooper and
Fairburn suggest that one factor for this disappointing outcome is the "neglect of the
contribution of cognitive factors to weight regain ."
Pharmacotherapy results in an average of 5-10% weight loss, however given the
historical problems with drug safety such as fenfluramine and phentermine , physicians
and patients are disinclined to implement drug treatment (NHLBI, 1998). Bariatric
surgery is intend ed only for obese individuals with a BMJ >40 or BMI >35 with at least
one comorbid health condition related to obesity. Those who qualify for this intervention
must have documented a consistent failure to lose weight with standard treatments
(NHLBI) .
However , a review of the literature on outcomes of bariatric surgery found that in
both long-term and short-term outcomes, weight loss improved or resolved diabetes in
over 76% of cases (Buchwald et al., 2004) . Because of the dramatic impact of weight
loss resulting from bariatric surgery, a more thorough discussion of these outcomes will
be presented in Chapter II.
Overall , the treatment options that physicians currently recommend have not
produced the long term weight loss that is sought. Thus , factors associated with
successful weight loss treatments and characteristics of successful weight loss
maintainers have been of keen interest to researchers, as incorporating such factors into
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future treatments may increase their efficacy (Perri et al., 1992). For example, Roter and
colleagues (1998) found that comprehensive interventions combining cognitive,
behavioral and affective components were more effective than single-focus interventions.
Therefore, a cognitive behavioral weight loss program may offer the best hope for
helping obese, type 2 diabetic adults regulate their weight and in tum their daily glucose
levels.

Characteristics of Successful Weight Loss Maintainers
Better weight management programs may emerge if evaluation researchers'
hypotheses can be guided, in part, by data derived from studies that identify the
characteristics of successful weight loss maintainers . Kitsantas (2000) suggested that to
enhance weight loss success, interventions must focus on strategies that optimize selfregulation and enhance self-efficacy perceptions.

Self-efficacy represents a judgment of

one's capability to accomplish a certain level of performance and includes the confidence
to overcome barriers . Self-efficacy has become an important concept in the treatment of
both diabetes and obesity because of the necessity for the individual to successfully
change behaviors . Satterfield and Davidson (2000) reviewed studies that investigated the
relationship between self-efficacy and diabetes self-care behaviors. Studies found that
high self-efficacy was highly predictive of diabetes self-care behaviors , including weight
management, among adults.
Dehahanty, Meigs, Hayden, Williamson, and Nathan (1992) found a relationship
between baseline BMI and several psychological constructs including self-efficacy in the
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Diabetes Prevention Study. Thus, the measurement of changes in self-efficacy may prove
useful in identifying those treatments that will improve weight maintenance outcomes.

Need to Measure Health-Related Quality of Life

Another likely shortcoming of past studies of diabetes-related interventions has
been a failure to evaluate the broad impact of the disease (and the interventions aimed to
treat it), on patients' quality of life. Indeed more than 50 years ago, the World Health
Organization stated that health was defined not only by the absence of disease and
infirmity , but also by the presence of physical , mental, and social well-being (Rubin,
2000). Thus, better evaluations of quality oflife among persons with diabetes, a
measurable construct, will lead to more adequate evaluation of treatments for chronic
diseases . Therefore, future studies of diabetic patients should incorporate broader
measures of outcome, such as quality of life.

Summary and Statement of the Problem

In summary, the general population is evidencing an increasing prevalence and
incidence of type 2 diabetes and the costs associated with diabetes and its treatment are
presently very high.
However, to date, treatment programs have not adequately incorporated
interventions that address the well-known relationship between obesity and the
development and maintenance of type 2 diabetes. Given the contribution of overweight
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to the development of type 2 diabetes, successful maintenance of weight loss might, in
tum help attenuate blood glucose control problems so common among type 2 diabetes .
Also, the need to evaluate the effect of treatment on quality oflife is of keen interest.
The present study sought to test the efficacy of a weight management approach for
type 2 diabetes which incorporates a focus on long-term weight loss maintenance
strategies. The following research questions were central to this study:

1. Does a cognitive-behavioral

treatment added to standard care-as-usual lead to a

decrease in BMI and weight?

2. Does a cognitive-beha vioral treatment added to standard care-as-usual improve
glycemic control as measured by HbA 1c?

3. Does a cognitive-behavioral

treatment added to standard care-as-usual change

diabetes-specific quality of life as measured by the Diabetes Care Profile DCP) and Short
Form-36 (SF-36)?

4. Does a cognitive-behavioral

treatment added to standard care-as-usual improve

diabetes related self-efficacy as measures by the Diabetes Empowennent

Scale (DES)?
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CHAPTER II
LITERATURE REVIEW

To place the present study in an appropriate context, a range of topics relevant to
treatment issues in the arenas of obesity and diabetes will be discussed in the literature
review that follows . A brief summary of the history surrounding the identification of
diabetes as a disease and the effect of weight loss in the remission of the symptoms will
be presented . A summary of the recent changes to Medicare policy regarding obesity
treatment will be discussed including : (a) and the implications of the change on broader
medical insurance coverage for obesity treatments and (b) the increased funds now
available for obesity treatment research. Next, a brief history outlining the relationship of
type 2 diabetes and weight-loss will be presented , and a summary of the contemporary

standards of care for diabetes will be outlined. This latter presentation will allow the
reader to gain a better understanding of the components found in most contemporary,
"care-as-usual" diabetes treatment. More specifically, the key topics of interest
associated with contemporary standards of care include: (a) procedures for attaining
glycemic control via diet; (b) a more detailed description ofHbA

1c,

the blood glucose test

used as an outcome in this study, (c) diabetes medication management, and (d) the
efficacy of patient education in diabetes intervention.
Research on typical weight loss treatments including diet therapy, physical
activity, and cognitive-behavioral modalities as well as anti-obesity medication and
surgery for weight loss will be specifically summarized. Also, research on self-
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monitoring/assessment procedures will be specifically summarized. Showcasing the
efficacy of treatments within the broader obesity /weight loss literature will be included;
this discussion is important because it has implications for selecting empirically-validated
approaches for further investigation and possible use in a type 2 diabetic population.
Also presented in this review will be evidence supporting the role that weight loss
treatment might play if diabetes treatments incorporated weight loss interventions with

demonstrated efficacy . Toward this end, a review of the literature pertaining to the
relationship between improved diabetic outcomes and weight loss will be offered. In
addition , a discussion of the efficac y of weight loss treatments for obesity and in
parti cular for weight loss treatm ents geared for those diagnosed with type 2 diabet es will
be presented. Of particular interest is research on how bariatric surgery impacts both
weight loss and diabetes , and the relationship between physical activity and weight loss .
Finally, some accessory issues relevant to the treatment of type 2 diabetes are
worthy of discussion in the present review , as they will almost certainly impact the design
of intervention studies . For example, the importance of both discovering and integrating
empirically-validated treatments more effectively is an important theme in this literature .
Also, there is a need to evaluate treatment outcomes beyond simple measures of glycemic
control and weight loss; for example, quality of life and self-efficacy indices are highly
relevant outcome measures to patients. Diabetes and obesity certainly impact a patient's
functional capacity and sense of effectiveness in many areas of life . Thus, the merits of
using health-related quality-of-life measures to more accurately assess health outcomes
will be presented in the review that follows .
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Efficacy of Obesity Treatment and Medical Insurance Coverage

An important issue, that of insurance reimbursement for medical treatment,
requires evidence of empirically supported treatment (EST). Obesity treatment has not
been covered by most insurance providers because until recently it was not considered a
treatable condition. In 2004, in a landmark decision, the Department of Health and
Human Services announced that the Medicare Coverage Policy would remove barriers to
covering anti-obesity interventions if empirically supported treatments demonstrate
efficacy in improving health outcomes (Department of Health & Human Services , 2004).
The need is great for research to demonstrate the efficacy of obesity treatment and
recently , a greater amount of grant money has been provided at the federal level to
support this research - in part, because of this Medicare policy change . In fact, in 2005,
National Institutes of Health received $440.3 million to fund obesity research. This is
truly a landmark event because Medicare is the flagship for private medical insurance
policy . That is, if Medicare makes a policy change to cover certain obesity treatments ,
typically private insurers follow suit (Betz, 2005). Hence , a good deal of contemporary
research has focused on the identification of ES Ts. Given the comorbidity of obesity and
diabetes, however, an optimal use of Medicare dollars would be to expend them on the
newest empirically supported weight loss strategies that have been incorporated into
treatments for type 2 diabetes .
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A Brief History of Diabetes and the Relationship of
Weight Loss to Diabetes Treatment

The disease diabetes mellitus has been known since ancient times. Two Hindu
physicians in 1000 B.C. first identified two forms of the diabetes syndrome: one
associated with emaciation, dehydration, and excessive urination, and the other with stout
build, excessive caloric consumption, obesity, and sleepiness. The first type was always
fatal until the development of exogenous forms of insulin in 1921. Although the
distinction between the two forms was described 3,000 years ago, a fonnal differentiation
in medical nomenclature was not made until 1979 with the International Classification of
Diseases (ICD) assignment of type I and type 2 diabetes. For more than 100 years, it has
been known that weight loss is an effective treatment for type 2 diabetes . Historical
accounts of the human effects of the Franco -Prussian War as well as World War I and II
showed that food shortages and rationing caused by large scale social disruption produced
weight loss across large portions of the population. This decrease in available food was ,
in each event, accompanied by a measurable lessening in symptomology in existing
diabetes cases . Physicians noted that overweight patients with diabetes became
aglucosuric (absence of glucose in urine), a sign that the severity of diabetes is
decreasing. With the advent of more sophisticated knowledge about the etiology of
diabetes, glucose levels are now measured in blood samples (Davidson & DiGirolamo,
2000).
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Contemporary Standards of Care and
Measurements for Diabetes Mellitus

For those newly diagnosed with type 2 diabetes by a physician, medical
management protocols typically include the prescription of an oral hypoglycemic agent
and educational materials on topics such as how to maintain a healthy diet. It also
commonly includes a referral to a diabetes educator or nutritionist, the initiation of selfmonitoring of blood glucose (SMBG), and screening for various complications, and
periodic measurements of glycosolated hemoglobin (GHb; ADA, 2007).
First and foremost in the treatment of diabetes is continued glycemic control and
adequate glycemic control is described as an HbA 1c measure of <7% (UK Prospective
Diabetes Study Group, UKPDSG, 1998) . GHb is a term used to describe a series of
stable minor hemoglobin components formed slowly and from hemoglobin and glucose
(Goldstein, 1995) . The rate of formation of GHb is directly proportional to the ambient
glucose concentration.

Because red blood cells ate freely permeable to glucose, the level

of GHb in a blood sample provides a glycemic history of the previous 2-3 months, the
average red blood cell life span. The HbA 1c test, which measures GHb often the preferred
standard for accessing glycemic control. This measure more readily predicts the risk of
developing diabetic complications than does daily glucose monitoring (Goldstein).
According to Harris, Eastman, and Cowie (1999), this level of control is achieved in less
than half of persons with type 2 diabetes .
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The UKPDSG (UKPDSG; 1998; Manley, 2003) found that the intensive treatment
group achieved a mean HbA 1c of 7%, while the standard care group maintained an HbA 1c
of7.9% based on a follow-up period of 10 years (p < .0001). In the control group the
HbA 1c value steadily increased over the 10 years. In the treatment group there was an
initial decrease in HbA 1c in the first year and then, like the control group, a similar
increase over the 10-year period . However, this difference between groups was
significant and translated into a 12% reduction for any diabetes complication (p = .034).
Most of the risk reduction was due to a 25% risk reduction in microvascular endpoint
such as retinopathy which translated into a 35% reduction in the risk of complications for
every percentage point reduction in HbA 1c (e.g., 9% to 8%; American Diabetes
Association , 2002) . There were no differences between groups in risk reduction for
macrovascular (cardiovascular) disease .
This study initially contained a diet-only treatment group as well as several groups
given different types of medications. The diet-only group treatment consisted of dietary
advice from a dietician including advice to eat a diet low in saturated fat, moderately high
in fiber and have about 50% of calories from carbohydrates. The overweight and obese
patients were advised to reduce energy content; however, there is no report on the percent
of participants who were overweight or obese. It can be assumed that with a study size of
5,102 patients, the percentage overweight or obese would be similar to the typical
reported statistics in other resources. Eighty-five percent of individuals diagnosed with
type 2 diabetes are overweight and of those 55% are obese (CDC, 2004; Norris et al.,
2004). It is not surprising, given the lack of comprehensive treatment of obesity, that
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none of the diet-only participants, over time, were able to control their glucose levels with
diet only and were transferred into a medication group. This study is now frequently
cited in diabetes treatment literature and is the benchmark for glycemic control
parameters in treatment (American Diabetes Association, 2007).

Glycemic Control via Diet, Medication Management,
and Patient Education
Standard care guidelines aimed at helping patients attain glycemic control
typically include : (a) the prescription of diet recommendations from the American
Diabetes Association (ADA) , or (b) a regimen of oral hypoglycemic medications along
with the aforementioned diet recommendations . Selection of one of these initial
treatment options appears to be based on physician preference or on severity of
hyperglycemia (ADA, 2007). For instance, according to a Utah survey of primary care
providers, respondents ranked diet and oral medication as the most common treatment for
type 2 patients; diet alone ranked second. It is unclear if the survey term "diet" indicates
endorsing a balanced and healthy diet or a combination of diet along with calorie

restriction . This survey's poor item construction also illustrates the lack of some critical
distinctions in the standards of diabetic care literature between healthy dietary balance of
nutrients and healthy weight indicators (BMI, for example) (Utah Department of Health,
Diabetes Prevention and Control Program , 2003).
Standard recommendations for diet include educating the patient about balanced
and healthy nutrition and, if overweight or obese, the use of caloric restriction and
increase in energy expenditure (activity) to induce weight loss (ADA, 2004). It is also
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common for a patient to be referred to a nutritionist or diabetes educator to receive
assistance in losing weight. National patterns of physician activities related to obesity
management indicate that physicians provide weight loss treatment for 25% of all obese
patients . If an obese patient had a comorbid condition (e.g., type 2 diabetes), the
physician provided treatment to 52% of obese patients (Stafford et al., 2000) . Barriers to
treating obesity by medical professionals include physician knowledge of high patient
relapse rates, lack of patient interest in obesity treatment, lack of knowledge about
appropriate weight management interventions , and lack of educational materials
(Timmerman, Reifsnider , & Allan , 2000). Based on literature reviews of randomly
controlled trials for m edical p atients recei ving weight los s treatm ent, medical patient
outcomes are similar to outcomes for weight loss treatment in general. That is, patients
experience initial weight loss followed by a trend of weight regain (Douketis, Macie,
Thabane & Williamson , 2005; Norris et al., 2004).
To complicate the issues of obesity treatment in medical settings by physicians,
extended treatment, peer support and cognitive-behavioral therapies are associated with
better weight maintenance outcomes (NHLBI, 1998) . These strategies do not map easily
onto physician-patient time constraints, and lack of physician knowledge about these
treatments is a clear impediment to treatment (Stafford et al., 2000). With the apparent
difficulty in treating obesity in the medical setting and the complexity of obesity
treatment it may be appropriate to develop more independent multi component weight
loss/weight maintenance programs (Perri & Corsica, 2002).
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Oral Hypoglycemic Medication Management
Treatment with oral medications tends to follow a predictable path that usually
begins with the prescription of one oral medication. As glycemic control diminishes (i.e.
blood glucose levels rise) with one medication, additional oral medications are
prescribed . The ability of oral medication to control blood glucose levels diminishes over
time, including combining multiple medications. Typically, tight blood glucose control
lasts no more than 9 years with oral medications before insulin (typically injected with a
syringe) is required for better glycemic control (Triplitt , 2007 ; UKPDSG , 1998) .

Effic acy of Pati ent Edu cation in Diabetes Interv entions
Patient education is considered to be important in cont emporary diabetes health
interventions ; it is based on the assumption that health-promoting behaviors will likely
occur , once patients have adequate information (Norris, Engelgau , & Narayan, 2001).
While some physicians may offer some education during an office visit, patient education
programs led by a nutritionist or health educator are the most common vehicle for
providing information about diet, exercise , and other self-care behaviors known to be
associated with better glycemic control and decreased complications (ADA , 2007) .
Physicians will direct the patient to a diabetes education program either as an
initial intervention strategy or if the patient continues to exhibit uncontrolled
hyperglycemia. Patient education includes training in self-care behaviors such as SMBG ,
adherence to medication management, monitoring and management of chronic
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complications, strategies to change behavior, meal planning and weight and exercise
management (ADA, 2004).
Unfortunately, the efficacy of patient education to improve glycemic control and
other diabetes-related outcomes have not been demonstrated over time (ADA, 2004). A
review of the literature conducted by Norris and colleagues (2001) examined the efficacy
of diabetes education on improvement of self-care behaviors, glycemic control, and
reduction of complications. The review concluded that most interventions increased
patient knowledge and improved glycemic control initially, but generally failed to
produce improvement in glycemic control long term , the maintenance of lost weight, or
sustained increases in physical activity.
Satterfield and Davidson (2000) acknowledge that education increases knowledge.
However, they belie ve most educators would agree that while necessary, knowl edge is
insufficient to stimulate the behavioral changes needed . In fact, interventions that
improve patient compliance in a variety of health outcomes found that "comprehensive
interventions combining cognitive, behavioral, and affective components were more
effective than single-focus interventions (Roter et al., 1998).

Standards of Care in Diabetes Treatment
In summary, contemporary standards of care for helping patients attain glycemic
control typically include the prescription of oral hypoglycemic agents, a referral to a
patient education program and diet recommendations. Well-controlled clinical trials have
established that the use of oral medications for glycemic control follows a predictable
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path, for example, to eventual dependence on insulin. Also, patient education is a
ubiquitous component of contemporary diabetes control programs. Yet the effects of
patient education on glycemic control tend to be moderate and to decrease over time.
More striking is the lack of significant effects of patient education on weight loss. It is
notable that standards of care and recommendations from governing bodies, such as the
American Diabetes Association, are often based on controlled clinical trials that evaluate
the efficacy of medication . However, it appears these institutions tend to minimize or are
unaware of current research regarding treatments for weight loss. Also, almost none
appear to actively participate in new research focused on improving the efficacy of weight
loss treatments. The implications of this body ofresearch are that heavy reliance on
glycemic control medications and passive education programs, and the failure to address
BMI through weight control interventions may well account for the minimal, long-term
effectiveness of most contemporary type 2 diabetes treatment programs. The research
points to a need to develop more effective treatments addressing obesity-diabetes
comorbidity .

General Efficacy of Weight Loss Treatments

As mentioned earlier, health professionals can recommend three evidence-based
approaches for treating obesity including: lifestyle therapy, pharmacotherapy, and
bariatric (weight-loss) surgery ( Cooper & Fairburn, 2001; NHLBI, 1998).
Lifestyle therapy was found to achieve the greatest likelihood of success of weight
loss and maintenance of lost weight for > 1 year. Lifestyle therapy included diet therapy
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with a low-calorie diet, increase in physical activity, and behavior therapy . Diet therapy
consists mostly of instructing patients on how to modify their diets to achieve a moderate
reduction in calorie intake. A decrease in calorie intake is the most important dietary
component of weight loss and maintenance (NHLBI, 1998). Guidelines for reduction in
calorie intake include a reduction of 500-1,000 kcal/day (depending on individuals
starting weight) from their maintenance calorie intake.

In weight loss treatments, most incorporate caloric restriction as the primary
component. In order to improve on the disappointing findings of weight loss
maintenance , treatments have included some variation in type of caloric restriction (e.g.,
restriction of carboh ydrates or fats or total calories; Avenell et al. , 2004). Of these
treatments some may employ other regimens to enhance weight loss or to improve
maintenance of lost weight. These regimens generally consist of behavioral or cognitivebehavioral interventions, increases in physical activity or pharmacotherapy as adjuncts to
a prescribed calorie-restricted diet plan , or a combination of these regimens (Ostman,
Britton, & Jonsson, 2004).
Behavioral therapy proves most necessary in helping patients maintain weight loss
by modifying lifestyle behaviors upon which patients tend to return after losing weight.
Treatments for obesity produce an average weight loss of I 0% of initial body weight.
Unfortunately this is almost always followed by a regain of the weight lost, with 40%
being regained over the first year following treatment. The rest is regained over the
following 3 years (Cooper & Fairburn, 2001; NHLBI, 1998). Without the addition of
behavior therapy, long-term effectiveness of weight-loss therapy has not been
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demonstrated (NHLBI). Cooper and Fairburn suggested that one factor for this
disappointing outcome was the "neglect of the contribution of cognitive factors to weight
regain."
It is important to note that the term behavioral therapy often contains strategies
that would also fall under the umbrella of cognitive therapies . For example, the clinical
guidelines for weight loss put forth by the NHLBI (1998) include behavioral therapy.
Two of the strategies put forth in behavioral therapy are stress management, which
involves coping strategies, and cognitive restructuring , which involves identifying and
modifying inaccurate beliefs and self-defeating thoughts. Typical cognitive strategies
address these same issues (Sharf, 2000). Therefore, for sake of clarity, it may be more
accurate to term the NIH reference to behavior therapy as cognitive-behavioral therapy.
The NIH identified seven strategies that have empirical support in cognitive -beha viora l
therapy including: (a) self-monitoring of eating habits and activity, (b) stress
management , (c) stimulus control, (d) problem-solving , (e) contingency management
such as use of rewards, (f) cognitive restructuring, and (g) social support.
Physical activity is an important component of weight loss because it expends
additional energy and contributes to weight loss both alone and in combination with diet
therapy . Activity may also inhibit food intake in overweight patients and may be helpful
in maintaining weight loss (NHLBI, 1998) . Physical activity has shown to improve
weight loss outcomes and to delay or prevent weight gain often associated with aging
(Blair & Holder, 2002; NHLBI). Along with a low fat diet and continued self-monitoring
of food intake, physical activity is one of three main behavioral characteristics shared
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with those who avoid significant weight regain (Cooper & Fairburn, 2001).
Use of anti-obesity medications (pharmacotherapy) has also shown to improve
weight loss outcomes. Typically these medications are not indicated for continued use
longer than 2 years, which precludes the use in the necessary long-term treatment of
obesity. Unfortunately, upon discontinuation of medication, individuals tend to
experience rapid regain of lost weight (Wadden & Osei, 2002). There have also been
serious health risks associated with some of these medications (Padwal, Li, & Lau, 2003).
Bariatric surgery is typically recommended for individuals with a BMI > 40 or
BMI > 35 with comorbid complications related to obesity. Patients typically experience
significant initial weight loss followed by various amounts of weight regain over time
(Ostman et al., 2004) . A comprehensive review of the literature regarding weight loss
maintenance was conducted by Ostman and colleagues and patients experienced more
weight regain after 2 years and up to 10 years . In fact, patients maintained an average
weight loss of only 16% of excess weight after an initial weight loss average of 50-75%
of overweight.

It appears that the invasive treatment of bariatric surgery has somewhat lower
weight regain outcomes, but it also fails to elicit maintenance of all weight initially lost.
However, a review of the bariatric surgery literature by Buchwald and colleagues (2004)
found that after 12 years, a weight loss of at least 9 kg was associated with a 53%
reduction in all obesity related-deaths.

A more comprehensive dis'cussion of bariatric

surgery is included in the section below.

23
Several reviews of the literature on weight loss treatments found that patients can
typically lose 5-10% of body weight within 1 year, but the majority begin regaining
weight in the year following treatment (Avenell et al., 2004; Curioni & Lourenco, 2005;
Douketis et al., 2005; NHLBI, 1998) . Within 3-5 years of completing treatment, the
majority of individuals have returned to their baseline weight (Wadden, Womble,
Stunkard, & Anderson, 2002). In fact, "the maintenance of treatment effects is the single
greatest challenge in the long-term management of obesity" (Cooper & Fairburn, 2002).

Efficacy of Specific Treatments for Weight Loss
in Type 2 Diabetes

The tendency for weight loss to be followed by weight regain is minored in
weight loss treatments for overweight and obese patients diagnosed with type 2 diabetes
(Wing et al., 2001). As mentioned earlier, approximately 85% of diabetic patients are
considered overweight or obese and a BMI >27 is considered the point at which
intervention is needed to induce weight loss in diabetic patients (Wadden & Osei, 2002).
The NHLBI algorithm recommends an individual with a BMI > 30 or a BMI of 25.0 29.9 with two or more disease risk factors, attempt to lose weight by adhering to a
lifestyle therapy program (1998). The beneficial effect of weight loss on reducing diabetic
risk as well as improving glycemic control and reducing complications has been welldocumented in several literature reviews (Anderson et al., 2003; Anderson & Konz, 2001;
Orzano & Scott, 2004).
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For example, Anderson and Konz (2001) found that 1-kg of weight loss decreases
fasting plasma glucose concentrations by -0.2 mM and a 5-kg weight loss would decrease
fasting plasma glucose concentrations by 1mM. This decrease is in the range produced
by many of the oral hypoglycemic agents that are currently approved by the Food and
Drug Administration. Orzano and Scott (2004) also found that moderate weight loss
could positively affect glycemic control. They identified a critical threshold weight loss
of

~

5% of body weight to improve glycemic control.
In a review of the literature concerning weight management in type 2 diabetes ,

Anderson and colleagues (2003) found that obesity is a major risk factor for the
developm ent of type 2 diabet es, accounting for 60 - 90% of the variance. The authors
reported on the findings of two studies that followed patients long-term and proved to
have similar patient outcomes . After a 6-year period both studies found that with
moderate weight loss of - 6% of body weight and increases in physical activity by - 50%,
subjects in the lifestyle interv ention group had a 58% reduction in risk for diabetes
compared to the control group. The reviewers concluded that for many obese diabetic
individuals , an emphasis on weight management may be the most important therapeutic
task .
The Diabetes Prevention Program Research Group (2004) conducted a study of
the effects of weight loss and physical activity on the development of diabetes in persons
considered high risk for developing diabetes . The study goals were for participants to
lose 7% of their baseline body weight and to achieve at least 150 min/wk of physical
activity, using activities similar in intensity to brisk walking. These goals were selected
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because they appeared achievable and likely to reduce the risk of diabetes. The entire 16week core curriculum was completed by 95% (1,024) of participants.

Weight loss over

the 16-week period averaged 6.5 ± 4.7 kg or 6.9 ± 4.5% of initial body weight. About 3
years after their initial visit, participants maintained an average weight loss of 4.5 ± 7.6
kg or 4 .9 ± 7.4% of initial body weight. This research indicated that the reduction of
baseline weight by 7% and an increase of physical activity to 150 min/wk reduced the risk
of diabetes by 58%. One unexpected finding from this study was that older individuals
were particularly successful at achieving both the weight and physical activity goals and
had the greatest reduction in diabetes incidence. This finding is particularly salient for
the diabetes population because average age of onset of type 2 diabetes is 50 years of age .
A dramatic demonstration of the efficacy of weight loss on diabetic outcomes can
be found in a review of studies investigating the effect of bariatric surgery on weight loss.
A systematic review of the literature on the impact ofbariatric surgery on weight loss
found the mean percentage of excess weight loss was 61.2% for all patients . Diabetes
was completely resolved in 76 .8% of patients. Further, it was resolved or improved in
86 .0% of cases (Buchwald et al., 2004). While this particular review did not report any
follow-up data, a study of the long-term beneficial effects of maintained weight loss on
the development of diabetes was investigated by Sjostrom et al. (2000) in an ongoing
prospective Swedish Obese Subjects (SOS) study. This large cohort study followed 346
patients who underwent gastric bypass surgery with 346 matched obese control subjects
who received the customary obesity treatment at the medical centers to which they
belonged. The gastric bypass intervention resulted in a maximum weight loss of -31.3 ±
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13.6 kg after 1 year. After 8 years, the maintained mean weight loss was 20.1 ± 15.7 kg
in the surgery group and the mean weight loss in the control group was +0 .09% .
Although the maintained weight loss of the surgery group was equivalent to only a 16%
reduction in weight, it had a dramatic effect on the 8-year incidence of diabetes (odds
ratio 0.16, 95% CI 0.07 to 0.36). Also , the incidence among control completers was
18.5% compared to 3.65% for surgically treated completers .

Relationship Between Physical Activity and
Weight Loss in Type 2 Diabetes
Persons who have been diagnosed with type 2 diabetes also benefit from weight
loss and increases in physical activity because these changes can reduce amount of
medications needed for glycemic control and, for some , these changes can eliminate
diabetic symptoms entirely (ADA, 2004). Exercise alone has also been shown to improve
glycemic control in the absence of weight loss (Swartz et al., 2003). Swartz and
colleagues (2003) conducted a study in which participants walked an average of 4,972
steps/day, but did not intentionally control caloric intake. This level of activity resulted in
a decrease in blood glucose levels .
A review of the literature on the effect of exercise on weight loss and maintenance
found that exercise alone (without diet) produced a small weight loss of 2 kg that was
significantly greater than the control group with a no-exercise condition (Wing, 2002) .
Wing also reviewed several studies that compared the effects of diet, exercise, and the
combination of diet and exercise. At 2 years, one study reported the diet and exercise
group had lost 2 .2 kg whereas the diet-only group had lost 0.9kg. This difference was not
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statistically significant, but the findings do reinforce the premise that a minimum amount
of weight loss found in the treatment group is clearly better than the untreated groups who
tend to gain weight.

Characteristics of Successful Weight Loss Maintainers

Better weight management programs may emerge if evaluation researchers'
hypotheses can be guided, in part, by data derived from studies that identify the
characteristics of successful weight loss maintainers. Kitsantas (2000) suggested that to
enhance weight loss success, interventions must focus on strategies that optimize selfregulation and enhance self-efficacy perceptions.

Se! f-efficacy represents a judgment of

one's capability to accomplish a certain level of performance and includes the confidence
to overcome barriers. Beliefs about whether making the behavior change will lead to a
particular outcome are referred to as outcome expectations . Characteristics of successful
weight maintainers include use of two interdependent self-regulating strategies: goal
setting and self-monitoring.

Those who use goal setting, the setting of goals that are

specific, realistic, proximal, and strategic tend to have higher self-efficacy perceptions
and are more likely to maintain behavior change
Self-efficacy has become an important concept in the treatment of both diabetes
and obesity because of the necessity for the individual to successfully change behaviors .
Satterfield and Davidson (2000) reviewed studies that investigated the relationship
between self-efficacy and diabetes self-care behaviors. Studies found that high selfefficacy was highly predictive of diabetes self-care behaviors, including weight
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management, among adults. The authors suggested three strategies for increasing selfefficacy: setting small, incremental goals; behavioral contracting, and monitoring and
reinforcement.

It is also important to help change negative outcome expectations and

thus increase self-efficacy by helping patients to see the relationship between the desired
behavior and the outcome. This might entail the use of creative teaching strategies (e.g.,
stories, role plays, drama).
Dehahanty and colleagues (1992) found a relationship between baseline BMI and
several psychological constructs including self-efficacy, perceived stress and emotional
eating in the Diabetes Prevention Program study . The authors suggest that interventions
that focus on how to manage stress , negative emotions and self-talk that may trigger food
cravings will elicit improved adherence to weight loss interventions.

Self-monitoring/ Assessment as an Adjunct
to Weight Loss Intervention

Self-monitoring, the act of paying deliberate attention to some aspect of one's
behavior , is associated with behavior change (Boutelle & Kirschenbaum, 1998). In
weight loss treatment, self-monitoring in the form of recording food eaten and comparing
one's weight with the healthy weight listed on a BMI chart are correlated with increased
weight loss and improved weight loss maintenance (Kirschenbaum, Germann, & Rich,
2005; Lappalanien, Pulkkinen, Oils, Parkka, & Korhenen, 2005). Some research
indicates that the act of self-monitoring food intake and activity levels can induce weight
loss as well as increase physical activity (Boutelle & Kirschenbaum; NHLBI, 1998). In
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fact, even though predictors of weight loss have proven elusive, early weight loss and
compliance with self-monitoring have been identified as the most useful predictors
(Devlin, Yanovski, & Wilson, 2000).
Self-monitoring may enhance self-efficacy through the increased attention focused
on behaviors related to goal attainment. Self-monitoring has been used as a behavioral
technique in a wide range of programs aimed at behavioral change. It has proven
effective in programs targeting decrease of women's cardiovascular risk, in smoking
cessation programs, in interventions aimed at increasing physical activity in older adults
and in improving academic skills and increasing academic engagement in children and
adolescents (Conn , Valentine & Cooper, 2002; Krummel et al., 2001; Manske, Miller,
Moyer, Rose, & Cameron, 2004; Rock, 2005).
Most psychological treatments of obesity involve some measurement, assessment
or self-monitoring to evaluate patients' progress. Self-monitoring is considered the
cornerstone of effective techniques in behavioral treatments of obesity (Institute of
Medicine, 1995). In summary, self-monitoring and intensive assessment procedures may
likely enhance a weight management intervention.

Maintenance of Weight Loss and "Moderate"
Weight Loss as a Primary Goal

With the evident failure rates of weight loss treatments on maintenance oflost
weight, researchers began to focus on strategies to help maintain weight .loss long-term
(Perri & Corsica, 2002). Such maintenance is important given the results of a number of
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studies showing that a moderate weight loss of 5-10% was sufficient to improve health
(IOM, 1995; NHLBI, 1998; Norris et al., 2005). The IOM issued a report on criteria to
assess the outcome of weight management programs (IOM). Defining what is meant by
long term maintenance oflost weight is subjective, therefore a definition of "success"
was proposed. Successful long term weight loss is defined as maintenance of 1 year or
more, a weight loss of 2:5% of body weight, or a reduction in BMI by 1 or more units
(IOM).
Perri and Corsica (2002) summarized the results of behavioral-based weight loss
studies with follow-ups of 2 or more years and found that the net mean weight loss from
base line was 1.8 kg. While this is a small net weight loss, they suggested that trend data
from the large Minnesota Heart Health Program showed that the natural course of obesity
in untreated adults entails steady weight gain. This finding indicated that maintenance of
a small weight loss relative to weight gain may be considered a positive outcome, because
the normative pattern of gradual, continual weight gain is arrested.
Ayyad and Andersen (2000) reviewed studies of long-term efficacy of dietary
treatment of obesity. Based on the authors' definition of successful weight loss
(maintenance of all weight initially lost [or further weight reduction] or maintenance of 911 kg of initial weight loss), 15% of dietary treatments of obesity were successful. Those
treatments deemed successful combined caloric restriction with group therapy or behavior
modification, and active follow-up.
Certain physiological facts also support the premise that moderate weight loss is
an appropriate goal for treatment. Aronne (2002) suggested that weight is controlled by a
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feedback mechanism and the lack of success in obesity treatments that focus on large
amounts of weight loss may be the re.suit of a counterregulatory response that prevents
more than a 5-15% reduction in initial body weight. The concept of plateau, which is
often witnessed in weight loss trials, has been studied arid it appears there is a relationship
between this plateau and reductions in leptin-a

hormone related to the facilitation of

weight loss beyond the plateau in animals (Aronne).

It appears that cognitive factors are also contributing to the lack of continued
weight loss or weight loss maintenance. Patients do not engage in behaviors necessary to
maintain lower weight, even if this weight is not characterized as an "ideal" weight. If
the state of obesity is viewed from a cost-benefit analysis perspective, it suggests that
weight regain is paradoxical (Cooper & Fairburn, 2001) . Weight loss, which is achieved
only with long-term, persistent effort , is associated with enhanced self-esteem and
interpersonal function , and reduced body dissatisfaction and depression. Weight regain
can be viewed as an aversive state because of its relationship to negative effects on selfconfidence, body image, and mood.
Cooper and Fairburn (2001) also noted that behavioral therapists have attempted
to minimize posttreatment gains with treatment components such as extended therapist
contact, provisions of food, monetary incentives, and telephone contact. These have all
demonstrated modest effects and tend to simply delay the weight regain. Cooper and
Fairburn suggested that this lack of engagement in behaviors need to maintain the lower
weight requires explanation and they posit it is likely due to cognitive factors. They
propose that because patients do not achieve their weight loss goals, nor the anticipated
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benefits of achieving them, they abandon weight loss efforts and do not appreciate the
need to acquire weight maintenance skills .
Moderate weight loss goals during the initial treatment phase appear to be the
most promising improvement for weight loss efficacy. However, strategies to improve
weight loss maintenance appear to be the cornerstone of best practices. Cognitivebehavioral strategies to address the "maintenance problem" of continued adherence to the
changes in eating and exercise patterns induced during the initial treatment phase appear
to hold the most promise for better outcomes (Perri & Corsica, 2002).
Maintenance methods that have been evaluated and provide beneficial effects
include: extended treatment that provides clients the opportunity for professional
assistance in negotiating obstacles to maintenance, skills training in relapse prevention ,
training in problem solving, social support, increase in physical activity, and
multicomponent treatment programs . Empirically tested multicomponent programs
include: ongoing professional contacts, training in problem-solving or relapse prevention
skills, social suppo1i, and exercise (Fairburn & Brownell, 2002) . Motivational
interviewing, a participant-centered approach to dealing with problems of ambivalence
and decreased motivation to change also holds promise for increasing success in extended
treatment (Perri & Corsica, 2002).
While historically, the research literature paints a dismal picture regarding weight
loss maintenance efficacy, recent studies that pursue more moderate weight loss goals and
adopt the idea that obesity is a chronic, relapsing disease, may now be demonstrating the
possibility that weight loss can be maintained (IOM, 1995; Perri & Corsica, 2000). With
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the limited success of treatment to induce weight loss maintenance, identification of
treatment components for study in future research can be deduced from consistent
recommendations from researchers. A clear set of empirically supported guidelines
established by controlled clinical trials and empirical studies has yet to be developed.

In summary, researchers recognize that effective treatments for obesity need to
pursue realistic, moderate weight loss goals. They also recognize that treatments must
include strategies to help maintain weight loss once it is achieved . Currently, the research
has identified the potential value of multicomponent treatment programs that include :
moderate weight loss goals, self-monitoring, strategies to increase self-efficacy , extended
treatment, physical activity, and relapse prevention. It is necessary for future researchers
to carefully evaluate these components in order to identify efficacious treatments for
weight loss in adults with type 2 diabetes , given its high comorbidit y with obesity.

Manualized Cognitive-Behavioral Treatment of Obesity

Cooper , Fairburn , and Hawker (2003) have proposed a new approach to the
treatment of obesity that is designed to minimize the weight regain that generally follows
weight loss. They have created a manual to facilitate treatment of obesity and this manual
will be employed in this research study. An outline of the treatment intervention is
provided in Appendix A. This treatment focuses on overcoming psychological obstacles
to the acquisition of and long term adherence to effective weight control behavior. The
authors suggest that three issues need to be addressed: first, there is a need to help
patients accept and value the weight loss they have achieved; second, it is necessary to
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encourage the adoption of weight stability not necessarily weight loss as their goal ; and
third, there is a need to help patients acquire and use behavioral skills and cognitive
responses required for successful weight control.
The treatment advanced by Cooper and colleagues (2003) includes weight loss
and weight maintenance phases. During the weight loss phase, patients both lose weight
and address the potential obstacles to subsequent weight maintenance . It includes a
moderate change in calori c intake and a moderate increase in energy expenditure along
with an expectation that this moderate approach will be represented by a loss in weight of
approximately 1 lb/wk. This moderate approach to weight loss will help address the
problem s found with typic al weight loss strat egies (e.g., low self-efficacy, depression, and
hopelessness) , which are frequent outcomes for patients undergoing more radical shifts in
caloric-intake and exercise (Perri et al., 1992). The maintenance phase is characterized
by focusing on weight stability and the frame of mind and behaviors needed for
successful weight loss maintenance.
The use of treatment manuals has become central in the effort to determine if the
efficacy of treatment is due to the specific intervention used (Weiner et al., 2006) .
According to McMurran and Duggan (2005), "the advantages of manualized
psychological treatment include: the promotion of evidence-based practice; the
enhancement of treatment integrity; the facilitation of staff training, and the potential
replicability of treatment" (p. 23 ).
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Other Considerations in Optimizing Treatment
for Type 2 Diabetes

When planning future research into effective treatments for type 2 diabetes, it is
important to emphasize a number of accessory measurement issues and procedural
themes. Measurement issues include the need to evaluate outcomes more broadly (i.e.
beyond blood sugar levels, weight loss per se ), such as overall quality of life , and the
general need to integrate treatments, given the multiplicity of problems in diabetes e.g.,
obesity.

Need for Treatment Integration : Moderate Weight Loss Goals
in Obesity Within Diabetes Treatment

As has been noted previously in the present review, research is justifying a need to
redefine weight loss for obesity in more moderate tenns. Unfortunately, this new focus
on more efficacious, moderate weight loss goals is not translating into practice. The
UKPDS study which has provided a benchmark for diabetes treatment, investigated the
benefits of a diet-only approach compared to medication-only to improve glycemic
control. All participants in the diet-only group were eventually moved to the medication
treatment group because of deterioration in glycemic control. This study is often quoted
in research regarding treatment recommendations.

However, this study did not include

intensive weight loss treatment intervention in the diet-only group, only intensive
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medication intervention; therefore, only data on medication management has been
disseminated.
The Utah Diabetes Practice Recommendations (Utah Department of Health, 2006)
do not include BMI as a key treatment target. It describes a medical management
protocol that does not include diet, exercise, or weight loss as an initial goal of treatment.

It does suggest that diet and exercise be "optimized" if glycemic control is not adequate
with oral medication. These recommendations were partly based on the UKPDSG study
(1998), yet with all the literature available that supports the premise that weight loss and
physical activity are cornerstones of diabetes management, it appears that mainstream
treatment is circumventing this treatment option. In a survey of national patterns of
physician activities related to obesity management, 55,858 physician office visits were
analyzed, and it was found that based on known obesity rates, physicians were reporting
obesity in only 38% of their obese patients . Of the obese patients who visited a
physician , only 25% received counseling for weight loss, and diet and exercise treatment
(Stafford et al., 2000).
Perri and colleagues (1992) have also proposed a continuous care model for the
treatment of obesity. Their model is similar to the chronic care model proposed for the
treatment of diabetes. Individuals who have lost weight often struggle to sustain the
substantial degree of psychological control necessary to override compensatory biological
mechanisms. The authors believe that obesity treatment must be supplemented with
programs of ongoing care and skills training in relapse prevention . The intervention
would include components aimed at enhancing patients' problem-solving abilities, so
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they can cope more effectively with stressful life circumstances. The authors suggested it
is crucial that therapists orient obese patients to understand and accept the long-term
implications of weight management.

Summary

Taken together, recent research suggests that moderate weight loss goals, selfmonitoring/assessment and an increased focus on empirically validated treatments for
weight loss/maintenance are likely critical to successful weight maintenance outcomes .
Research has also demonstrat ed that overweight adults with type 2 diabete s are better able
to control their disease through moderate weight loss. Given that diabetes is a chronic
disease requiring ongoing monitoring and treatment , and the addition of weight
loss/maintenance interventions to treatment, or at the very least avoidance of the pattern
of continual weight gain, has been demonstrated to improve outcomes for adults with
type 2 diabetes , it becomes apparent that the maintenance of weight is critical to the long
term management of the disease .
Both type 2 diabetes and obesity can be viewed as chronic diseases requiring
continuous care. The cornerstones in the management of obesity are weight loss followed
by successful weight maintenance. Because weight loss in overweight patients leads to
improved glycemic control and reduced risk of complications there is significant overlap
in the continuous care models of both type 2 diabetes and obesity. However, current
diabetes treatment regimens do not adequately include weight loss or weight maintenance
as treatment goals. Typically, most individuals can lose weight during a committed
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weight loss phase; unfortunately, most regain lost weight within 3 years. Research
indicates weight loss treatments that emphasize cognitive-behavior techniques, extended
treatment, and relapse prevention training, lead to better weight loss maintenance. Thus,
it would be useful to evaluate the relative efficacy of diabetes programs that strongly
emphasize such weight management interventions.

It should be noted that in the study conducted by the present author, a primary
justification was recognition that the problem of poor weight loss maintenance requires
investigation. Relatedly however, with no clear evidence that a multicomponent
empirically based treatment exists , it was deemed necessary to use the Cooper and
colleagues (2003) manual even though empirical evidence demonstrating its efficac y is
not yet available.
Cooper and colleagues (2003) have undertaken a large scale study to evaluate the
long-term efficacy of their treatment manual in a randomized controlled trial. Because
these data have not been disseminated, this research study is considered a pilot or
feasibility study to evaluate the efficacy of the manual. This pilot study can certainly
enhance the findings of Cooper and colleagues and help establish the feasibility of using
this treatment manual with a subset of the overweight and obese population (i.e., adults
with type 2 diabetes). Teijlingen and Hundley (2001) stated that the complete findings of
pilot studies are rare in the research literature. Often researchers report only what they
learned from the pilot study and not many details. They suggested much can be learned
regarding processes and outcomes from both the successful and failed pilot study.
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Upon contact of Dr. Cooper, one of the manual authors, it was found that they will
be disseminating the findings in a paper presentation at the World Congress of
Behavioural and Cognitive Therapies in Barcelona, Spain in July, 2007. Unfortunately,
she is unable to disclose the findings before the conference (personal communication ,
June 20, 2007).
The authors developed the treatment manual based on extensive successful
experience in treating eating disorders. They became aware that some of the problems
that are successfully addressed in the context of treating bulimia nervosa and anorexia
nervosa were also relevant to patients with obesity. Issues included binge eating ,
dissatisfaction with body shape and weight, and issues concernin g control over eating .
The y were also aware of the problems with existing obesity treatments , particularl y the
problem of weight regain after successful weight loss. With careful clinical observat ion,
the theory of the psychological processes involved in weight regain was developed and
then gradually the treatment protocol in the manual was fully developed.
The present study specifically examined the efficacy of successively adding selfmonitoring/assessment and cognitive-behavioral treatments to standard care-as-usual to
improve the range of diabetes outcomes including: BMI, HbA 1c, diabetes-specific quality
of life, and diabetes-specific self-efficacy .
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CHAPTER III
METHODS

Participants

Participants were recruited by conducting physician presentations during monthly
physician meetings at the 7 participating University of Utah Community Medical Clinics
(Appendix A). Flyers were displayed in clinic waiting rooms and in treatment rooms
(Appendix B). Public service announcements were made on three local radio stations and
run over the course of 2 months (Appendix C).
Physicians were given business cards with the researcher name and phone number
and were asked to refer patients to the study. Flyers provided a brief description of the
study, participant requirements (i.e., type 2 diabetes diagnosis and BMI 2: 27), and
information about ways to contact the researcher by phone. The newspaper ad was
similar in that it provided a brief description of the intervention , participant requirements ,
and a researcher phone number.
Participants who contacted the researcher and who met inclusion criteria: (a) a
diagnosis of type 2 diabetes, (b) a BMI 2: 27, (c) secure permission from physician to
participate in study where they might lose weight and increase activity level (Appendix I),
and (d) ability to commit to participation in a 12-week study, were invited to participate
in the study. Participants were then scheduled for an initial intake appointment. Fiftyfour participants who contacted the researcher by phone were found eligible to participate
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in the study. Two potential participants were not eligible for the study because they did
not have a diagnosis of type 2 diabetes.
Upon arrival, for this first meeting with researchers, all subjects were given a
consent form that detailed all necessary information for them to make an informed
decision regarding their participation . During this appointment, participants were
informed that the process would take approximately 1 hour and all agreed to complete the
consent forms and the three outcome measures. Once informed consent procedures were
finished, the participants completed the initial assessment measures and had their weight
and height measured to calculate BMI. Initial assessment measures included having
blood drawn at the hospital lab or signing a release of information for current HbA 1c
measure (taken within prior 2 weeks) and for the researchers to have access to their final
HbA 1c measure. The subjects also completed two self-report measures including: a
diabetes specific quality of life (QOL) measure, a general measure of QOL embedded in
the diabetes specific QOL measure, and a measure of diabetes-related psychosocial selfefficacy, all three of which are described in the measures section below. The subjects
were then randomly assigned to their respective groups and told they would again
complete the outcome measures in 12 weeks. Participants assigned to the CB treatment
group were scheduled for an appointment the following week. Paiticipants in the control
group were told they would be contacted in 12 weeks for the next appointment.

All

participants were informed that they would be contacted for a 2-month follow-up
appointment after the 12-week intervention to measure their weight and BMI only.
An agreement was reached with the Utah Health Research Network (UHRN), the
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committee approving research at the University of Utah Community Clinics (Appendix
J). The committee would grant access to the community clinic patients if researchers

would hold the treatment appointments at each participant's respective clinic. The
UHRN had concerns about potentially losing patients to the Utah Diabetes Center (UDC),
the site which was originally planned to conduct the study. They were concerned that
patients might transfer their care to physicians at the UDC. They also had concerns about
the cost of transportation for patients living longer distances from the UDC. The
participants were scheduled for the initial assessment appointment.
The size of this study was limited by the number of therapist hours available for
individual sessions in the Cognitive Behavioral (CB) treatme nt group. It was determined
that a maximum number of 27 participants per group (N

= 54) would be enrolled

in the

study. A power analysis was calculated in order to determine what power the study
would have in identifying a significant interaction effect. A repeated measures power
analysis calculated that in order to obtain power of .8 with a sample size of 54 and an
alpha level of 0.05, effect sizes of .43 for the main time by group interaction would be
expected .

Design

This study featured a two-group randomized controlled design, including a waitlist comparison group, with pretest-posttest assessment points. The relative contributions
of successively adding self-monitoring and a manualized CB treatment to a care-as-usual
(CAU) approach to weight loss in adults with type 2 diabetes was examined in the study.
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Participants were randomly assigned to one of two groups: (a) the CB+CAU intervention
or (b) the standard CAU intervention group . Participants in the CB intervention group
were provided manualized treatment for the reduction of BMI based on the CognitiveBehavioral Treatment of Obesity manual (Cooper et al., 2003).
Directly addressing the body weight issues by examining the efficacy of a
cognitive-behavioral treatment for obesity was of fundamental interest. The CB treatment
needed to be contrasted with contemporary standards of care, for example, care-as-usual,
to assess whether treatment augmented the effectiveness of usual care. Thus, a CAU
group served as the reference group for the CB intervention. A true control group
involving no intervention was not practical because the American Diabetic Association
directs physicians to address issues of overweight and obesity in their patients with type 2
diabetes.
With regard to the outcome measures, assessment points varied depending on the
measure and these time points are delineated in Table 2 below . In effect, for the primary
outcome measures of BMI and weight, a 2 (group) by 3 (time) design was applied. For
the secondary outcome measures (HbA 1c, DCP, SF-36, and DAQ) a 2 (group) by 2 (time)
design was applied. The strength of this design is that only the posttest change scores of
the intervention group were attributed to the effects of treatment.

The comparison group

would control extraneous variables that may have brought change in scores due to reasons
other than the actual treatment. The comparison group also allows for better assessment
of treatment efficacy because comparison groups represent what might occur in clinical
practice (Douketis et al., 2005).
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Table 2

Assessment Time Points of Outcome Measures
Outcome
measures

BMI
Weight
Hbalc
DCP/SF-36
DAQ

Assessment time points
Baseline
time point 1
X
X
X
X
X

Treatment end
time point 2
X
X
X
X
X

2-month
follow-up
time point 3
X
X

During the intake appointment, participants were randomly assigned to either the
treatment group or the comparison group. A set of 54 random numbers was generated by
the author using a website that provided a random number generator. The website,
randomizer.org, uses the "Math.random" method within the JavaScript programming
language to generate its random numbers (Urbaniak, & Prous, 2007). Participant names
were recorded on a master list and those participants identified as random number 1 to 27
were assigned to the treatment group and random number 28 to 54 were assigned to the
comparison group. The comparison group was constructed as a waitlist group, which
underwent an equivalent treatment as soon as the treatment group had completed the
intervention. By the end of treatment both the treatment and control group had 7
participants withdraw . Participants were informed that individuals who completed the
study would have their names entered in a drawing for a $100 cash prize at the end of the
intervention .
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Procedure

Cognitive-Behavioral Treatment
During the intake session, each participant was given a food diary, a calorie-count
reference book, a pedometer, and written instructions to record all food consumed, calorie
content of food, and daily steps. Participants were also told to not change food intake or
activity for first week in order to get a baseline measure of a typical week of food intake
and activity.
The intervention consisted of 12 weekly individual cognitive-behavioral treatment
sessions. Each session was approximately 45minutes in length. Treatment consisted of a
12-week cognitive-behavioral treatment module , which is outlined in Appendix D.
During the treatment module, participants met individually with a treatment provider
once a week to complete the current week's agenda topics .
The treatment providers were two upper-level doctoral students in psychology.
One of the doctoral students was also the author of this study. The author provided
treatment to 16 (80%) participants and the second student treatment provider provided
treatment to 4 (20%) participants. The treatment modules are described in detail in the
manual, therefore the students completed a thorough review of the manual and became
well-versed in the procedures . A mock treatment session was conducted prior to
commencement of the treatment study and the student researchers were evaluated for
adequacy of implementing a treatment module by each other and a research assistant.
During an actual treatment session, both student researchers were assessed for treatment
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integrity by each other and a research assistant every 4 weeks. An outline of the session
was provided to the evaluators and adherence to the outline was discussed after the
treatment session . Any needed adjustments were made to ensure the student investigators
implemented the manualized treatment appropriately.
Each treatment session followed a basic outline which included: (a) weighing the
patient and recording weight; (b) jointly review self-monitoring records; (c) setting
agenda for session collaboratively ; (d) working through agenda topics; (e) agreement on
homework assignments, and; (f) summary of the session . While the collaboration on
creating an agenda allowed participants to include personally relevant issues, the bulk of
the agenda consisted of the cognitive-beh avioral treatment focus for that session.
Once per week , a research assistant called partic ipants to gather the food and daily
steps data. This procedure was implemented to address the likelihood of recall bias
inherent in retroactive reporting, which is known to decrease accuracy of self-report
records (Jain, 2004).
The student researcher collected this data via phone calls using a phone script that
is included in Appendix E. The student researcher received training regarding what
questions to ask and was coached in how to ask and/or refer questions from participants
regarding research participation. Participants were instructed to submit their food and
exercise record at the end of the study.

Care-as-usual (CA U) Treatment Within Comparison
and Treatment Groups
Participants in both groups received the CAU treatment and complete d all pre-
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posttest evaluations . None of the elements of the CAU treatment were influenced or
managed by the present investigator, because this "treatment" represents contemporary
medical practice for type 2 diabetes as it naturally occurs in regional clinics. That is, it
represents physicians' clinical judgment regarding how they should implement
recommendations of the American Diabetic Association regarding type 2 diabetes
treatment. Therefore this treatment may have included physician referral to a nutritionist ,
referral to additional education classes that may include weight loss treatment , or direct
management by the physician of weight loss treatment. However, it is possible that no
weight loss treatment will be initiated by the physician. Because physician-directed
weight loss treatment or patient referral is idiosyncratic, the present investigators offer no
clear description of weight loss treatments in the CAU intervention . Also, physicians
who provided care as usual were "blind" to assignment of subjects and only gave
participants permission to participate in a weight loss treatment study.
In order to identify if the two groups differed regarding the use of other weight
loss interventions , all participants were asked at both baseline and treatment end if they
were engaging in any weight loss activities or taking any weight loss medications. All
participants reported no current weight loss activities other than participation in this study
and no use of weight loss medications.
Participants in the comparison group completed the initial assessment and were
then told they had been placed on a waiting list. They were instructed to return in 12
weeks to complete the post intervention measures which are described below. Upon
completion of th~ 12-week intervention all participants completed two post-treatment
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self-report measures, had BMI measured and provided the results of the HbA 1c measure.
Initially the research design included three groups: the cognitive-behavioral
intervention, the monitoring-only intervention and the care-as-usual wait list group.
During the early stages of enrollment, 8 participants had been randomly assigned to the
monitoring-only

group. However, within three weeks, two participants dropped out and

the investigator discovered that three other participants were not completing their
monitoring records. When briefly interviewed, these five participants reported the
monitoring was too time consuming.

The three participants not completing records

subsequently dropped out of the study leaving three participants enrolled in the
monitoring-only

intervention group. Therefore, due to slow rates of enrollment, high

initial attrition, and low adherence in the monitoring-only

group, the decision was made

to omit the monitoring group from the research design. Thus, two remaining
comparisons groups were the cognitive-behavioral

treatment group and the wait-list

group. This left only one participant in the study from the monitoring-only
last monitoring-only

participant was moved to the cognitive-behavioral

group. This

treatment group.

Because of the limited client hours available, the number of participants enlisted
in the CB group could not be increased. It was determined that 27 participants could be
enrolled in the CB treatment group, thus changing the total number of stud¥ participants
to 54.
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Materials

Participants in the CB group received a folder with blank food diary pages,
instructions on how to record entries as well as two samples of food diary entries. They
were instructed to bring the folder to the weekly treatment appointments in order to return
diary pages weekly and to place handouts in the folder. Participants were also given a
calorie counting guide and a pedometer to record daily steps. Throughout the study, the
CB group received handouts regarding specific treatment topics discussed in session and
these a:re contained in Appendix F.

Outcome Measures
For clarity, a listing of all outcome variables for this study is provided in Table 3.
The primary outcome measure was body mass index calculated as follows: [weight in
pounds / (height in inches)2] * 703. Secondary measures included changes scores on the
Diabetes Care Profile (DCP), Short-Form 36 (SF-36) and Diabetes Empowerment Scale
DES). These three outcome measures were selected to evaluate the effect of treatment
based on either their widespread use in the literature or their merits as an instrument for
measuring the construct under investigation based on their reliability and validity data as
well as their fit with the needs of the study. These measures are more fully described
below. Two of the three outcome measures were diabetes specific measures which also
assess global functioning of people with diabetes.
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Table 3

Listing of Study Variables : Descriptive and Outcome Variables
Demographic and diabetes-related variables
Demographic variables
Gender
Age
Marital status
Employment status
Annual income
Ethnicity
Diabetes-related variable
Year of diagnosis
Use of oral medications
Use of insulin
Glucose monitoring
Diabetes education
Dr. Advice to follow food plan
Dr. Advice to follow exercise plan
Do you follow a meal plan

Outcome variables
Body Mass Index/weight
HbAlc
Diabetes Care Profile
Understand management
Support needs
Support received
Support attitudes
Control problems
Social and personal factors
Positive attitude
Negative attitude
Care ability
Importance of care
Self-Care adherence
Diet adherence
Long-term care benefits
Exercise barriers
Monitoring barriers
Diabetes Attitude Questionnaire!. Managing psychosocial aspects
of diabetes
II. Dissatisfaction and readiness to
change
III. Setting and achieving
diabetes goals
Short Form-36
Physical function
Role-physical
Bodily pain
General health
Vitality
Social Functioning
Role-emotional
Mental health
Physical component
summary
Mental component summary
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Diabetes Care Profile (DCP)
The DCP is a self-administered questionnaire containing 234 items, which include
demographic information, self-care practices, and 116 questions divided into 15 profile
scales with 4 to 19 questions per scale. It takes approximately 30 to 40 minutes to
complete. The DCP assesses social and psychological factors related to diabetes and its
treatment. The 15 profile scales assess control problems, social and personal factors,
positive attitude, negative attitude, self-care ability, importance of care, self-care
adherence, diet adherence, medical barriers, exercise barriers, monitoring barriers,
understanding management practice , long-term care benefits, support needs, support, and
support attitudes (Appendix G). The item responses on the scales vary between yes/no,
multiple choice and Likert scales. A sample question is "In general , would you say your
health is:" and the question responses include: 1 = excellent, 2 = very good, 3 = good, 4 =
fair, 5 = poor. The 15 primary scales each yield weighted average scores but the DCP
does not yield a total score. Table 4 provides a sample item from each scale, the scoring
ranges, the interpretation of the end points and the number of items for each scale .
Watkins and Connell (2004) reported that investigations of the internal consistency of the
DCP have reported Cronbach's alphas ranging from .60 - .95. The scale reliabilities
range from .68 to .96. The DCP demonstrated significant correlations (2: .30) to support
concurrent and construct validity (Fitzgerald, et al., 1996).

Short-form-36 (SF-36 version 1) Health Survey
Given this study's emphasis on health-related components, it was important to

Table 4

Scoring and Sample Items for the Diabetes Care Profile Scales
Diabetes Care Profile scale
Understanding Management
Practice
Support Needs
Support Received
Support Attitudes
Control Problems

Scoring
Good
Poor
5
1
5
5
5
1

Social and Personal Factors
Positive Attitude
Negative Attitude
Self-care Ability
Importance of Care
Self-Care Adherence
Diet Adherence
Long-Term Care Benefits

l*

Sam_EleItem
How do you rate your understanding of diet for blood sugar control?

6

I want a lot of help and support from my family and friends in following
my mean plan.
My family and friends help and support me a lot to follow my meal plan.
My family and friends accept me and my diabetes.
During the past year, how often have you had changes in your blood sugar
(too high) because you were feeling stressed.
How often has your diabetes kept you from doing your normal daily
activities during the past year?
I feel satisfied with my life
I am afraid of my diabetes.
I am able to keep my blood sugar in good control.
I think it is important for me to keep my blood sugar in good control.
I keep my blood sugar in good control.
How often do you follow a meal plan or diet?
Taking the best possible care of my diabetes will delay or prevent kidney
problems.
How often do you have trouble getting enough exercise because you are
too busy?
When you don't test for sugar as often as you have been told, how often is
it because you forgot?

6
6
5

19

5

13

5

5
6

5

1
5
5
5
5
5

Item (n)
13

4
4
4
4
4

Exercise Barriers

5

5

Monitoring Barriers

5

11

*No prefened score exists for the Support Needs scale because the scale is an assessment (5=needing more support and 1-needing less support)

V,

N
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select a measure that would provide indicators that would take into account physical
aspects as well as psychological adjustment.
A measure of comprehensive health status is the Short Form-36 (SF-36), which
has been used in a variety of studies including those that have studied chronically patients
(Ware, Snow , Kosink & Gandek , 2000). This outcome measure was an embedded
section in the Diabetes Care Profile as Section II (Appendix G). This inventory is
designed to assess the participant's general level of health along eight different
dimensions and asks about changes in these areas over the past month, in addition to
longer time frames . These dimensions include physical functioning, role limitations due
to physical problems, social functioning, bodily pain, general mental health , role
limitations due to emotional problems, vitality, and overall health perception. Two
additional summary scales are derived from the initial eight scales and represent the
findings of factor analytic studies which revealed two distinct clusters. These two scales,
the mental and physical component summary scales, were identified based on the amount
ofrespective physical or mental health variance each of the eight primary scales had in
common (Ware et al.).
All eight primary scales and the two component summary scales were utilized in
this study . The physical functioning scale , consists of 10 items, rated on a 3-point Likert
scale and asks participants about limitations to physical activities due to health (1 = yes,
limited a lot; 2 = yes, limited a little; 3 = no, not limited at all). The total score range of
this scale is from 10-30. The role-physical scale consists of four items rated on a 5-point
Likert scale and asked participants about problems with work and daily activities due to
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health (1 = all of the time, 2 = most of the time, 3 = some of the time, 4 = a little of the
time, 5 = none of the time). The total score range of this scale is from 4-8. The bodily
pain scale consists of two items rated on a 6- and 7-point Liker scale, respectively, and
asked participants about amount of pain over the past 4 weeks (1 = none, 2 = very mild, 3

= mild, 4 = moderate, 5 = severe, 6 = very severe) and limitations due to pain (1 = not at
all, 2 = a little bit, 3 = moderately, 4 = quite a bit , 5 = extremely). The total score range
for this scale is 2-12. The general health scale consists of five items rated on a 5-point
Likert scale asking participants about their perception of their general health (1 =
definitely true, 2 = mostly true, 3 = don't know, 4 = mostly false, 5 = definitely false).
The total score range for this scale is 5-25. The vitality scale consists of four items rated
on a 5-point Likert scale asking participants about the amount of energy they have
experienced over the past month (1 = all of the time, 2 = most of the time, 3 = some of
the time, 4 = a little of the time , 5 = none of the time) . The total score range for this scale
is 4-24. The social functioning scale contains two items on a 5-point Likert scale. The
questions assess the degree to which a participant's physical and emotional difficulties
have interfered with his/her social activitites (question 1; 1 = not at all, 2 = slightly , 3 =
moderately, 4 = quite a bit, 5 = extremely; questions 2; 1 = all of the time, 2 = most of the
time, 3 = some of the time, 4 = a little of the time, 5 = none of the time). The total score
range for this scale is 2-10 . The role-emotional scale consists of three items rated on a 5point Likert scale asking participants the degree to which they have experienced problems
with work or other daily activities as a result of emotional problems (1 = all of the time, 2

= most of the time, 3 = some of the time, 4 = a little of the time, 5 = none of the time).
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The score range for this scale is 3-6. The final primary scale is the mental health scale,
which contains five items and is rated on a 5-point Likert scale and asks participants to
what extent they believe their mental health has improved over time (1 = all of the time,
2 = most of the time, 3 = some of the time, 4 = a little of the time, 5 = none of the time).
The total score range for this scale is 5-30 .

In studies ofreliability, the SF-36 has shown to have test-retest reliability ranging
from .43 to .90 (Ware et al., 2002) . Internal consistency studies using Cronbach's alpha
have shown median reliability coefficients equal to or exceeding .80. All eight primary
SF-36 scales as well as the two component summary scales were utilized as outcomes in
this study. In a psychometric and clinical test of validity conducted by McHomey, Ware ,
and Raczek (I 993 ), seven of the eight scales demonstrated strong construct validity (r2:
0.70).

Diabetes Empowerment Scal e (DES)
The DES is a self-administered 28-item questionnaire (Appendix H). The DES
questions cover general demographic infonnation such as age and gender as well as
diabetes-related psychosocial self-efficacy . Most items contain a 5-point Likert scale
asking participants to the degree to which they agree with statements (I = strongly agree,
2 = agree, 3 = neutral, 4

=

disagree, 5 = strongly disagree) . A sample question is "In

general, I believe that I know what part of taking care of my diabetes I am ready to
change".
The DES has demonstrated adequate construct validity with correlation
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coefficients ranging from .32-.59. The DES has sufficient test-retest reliability
correlation of .79 (Anderson, Fitzgerald, Funnell & Marrero, 2000).
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CHAPTER IV
RESULTS

Patient Variables

Fifty-four individuals who met the criteria for inclusion in this study completed
the intake process including the consent form, the two initial surveys, and measurement
of weight to calculate BMI. All individuals obtained written physician approval to
participate in the study and either recently completed an HbA 1c blood test or agreed to
return to their primary care physician to have the blood test done. Twenty of the 27
participants assigned to the treatment group completed the posttreatment assessment.
Also, 20 of the 27 participants assigned to the control group completed the posttreatment
assessment. This 26% attrition rate is within the range of attrition rates reported in other
weight-loss treatment studies (Grave et al., 2005).

Preliminary Analyses

Demograhic Variables
For convenience, a list of all descriptive and outcome variables are provided in
Table 3. To determine if the control and treatment groups were equivalent at pretest,
descriptive statistics were computed for demographic variables including: age, gender,
marital status, ethnicity, education, employment, annual income, insurance, living
arrangements and number of people living with participant. Diabetes-specific variables
were also collected including years since diagnosis, use of oral medications; use of
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insulin; weekly glucose monitoring; receipt of formal diabetes education; advice from
health care providers to follow exercise or meal plan and; actually following a food plan.
Independent sample t tests were utilized for continuous variables and

-1analyses

for dichotomous variables. Refer to Table 5 for the results of these analyses. Not all
variables initially qualified for

-1analysis due to several variables yielding empty cells.

Categories were collapsed to the degree needed for the variable to yield a minimum cell
count for the analysis.
The mean ages of the treatment and control groups were not significantly different
(treatment group x =55.95; control group x = 50.50; p = .160). Gender distribution was
equal between groups with 90% female and 10% male in both groups. Marital status was
also equivalent in groups with 50% of the treatment group reporting being manied versus
60% in the control group.
With regard to ethnicity, 90% of the treatment group paiiicipants were white as
were 70% of the control group. However, this percentage was not statistically significant
(p= .114).
A majority of the participants in both the control group and the treatment group
reported attending some college (85% and 75%, respectively). The control group also
reported more participants as employed full-time (55%) while the treatment group
reported 35% working full-time . This difference was not statistically significant (p =
.059). There was, however, no notable or significant differences between categories of
income for groups (p = .112).
When considering the participants living anangements, almost all lived in a home

Table 5
Demographic Variables on All Parti cipants (N=46)

Variable
Age, yrs
Years since diagnosis

Variable

Treatment
mean (SD)
{n = 20)
55.95 (8.781)
5.75 {4.983)
Treatment
percent
(n = 20)

Control
mean (SD)
(n = 20)
50.50 (14.54 8)
6.60 (3.926)
Control
percent
(n = 20)

Gender
Female
Male
Marital Status
Married
Not Married
Ethnicity
White
Other
Education
High school grad/GED
Some college/graduate
Current Employment Status
Work full-time 35+ hr
Work part-time <35 hr
Other

90.0
10.0

90.0
10.0

50.0
50.0

60.0
40 .0

90.0
10.0
25.0
75.0
35.0
35.0
30.0

t ratio
1.434
0.599

p_value
0.160
0.553

.000

P..value
1.000

Degrees of
freedom
1

.404

.525

1

2.500

.114

1

.625

.429

1

5.675

.059

2

2

X

70.0
30.0
15.0
85.0
55.0
5.0
40 .0
(table continues)
Vl

\0

Variable

Treatment
percent
(n = 20)

Control
percent
(n = 20)

Income
Less than $19,999
$40,000 - $49,999
$50,000 and over
Living arrangements
Home or Apt
Other
Number of people living with you
1-2 person
2.3 persons

Diabetes-specific variable
Insulin
¾Yes
Diabetes pills
¾Yes
Diabetes education
¾Yes

25.0
25.0
50.0

5.0
50.0
45.0

95.0
5.0

95.0
5.0

50.0
50.0
Treatment
percent
(n = 24)

55.0
45.0
Control
percent
(n = 22)

25.0

25.0

90.0
80.0

l

P..value

4.386

.112

Degrees of
freedom
2

.000

1.00

1

1.00

.752

1

.000

1.000

1

.588

.560

1

.370

.714

1

95.0
75.0
(table continues)

°'
0

Diabetes-specific variable
Health care provider advise to meal
plan
%Yes
Health care provider advise to
exercise
%Yes
Follow a meal plan
Never-sometimes
Sometimes-always
Do you test your blood sugar?
%Yes
Days per week test blood sugar
None-3
4-7
Times per day
0-1
2-4
Significant p value :S.05

Treatment
percent
(n = 20)

Control
percent
(n = 20)

85.0

60.0

80.0

75.0

55.0
45.0

55.0
45.0

90.0
25.0
75.0
40.0
60.0

I

p value

Degrees of
freedom

3.135

.077

1

.143

.705

1

.000

1.000

1

2.105

.147

1

.000

1.000

1

.102

.749

1

100.0
25.0
75.0
45.0
55.0

0\
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or an apartment (95% treatment; 95% control). In regard to number of people living with
participants, groups were relatively equal with 50% of treatment participants and 55% of
control participants living with 0-2 people (p = .752). Again, the difference between
groups regarding living arrangements was not significant (p = .291). All participants
reported being insured. The majority of participants were insured under a group plan
In tenns of diabetes-specific variables, the mean number of years diagnosed with
diabetes was reported as 5.75 years for the treatment group and 6.60 years for the control
group (p = .553; d = .850) . Most participants reported receiving formal diabetes
education (80% treatment; 7 5% control; p = .714 ).
Most participants in both groups also reported testing their blood sugar i.e., 75%
of the treatment group and the control group repo1iedly tested 4-7 days per week. A
much smaller number repo1ied testing either zero to three times (25% both treatment and
control; p = 1.000). The majority in both groups tested their blood sugar 2-4 times per
day (40% treatment; 45% control;p = .749). An equal number of participants in both
groups reported using insulin to control blood sugar levels (25% treatment ; 25% control).
While a smaller number of participants reported using insulin, the vast majority reported
taking an oral medication to control blood sugar (90% treatment; 95% control: p = .560) .
The majority of both treatment and control groups reported their health care
provider had advised them to exercise (80% treatment; 75% control;p

= .705).

Similarly, the majority of both treatment and contro l groups reported their health care
provider had advised them to follow a meal plan (85% treatment; 60% control; p = .077).
While not statistically significant, it is notable that a slim majority of controls compared
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to the treatment group subjects reported they have been advised to follow a food plan.
Finally, 55% of both the control group and treatment group reported they never
follow a food plan.
Overall, there are no major differences between the treatment and control group in
tenns of demographic variables, both in general and diabetes-specific variables. No
statistical differences between groups in regard to demographic variables were found . It
is then assumed that the blind random assignment of subjects to groups was adequate in
creating equivalent groups in regard to demographic variables . Additionally, it is
important to note that during the intake procedures participants were asked if they were
currently participating in any type of weight loss activity or currently taking any weight
loss medications . All participants reported they were not currently participating in weight
loss activities nor were they taking medications .

Outcome Variables
Independent sample t-tests were conducted for baseline mean scores on all
outcome variables to determine equivalence between groups. For reference, Table 3
provides a comprehensive list of all outcome variables . Results of the independent
sample t-tests are provided in Tables 6, 7, 8, and 9 below. Groups were found to be
equivalent at baseline on all outcome measures except HbA1cand the Diet Adherence
(DA) subscale of the Diabetes Care Profile.
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Table 6

Independent t Comparisons for BML Weight, and HbA1cOutcome Variables (N = 40)
Baseline t

p-value

BMI

.322

.749

Weight

.261

.796

HbA 1c

2.156

.037*

Measure

*Significant p value s .05

Table 7

Ind ependent t Comparisons for Diabetes Care Profile Scales (N = 40)
Measure
Section IV
Understanding Management Practice
Section V
Support Needs
Support Received
Support Attitudes
Section VI
Control Problems
Section VII. Social and Personal Factors
Section VIII
Positive Attitude
Negative Attitude
Self-care Ability
Importance of Care
Self-care Adherence
Section IX Diet Adherence
Section X
Long-term Care Benefits
Section XI
Exercise Barriers
Section XII
Monitoring Barriers
*Significant p value s.05

Baseline t

p-value

-.213

.832

-.299
-.470
1.133

.767
.641
.265

.678
-.865

.502
.393

.473
-1.268
.305
.583
.266
-3.252

.639
.213
.762
.563
.792
.002*

1.694

.098

1.086

.284

-.404

.689
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Table 8
Independent t Comparisons for Short Form 36 Scales (N = 40)

Measure
Physical Function
Role-Physical
Bodily Pain
General Health
Vitality
Social Functioning
Role-emotional
Mental Health
Physical component
summary
Mental component
summary
*Significantp value

Baseline t
.550
.420
-.495
1.098
-.949
-1.776
-.646

p-value
.912
.585
.677
.624
.279
.349
.084
.522

.411

.684

-1.105

.276

.111

:'.S.05

Table 9
Independent t Comparisons for Diabetes Empowerment Scale (N = 40)
Measure
Managing psychosocial
aspects of diabetes
Assessing dissatisfaction
readiness to change
Setting/achieving diabetes
goals
*Significant p value :'.S.05

Baseline t

p-value

-.128

.898

.571

.571

-.602

.551
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Individual HbA 1c scores were converted to z-scores in order to identify outliers.
The z-scores for cases with an absolute value of 3 are considered outliers and two cases
were identified. These two scores were then converted to M +3SD in order to pull in the
outliers so as not cause violations of normal distribution.

Independent sample t-tests were

again conducted and it was found that the groups were still not equivalent (t = 2.156, p

=

.037) . HbA 1c is an average of blood glucose levels over a 2-3 month period (as described
in Chapter I). Therefore HbA 1c was used as a covariate in the remaining analyses of
outcome variables.
The independent t test for the Diet Adherence subscale showed a significant
difference at baseline (t = -3.252,p = .002), indicating that the two groups were not
equivalent at the outset as the treatment group reported higher scores on this measure
initially . The Diet Adherence scale represented a central theme in the outcome of this
study. Therefore, this variable was of importance and was controlled in the data analysis,
but did not yield any changes in statistical significance of any of the outcome measures .

Primary Analys .es

In order to identify differential effects between the two treatment providers,
therapist was coded as a covariate and then included in the analysis. No significant
differences were found between the two treatment providers on any outcome variables .
The results of the primary research questions posed in this study are presented
below. These four questions seek to quantify change in regard to participants BMI,
weight, Hbalc, diabetes-specific quality of life (Diabetes Care Profile-DCP) and diabetes-
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specific self-efficacy (Diabetes Empowerment Scale-DES). All outcome measures except
BMI and weight were assessed at both baseline and treatment end. BMI and weight were
assessed at baseline, treatment end and at a 2-month follow-up. Thus the treatment
design for Hbalc, DCP and DES was a 2 (group) by 2 (time) design and the treatment
design for BMI was a 2 (group) by 3 (time) design. The research design utilized a
randomized controlled pretest-posttest control group experimental treatment with
repeated measures.
Statistical analyses were conducted using repeated measures factorial ANOV A for
each variable to determine whether effects existed by either time , group or time by group
interaction . For BMI and weight , a 2 by 3 AN OVA was applied and for HbA 1c, DCP,
SF-36 and DES, a 2 by 2 ANOVA was applied . The fact that a repeated measures design
was utilized allowed for measurement of outcomes for both the treatment and control
groups both at time 1 (baseline), prior to the start of the intervention , as well as at time 2
(following the intervention for the treatment group and following the waiting period of
care-as-usual for the control group) and time 3 (2-month follow up measure of BMI and
weight only). As mentioned in the preliminary analysis section, results indicated that
groups were not equivalent at pre-test for HbA 1c and Diet Adherence subscale, therefore,
all analyses were conducted using HbA 1c and Diet Adherence subscale as covariates.
In addition, descriptive statistics including means and standard deviations were
calculated. In addition change scores were calculated as well as effect sizes to capture the
magnitude of change for both treatment and control groups at baseline, treatment end and
follow-up for BMI and weight. For all other outcome variables, results are reported for
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baseline and treatment end. The effect size was calculated using a modification of
Glass's guidelines for calculating d based on the need to devise a common denominator
for the treatment and control group. The following formula was used:
~1-X2

(S1 + S2 + S3 + S4)
Cohen's effect size categorization system (1988) was used for comparing effect"
sizes with .20 for "small" effect, .50 as "medium" effect and .80 as "large" effect.

Description of Tables

In Tables 10 and 11 the BMI and weight results are listed . Table 10 includes the
means and standard deviations for the treatment and control groups at baseline (Tl),
treatment end (T2) and follow-up (T3) . Table 11 displays the repeated measures
ANOV A for the three time points including the respective F, p-values and eta 2 values for
time, group and time-by-group interactions . The eta 2 statistic is an effect size calculated
in relation to the repeated measures ANOV A. The final two columns of this table report
the results of the simple contrasts for time between Tl vs. T3 and T2 vs. T3. All
statistically significant scores at the p < .05 level are highlighted by asterisks . For
convenience, results of the HbA 1c analyses are included in Tables 10 and 11 although it
was not measured at follow-up (T3).
Results for the three instruments (which include the remaining outcome variables)
utilized in this study (DCP, SF-36, DES) are presented in separate tables in this section.
There are two tables per measure. The first table for each measure lists the name of the

Table 10
Baseline, Treatment End and 2-month Follow--up, Mean and Standard Deviations(SD)for Body Mass Index, Weight and HbA1c
Outcome Variables (N = 40)

Measure

BMI
Weight
HbA1c

· Baseline (Tl)
Ml(SD)
37.724
(9.011)
229.20
(59.849)
6.415 .
(1.075)

Treatment End
(T2) Ml(SD)
36.556
(8.842)
222.00
(58.447)
6.455
(l.01~2__

2-month
Follow-up (T3)
M/(SD)
36.590
(8.735)
222.25
(57.837)

Baseline (Tl)
M/(SD)
38.685
(9.841)
234.00
(56.459)
7.490
(2.025)

Treatment End
(T2) M/(SD)
38.887
(9.532)
234.90
(55.585)
7.390
(1.926)

2-month
Follow-up
(T3) M/(SD)
38.890
(9.536)
235.25
(54.678)

0\
\0

Table 11
ANOVA Results and Simple Contrasts of BMI, Weight and HbA 1c Outcome Variables (N=40)
Sim12leContrasts for Time
T2 vs. T3
Tl vs. T2

ANOV A Results

Time
Measure

F(p)

Partial
Eta 2

Treatment
Group

F(p)

Partial
Eta 2

Timex
Group

F(p)

Partial
Eta 2

F (p)
16.766
(.000)*
16.024
(.000)*

Partial
Eta 2

F (p)
.102a
(.751)
.01la
(.917)

.850
.906
13.190
(.432)
.318
.023
(.414)
(.000)*
.268
.051
.514
.949
11.346
Weight
(.600)
.014
(.397)
(.001)*
.240
.308
.053
1.247
.008
1.563
HbA1c
(.27_1)
.033
.000
(.219)
.041
(.9322
*Significant p-value < .05 (Dunn's procedure-adjusted familywise error rate: significant if p-value < .03)
Scheffe adjustments for simple contrasts: F > 4.3
(Tl= Baseline, T2 = Treatment End, T3 = 2-month Follow-up)
aNonsignificant results expected and represents desired outcome of no change in weight and BMI during maintenance.
BMI

Partial
eta 2
.003
.000

--J
0
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outcome variable analyzed, followed by the means, standard deviations, change scores
and effect sizes for both the treatment and control groups at baseline (Tl) and treatment
end (T2). Table 10 displays the results of the repeated measures ANOVA for Tl and T2
including the respective F, p values, and effect sizes for time, group, and time-by-group
interactions. All statistically significant scores at the p < .05 level are highlighted by
asterisks.

Statistical Outcomes for BMI, Weight, and HbA 1c

BM! and Weight Outcomes
Research question 1 was posed as follows: Does a cognitive-behavioral treatment
added to standard care-as-usual lead to a decrease in BMI and weight? The Body Mass
Index (BMI) (as described in detail in Chapter II) is a ratio of weight and height. Figure 1
represents graphically the difference between groups on the BMI outcome between
baseline (Time l=Tl), Treatment end (Time 2=T2) and 2-month follow-up (Time 3=T3).
Because groups were not equivalent at baseline for HbA 1c, it was included in the analysis
as a control variable. A significant difference was found between treatment and control
groups for BMI (F = 21.711, p = .000) and is reported in Table 11. In order to adjust the
familywise error rate for the multiple simple main effects, Dunn's procedure was utilized.
Simple main effects were found to be significant on the adjusted alpha level of .03.
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F igure I. Body Mass Index time by group interaction .

Two months following completion of the 12-week intervention for the treatment group,
both groups were again measured only on the BMI and weight outcome variables. The
most significant change occurred between baseline and treatment end for both BMI and
weight loss (treatment participants: average weight loss 7.2 pounds ; control group :
average weight gain .9 pounds). However , the simple contrasts for time revealed that the
effects did not significantly diminish between treatment end and follow-up . Treatment
participants gained an average of .25 pounds and the control group remained the same.
Neither the change in weight nor BMI between treatment end and follow-up were
significant (weight F = .154, p = .696, BMI F = .093, p = .762). It is important to note
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no change in the weight and BMI variables was the anticipated treatment group outcome
during the follow-up /maintenance period. In order to account for actual group differences,
simple contrasts were again calculated for each group separately and reported in Table 8.
Both BMI and weight outcomes for the treatment group were statistically significant at
treatment end (T2) and the effects were sustained through follow-up (T3). A familywise
error adjustment was calculated for the simp le contrasts using the Scheffe adjustment. With
this procedure, the F-test of a simple contrast is significant if F exceeds
4.3 which was calculated using the foliowing formula:
(dfl * F(alpha; dfl; df2)) / df3
In order to understand the magnitude of any differences between the two groups at
baseline and follow-up, effect sizes was calculated for all scores and reported as partial
eta2. According to Glass's categorizations, the effect size for both BMI (.27) and weight
(.24) was "small" in the time by group condition.
HbA 1cOutcomes
Research question 2 was posed as follows: Does a cognitive-behavioral treatment
added to standard care-as-usual improve glycemic control as measured by HbA I c? HbA le
mean scores, while not equivalent at pretest (treatment= 6.415, control = 7.520), showed
no statistical significance at posttest (treatment= 6.455, control= 7.390) . (F = 1.563, p =
.213). Results of HbA 1c analysis are included in Table 10 and 11. However, two
participants in the control group had pretest HbA 1c levels above 12 which indicated very
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participant was hospitalized for several weeks and her score decreased at posttest by 2.3,
a much larger change than any other participant score. The other participant score
remained unchanged. As mentioned above, all analyses were conducted with the
baseline HbA 1c controlled as a covariate.

Diabetes Care Profile and Short Form-36 Outcomes
Research question 3 was posed as follows: Does a cognitive-behavioral treatment
added to standard care-as-usual change diabetes-specific quality of life as measured by
the Diabetes Care Profile and Short Fonn-36? Another outcome of interest was whether
the intervention had an impact on diabetes-related quality of life as assessed by change
scores in the Diabetes Care Profile (DCP). The DCP is used to assess social and
psychological factors related to diabetes and its treatment. The DCP contains 15 primary
scales that yield 15 weighted average scores but does not yield a total score. Only the
scales with significant results will be discussed below.
A repeated measures analysis of variables was conducted to determine if any
change in scores between groups was statistically significant. Results of the DCP are
displayed in Table 12 and 13. The repeated measures analyses of the DCP variables
showed the change in scores did not reach statistical significance . However , the
treatment group means scores on the DCP subscales did show improvement between
baseline and follow-up. In fact, 12 of the 15 subscales showed an improvement in that
nonsignificant results between treatment end and 2-month follow-up (T2 vs. T3) were
expected. The treatment group was to intentionally maintain weight loss and thus

Table 12
Baseline, Follow-up , M ean(SD) and Change Scores for Diab etes Care Profile Outcome Variables (N = 40)
Control Group (n = 20)

Treatment Group (n = 20)
Baseline
Ml(SD)

Follow-up
Ml(SD)

Pre-Post
Change/(d)

Baseline
M/(SD)

Follow-up
Ml(SD)

Pre-Post
Change/(d)

2.38 (1.57)

2.88 (1.38)

-0.50/-0.34

2.28 (1.55)

3.04 (1.58)

-0.77 /-0.49

3.33 (1.18)
2 .83 (1.08)
3.63 (0.68)

3.70 (1.16)
3.34 (1.34)

-0.37 /-0.32
-0.53/-0.42

3.73 (0.82)

3.12 (1.37)
2.41 (1.45)
4.00 (0.76)

0.10/0.08
0.22/0.26
-0.084/-0 . l 0

2.11 (0.96)

2.31 (0.92)

-0.09/"0. l 2
-0.23/-0 .23

3.22 (1.20)
2.63 (1.57)
3.92 (0.9)
2.28 (0.78)

2.15(0.71)

0.14/0.19

2.66 (0.81)

2.41 (0.72)

0.26/0 .33

2.43 (0.85)

2.34 (0.86)

0.09/0.10

Positive Attitude

2.93 (0.82)

3.10 (0.89)

-0.17/-0.20

3.06 (0.92)

3.18 (0.82)

-0 .12/-0.14

Negative Attitude

2.98 (0.96)

2.73 (0.89)

0.25/0.27

2.63 (0.77)

2.58 (1.04)

0.042/0.05

Self-care ability
Importance of Care

2.56 (0.70)

3.13 (0.72)

2.93 (0.87)

-0 .29/-0 .34

4.40 (0.64)

-0.56/-0.80
0.13/0 .22

2.64 (0.85)

4.53 (0.52)

4.63 (0.56)

4.49 (0 .50)

Self-care Adherence

• 2.78 (0.65)

3.18(0.68)

-0.13/-0 .61

2.84 (0.65)

3.10 (0.82)

0.13/0.26
-0.26/-0.35

2.9i (0.84)

-0.68/-0.75

1.24 (0.98)

1.94 (1.27)

4.66 (0.658)
2.29 (0.78)

-0.31/-0.35
0.34/0.45

4.79 (0.40)
2.91 (0.88)

4.66 (0.43)
2.67 (0.83)

t59 co.88)

0.237/0.25

_ _J_._71_(0
.69)

1.66 (0.90)

Measure
Section IV. Understanding
Management Practice
Section V
Support Needs
Support Received
Support Attitudes
Section VI Control Problems
Section VII. Social and Personal
Factors
Section VIII

Section IX Diet Adherence
Section X. Long-term Care Benefits

2.23 (0.97)
4.35 (1.04)

Section XI. Exercise Barriers

2.63 (0.740)

Section XII Monitorin!i; Barrier_§__ _

_!_.~3(0.93) ___

-0.70/-0.62
0.13/.31
0 .24/0.28
0.24/0.07

*Significant p-value :S.05

-.J
V1

Table 13

ANOVA Results for Diabetes Care Profile Outcome Variables (N = 40)
ANOV A Results
Treatment Group
Partial
Eta 2
F(e)

Time F(e)

Partial
Eta 2

.931 (.341)

.025

.010 (.922)

.001

.641 (.429)

.017

Support Needs

.502 (.483)

.000

.230 (.635)

.006

1.945 (.172)
1.437 (.238)
2.717 (.108)

.014
.051
.038
.070

.006 (.941)

Support Received

.286 (.600)
1.702 (.209)
.394 (.539)

.017
.091
.023

.580 (.450)
.013 (.911)
1.169 (.287)

.016
.000
.031

.006 (.940)

.000

.046 (.834)

.003

.684 (.414)

.0 19

1.156 (.289)

.031
.226

2.164 (.160)
10.432 (.005)*

.238 (.629)
.246 (.623)

.007
.007

.038
.096
.035

1.107 (.307)
3.517 (.078)
1.289 (.272)
5.086 (.037)*

.113
.380
.061

.714 (.404)

.171
.070

.035 (.852)
.172 (.681)
.086 (.772)

.019
.001
.005
.002

Section IV. Understanding
Management Practice

Time

X

~roue F(e)

Partial
Eta 2

Section V

Support Attitudes
Section VI. Control Problems
Section VII. Social and Personal
Factors
Section VIII
Positive Attitude
Negative Attitude
Self-care Ability
Importance of Care
Self-care Adherence
Section IX Diet Adherence
Section X. Long-term Care Benefits
Section XI. Exercise Barriers
Section XII Monitoring Barriers

10.494 (.003)*
1.405
3.833
1.321
2.256

(.244)
(.058)
(.258)
(.142)

.881 (.354)
.078 (.782)
.019 (.891)

.057
.023
.002
.001

.387 (.542)
2.304 (.147)
1.237 (.281)

.220
.022
.119
.068

1.805 (.187)
.06 1 (.806)
l.309_Q_60)

.047
.002
.035

Significant p-value > .05.
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Figure 2. Effect sizes for change scores on Diabetes Care Profile subscales

scores between baseline and follow-up, reflecting effect sizes of interpretable magnitude.
The subscale reflected effect sizes ranging from small (.20) to large (.80) for the
treatment group. It is also important to note that the control group also demonstrated
change in scores that yielded small to medium effect sizes ranging from .28 to .62 on five
of the 15 subscales. For clarity, the following scales show improvement when scores
decrease and thus the magnitude of change is reflected as a positive number for effect
size: Control Problems; Social and Personal Factors; Negative Attitude; Exercise Barriers
and Monitoring Barriers.
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The Short Fonn-36 (SF-36), a generic health-related quality of life measure, was
embedded in the Diabetes Care Profile (DCP). The SF-36 is sometimes embedded in
longer, health-specific measures because of its widespread use and acceptance and its
strong reliability and validity . The SF-36 results will be reported separately because it is
a measure that is scored independently of the DCP. The SF-36 contains eight primary
scales as well as two component summary scales . The two summary scales are derived
by factor analyses of correlations between the eight scales to identify a separate
"physical" component of health status and a "mental" component of health status.
Results of the SF-36 are displayed in Tables 14 and 15.
Like the means scores of the DCP, the treatment group means scores on the SF-36
showed improvement between baseline and follow-up , however, none of the results of the
repeated measures ANOV A proved to be significant. Several of the subscales showed a
notable change in scores between baseline and follow-up which translated into effect
sizes of interpretable magnitude. The subscale effect sizes are represented in Figure 3
and subscales with notable effect sizes are discussed below.

Role Physical
The Role-Physical scale assesses an individual's difficulties in performing their
work responsibilities or other daily activities as a result of physical health concerns (Ware
et al., 2002). The mean scores between baseline and follow-up increased 18.75 for the
treatment group and increased 1.25 for the control group. Although the repeated
measures ANOV A showed no statistical difference, the effect size calculated was .46,

Table 14
Baseline, Follow-up , Mean(SD) and Change Scores for Short Form-36 Outc ome Variables (N = 40)

Measure
Physical Function
·Role -Physical
Bodily Pain
General Health
Vitality
Social Funct ioning
Role-emotional
Mental Health
Physical component
summary
Mental component
summar· ·

Treatment GrouE (n =20)
Follow-up
Pre-Post
Baseline
M/(SD)
Ml(SD)
Change/(d)
61.50 (24.714)
66.25 (27.904)
-4.75/-0.18
45.00 (41.039)
63.75 (40.127) -18. 75/-0.46 a
50.85 (23.944)
52.20 (24.638)
-1.35/-0.06
-4.6/-0.20a
49.15 (19.066)
53.75 (26.111)
44.25 (19·.076) 46.00 (21.679)
-4.6/-0 .07
-10.62/
-0.37a
70.00 (28.504)
59.38 (28.641)
-18.33/0.43 a
40.00 (39.883)
58.33 (44.426)
60.20 (19 .138)
60.80 (20.046)
-0.6/-0.03

Control Groue (n =20)
Baseline
Follow-up
Ml(SD)
Ml(SD)
·
63.25
(27.828)
60.50 (31.908)
53.75 (45.360)
52.50 (45.087)
47.85 (21.189)
54.20 (31.675)
51.55 (26.045)
52.60 (24.686)
39.50 (26.798)
35.75 (28.895)
68.13 (29.657)
67.50 (34.745)
63.33 (43 .124) 65.00 (42.543)
67 .00 (22.845)
64.60 (23.692)

Pre-Post
Change/(d)
-2.75/-0.09
-1.25/-0.03
-6.35/-0 .24a
1.05/0.04
-3.75/-0.13
0.63/0 .02
-1.67/-0.04
-2.4/-0.10

39.85 (9.553)

42.27 (11.243)

-2.42/-0 .23a

38.42 (12.240)

39.45 (12.952)

-1.03/-0.08

40 .65 (11.349)

43.44 (11.037)

-2.79/-0 .23a

44 .92 (13.037)

45 .56 (13.203)

-0.64/-0.05

a Effect size of~ .20

-..J
\0

Table 15
ANOVA Results for Short Form-36 Outcome Variables (N = 40)

Measure
Physical Function
Role-Physical
Bodily Pain
General Health
Vitality
Social Functioning
Role-emotional
Mental Health
Physical component
summary
Mental component
summar

Treatment Group
F (p)
1.847 (.192)
.008 (.930)
3.552 (.077)
.682 (.420)
1.556 (.229)
.393 (.539)
.198 (.662)
1.265 (.276)

Partial
Eta 2
.098
.000
.173
.039
.084
.023
.012
.069

Timex group

Time F (p)
1.126 (.296)
.255 (.617)
.935 (.340)
2.035 (.162)
2.539 (.120)
.021 (.885)
.892 (.351)
.069 (.794)

Partial
Eta 2
.030
.007
.025
.053
.066
.001
.024
.002

.998 (.325) .
1.683 (.203)
1.682 (.181)
1.346 (.254)
12.226 (.085)
4.628 (.038)*
2.698 (.109)
.479 (.493)

Partial Eta 2
.027
.045
.049
.036
.002
.114
.070
.013

.185 (.670)

.005

.885 (.360)

.050

.742 (.395)

.020

.001_(.982)

.000

.026 (.873)

.002

._ }.Q_4_§_J089)

.078

--

F(p_) .

*Significant p-value :S.05
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Figure 3. Effect sizes for change scores on Short Form-36 subscales

which demonstrates a medium effect of the treatment intervention .

Bodily Pain
The Bodily Pain Scale accounts for the intensity of pain and individual
experiences as well as the extent to which the pain interferes with the ability to perform
normal work (Ware et al., 2002).

This scale measured no demonstrable effect for the

treatment group but did have a small effect size for the control group (.24). This result
would indicate that although the treatment did not appear to produce a change in this
outcome variable, the passage of time may account for the result in the contro l group.
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General Health
The General Health Scale measures an individual's perception of his or her
personal health and belief that it will either improve or worsen over time (Ware et al.,
2002) The treatment group effect size was small (.20) for the treatment group.

Social Functioning
The social functioning scale assesses the degree to which physical or emotional
concerns interfere with an individual's ability to engage in normal social activities
(Wareet al., 2002). The treatment group mean scores changed 10.62 and represented a
small effect size (.372).

Role Emotional
The Role-Emotional scale measures an individual's difficulties with work or daily
activities due to emotional concerns. The mean score difference between baseline and
follow-up was 18.33 for the treatment group and 1.67 for the control group. Again, the
repeated measures ANOV A showed no statistical difference in scores, but a medium
effect size of .43 was demonstrated.

Physical Component Summary
The eight scales of the SF-36 have been found to form two separate higher order
clusters, derived from the physical and mental health variance they have in common
(Ware et al., 2002). This scale summarizes the physical component of the eight scales
and includes: physical functioning, role-physical, bodily pain, and general health. The
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mean score differences between baseline and follow-up for the treatment group yielded a
small effect size (.23).

Mental Component Summary
The second summary score, the mental health component summary, consists of
the remaining primary scales: vitality, social functioning , role-emotional and mental
health . The treatment group mean score differences for this scale were also small yet
yielded a small effect size (.23) . Overall 6 of the 10 SF-36 scales showed a small to
medium effect of treatment.
Finally , Table 16 presents the comparison of the results of the SF-36 analysis of
this sample to nom1s of a group also diagnosed with type 2 diabetes . This table compares
the means of this study sample to the nonns of a group of individuals with type 2 diabetes
(N=54 l ). It is important to note that the median scores for the scales are also represented

on this table for comparison.

The effect size calculations reveal a small to medium effect

size on all but the Mental Health Summary Scale. This finding indicates that overall, this
group of participants report somewhat worse to notably worse subscale scores compared
to this normative group. The Mental Health Summary Scale revealed a large effect size
(.94) demonstrating significantly worse mental health scores compared to the normative
group.
Research question 4 was posed as follows: Does a cognitive-behavioral

treatment

added to standard care-as-usual improve diabetes related self-efficacy as measures by the
Diabetes Empowerment Scale? The research study question posed whether diabetes-

Table 16
Short-Form 36 Mean Comparisons between Study Sample and Normativ e Group

SF-36 Version 1 Scale
Physical Functioning (10 items)
Role Physical (4 items)
Bodily Pain (2 items)
General Health (5 items)
Vitality (4 items)
Social Functioning (2 items)
Role Emotional (3 items)
Mental Health Index (5 items)
Physical Health Summary Scale
Mental Health Summary Scale
a

Normative group Type
Study group mean
2 Diabetes mean (SD)
(SD)
(N=541)
61.00(28.16)
67.69((28 .66)
48.75(42 .72)
56.75(41.72 )
49.35(22 .37)
68.52(26.48)
50.86(21.84)
56.11(21.12)
40 .00(24 .55)
55.73(21.58)
63.75(29.12)
82.04(24.96)
51.67(42 .67)
75.60(36 .63)
62.40(21.37)
76.74(18.32)
41.52(11.27)
39.13(10.86)
. 42.78(12 .26) . -- - ____51.90(9 .55)

50tn Percentile
(median) for SF-36
Scale Norms
75
75
74
52
55
100
100
84
43 .72
54.56

Effect Size
-0.23
-0.19
-0.73
-0.25
-0.73
-0.73
-0.65
-0.78
-0.21
-0.94

Effect size of 2: .20

00
~
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related self-efficacy would change due to the treatment. The Diabetes Empowerment
Scale (DES) is a measure of diabetes-related psychosocial self-efficacy. The DES
contains three scales which were derived from a behavior change model (Anderson,
Funnell, Fitzgerald, & Manero, 2000) . The results of the analyses are contained in
Tables 17 and 18. The independent t tests analyses of the three scales showed no
statistical differences between the treatment and control group scores at baseline and at
follow-up. A repeated measures ANOVA was conducted on the three scales and no
significant differences were found. When considering effect size , scale 1, "Managing
psychosocial aspects of diabetes" showed a small effect size (.29) for the treatment group.

Table 17

Baseline, Follow-up, Mean(SD) and Change Scores for Diabetes Empowerment Scale Outcome Variables (N = 40)
Treatment Grou,El_n= 20)

Control GrouE. (n = 20)

Measure
Managing psychosocial
aspects of diabetes

Baseline
M/(SD)

Follow-up
M/(SD)

Pre-Post
Change/(d)

Baseline
M/(SD)

Follow-up
M/(SD)

Pre-Post
Change/(d)

2.405 (.533)

2.230 (.6602)

0.l 75/.29a

2.380 (.689)

2.335 (.498)

0.045/0.08

Assessing dissatisfaction
and readiness to change

2.172 (.450)

2.189 (.390)

-0.017/-0.04

2.250 (.411)

2.22 (.436)

0.03/0.07

Setting and achieving
diabetes goals

2.295 (.463)

2.24 (.684)

0.055/Q.Q9__ 21_29_J.627)

_2_.2_~_(.430)

-0 .1/-0.17

a Effect size of~ .20

00

0\

Table 18
Independent t Comparisons and AN OVA Results for Diabetes Emp owerment Scale Outcome Variables (N = 40)

Measure
Managing psychosocial
aspects of diabetes

Time F(p)
2.450JJ26)

Partial
Eta2

Treatment
Group F(p)

.064

.240 (.6~ 1)_

Partial
2
Eta

Timex group

F(p)

Partial Eta 2

-- .014 ____ .988 (.051)

.000

Assessing dissatisfaction
readiness to change

.112 (.740)

.003

.237 (.633)

.014

.055 (.816)

.002

Setting/achieving
diabetes goals

.590 (.447)

.016

.004 (.951)

.000

.366 (.549)

.010

*Significant p-value :S .05

00

--l
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CHAPTER V
DISCUSSION

Summary

The aim of this study was to determine if a cognitive behavioral treatment for
weight loss would lead to improvement in a range of type 2 diabetes related outcomes
including: Body Mass Index (BMI), glycosolated hemoglobin (HbA 1c), diabetes-specific
quality oflife, general quality oflife and diabetes-related self-efficacy. The results of this
research study, a randomized controlled intervention , demonstrated that a cognitivebehavioral intervention can assist overweight individuals with type 2 diabetes in losing
weight and maintaining it for two-months. The treatment group demonstrated a
significant drop in BMI between baseline and the end of the 12 weeks of treatment
compared to the control group. Between end of treatment and the 2-month follow-up
there was a small mean increase in BMI, however it was not statistically significant. As
was predicted, the control group gained weight over the entire course of the study .
However, other primary outcome variables including a blood glucose measure (HbA 1c),
quality of life and self-efficacy measures, showed that the groups were comparable
overtime.
Independent t tests were computed for all demographic variables and all outcome
measures to determine if groups were equivalent at baseline. All variables, except HbA 1c
and the Diabetes Care Profile (DCP) Diet Adherence (DA) subscale, were not statistically
significant. Repeated measures analyses were conducted both with and without using the
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baseline HbA 1c and DA subscale as covariates, due to group differences at pretesting.
Controlling HbA 1c and DA did not change the significance of outcomes. While the
repeated measures analyses did not yield significant results for HbA 1c, quality of life and
self-efficacy measures, the effect sizes calculated on the change in scores indicated the
intervention may have had a clinically-meaningful weight loss impact and helped
improve some aspects of quality of life.
The treatment did yield small to medium effect sizes on some of the subscales of
the quality of life and self-efficacy outcome measures. The findings will be discussed in
light of existing type 2 diabetes literature. Implications, limitations and recommendations
for future research will also be discussed.

Discussion

Equivalence of Groups at Baseline
The researchers' random assignment of participants to groups was largely
successful i.e., for the most part, the treatment group and control group were equivalent at
pretesting. It is noteworthy that the groups were not equivalent on two important
variables: HbA 1c and the Diet Adherence (DA) subscale of the DCP. However, as noted
in the results section, the difference in I-Iba1c was accounted for by two outlier cases.
When these were omitted from analyses, additional t-tests showed the groups were then
equivalent at baseline.
The other variable, Diet Adherence (DA), is worthy of discussion because
adherence to diet is one of the primary factors in restricting calories for the purpose of
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weight loss. In order to better understand what the DA subscale measures, Table 19
includes the eight items which make up the scale. Two questions stand out from the
others in regard to diet adherence. First, within the treatment group, a majority (90%) of
participants reported that they had been told by their doctor to follow a meal plan, while
just 60% of control group participants avowed being told. Also, 55% of the treatment
group reported they actually follow a meal plan whereas 25% of the control group
reported they follow a plan. While this difference was statistically significant , it did not
change the significance of the primary outcome variable , BMI, when the DA variable was
controlled statistically. It appears that the lack of equivalence between groups on this
variable may be due to the characteristics of this sample.

Primary Outcom es
Body mass index. BMI was the primary outcome variable in this study of weight
loss . A significant effect of the intervention was observed for the treatment group whose
mean weight loss was 7.2 pounds. The control group reported an average gain of .9
pound. The percent of weight lost in the treatment group was 3% in a 12 week period
which is quite !audible, relative to the normative literature in this area (Norris, et al.,
2005).
Most weight loss studies incorporate diet, exercise and broadly defined behavioral
therapies and few studies explicitly describe cognitive-behavioral therapy as a treatment
intervention. Kalendona and DeLucia (1999) found that a group receiving cognitive
therapy (CT) did not lose significantly more weight than a behavioral modification group.
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Table 19
DCP Diet Adherence Subscale Questions
1.
2.
3.
4.
5.
6.
7.
8.

Has any health care provider or nurse told you to follow a meal plan or diet?
How often do you follow a meal plan or diet?
Have you been told to follow a schedule for your meals and snacks?
Have you been told to weight or measure your food?
Have you been told to use food group lists to plan your meal?
How often do you follow the schedule for your meals and snacks?
How often do you weigh or measure your food?
How often do you (or the person who cooks your food) use the exchange lists or
food group lists to plan your meals?

However, the CT group reported significant differences in adaptive weight-loss
cognitions and continued to lose weight through the 6-month follow-up.
In weight loss studies for adults with type 2 diabetes , using at least one dietary,

physical activity, or behavioral intervention, a 3% weight loss was sustained at 1-2 year
follow-up (Norris et al., 2005) .

In diabetes prevention studies, also using at least one

dietary, physical activity or behavioral intervention, the mean weight loss was 3 .1% of
baseline body weight after an average follow-up of 1-2 years (Norris et al., 2004).The
Diabetes Prevention Program (2004) set a goal for participants to lose 7% of body weight
during the 1 year treatment arm of the program . The average weight loss was 4.5% and
49% of participants reached the 7% goal. At the end of a 2-year follow-up, 37% had
sustained the 7% weight loss goal.
The groups were again assessed on weight loss/BMI variables after a 2-month
maintenance period. The treatment group BMI slightly increased (.03) as did mean
weight (.25 pounds) and the control group remained unchanged. The treatment group
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was instructed to stop attempting to lose weight and to "practice" maintaining weight
based on the skills taught in treatment. In conducting the data analyses, this lack of
change in weight and BMI variables translated into nonsignificant results . However, no
change in the weight and BMI variables was the anticipated treatment group outcome for
the 2-month follow-up /maintenance period. Thus, this nonsignificant finding is
meaningful and supports the theoretical implications of maintenance strategies for weight
loss. It is uncertain and umeported whether other programs intentionally instruct
participants to stop losing weight, therefore, this finding may be a more accurate appraisal
of wei ght loss maintenance.
The weight gain in the control group during the treatment study was expected .
Resea rch indicates that individuals who are overweight or obese will tend to gradually
gain weight over time if no intervention is attempted (Perri & Corsica, 2002). Research
indicates that a loss of excess weight equal to 5-15% of body weight is sufficient to
improve health and decrease diabetes complications (Perri & Corsica, 2002) . Individuals
typically can lose 5-15% of body weight within a 6 month period with a moderate
restriction in calories (-500 /day). It is speculated that with a longer treatment period,
participant could reach the goal of 5-15% weight loss.

HbA1c. An expectation in conducting the present study was that greater weight
loss would be associated with another physiological health benefit - decreases in HbA 1c
levels. Certainly, while some studies have shown weight loss and decreases in HbA 1c to
be positively correlated, a few studies have shown no correlation (Norris, et al., 2004).
For instance, Norris, et al., (2004) reviewed 22 studies evaluating the effect of a weight

93

loss intervention in adults with type 2 diabetes. With a total of 4,659 participants and
follow-up periods of 1 to 5 years, Norris et al. concluded that the changes in weight
generally corresponded to minimal changes in HbA 1c, but the between-group-pooled
estimates were generally not significant.

In the present study, change in HbA 1c scores was not significant, however, scores
rose slightly for the treatment group (.04) and decreased in the control group (-.13). Also,
any differences between groups cannot be attributable to the use of insulin or the use of
oral diabetic agents because the percent of participants using insulin was identical (25%)
and there was a negligible difference between groups in use of pills (treatment= 90%,
control

= 95%). The lack of change in scores could also be due to the limited time

intervention of 12 weeks. HbA 1c measures average blood glucose levels over a two to
three month period and a change in HbA 1c may require a longer period of intervention
(Ellis et al., 2004). \Vhile conflicting reports exist regarding the necessity of tight glucose
control, most standards of care consider tight glucose control a goal of treatment
(Shaughnessy, 2003).

Diabetes care profile. Another important hypothesis in the present study was that
weight loss and improved glucose control would in tum, be reflected in more global
indicators of one's quality oflife. The Diabetes Care Profile, a diabetes-specific quality
oflife measure was employed in this study to assess this domain. None of the 15
subscales demonstrated statistical significance, though several subscales revealed notable
effect sizes. This lack of statistical significance relative to the size of effect is observed
frequently when small sample sizes are utilized. Overall, the treatment group scale scores
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increased more than the control group scores and yielded effect sizes for 12 of the 15
scales. Though the sample size was small, it is possible that the cognitive-behavioral
treatment had an effect that can be construed best in terms of the four constructs
associated with this measure, namely: patient attitudes, patient beliefs, adherence to selfcare and difficulties of diabetes self-care, with the cognitive-behavioral treatments used in
the study. Table 20 outlines the range of effect sizes in the four DCP constructs and the
treatment group demonstrated a small to medium magnitude of effect in all four domains
The ability to perform self-care behaviors is a cornerstone of diabetes treatment and
social and psychological factors are hypothesized to underpin the establishment and
maintenance of these behaviors (Sarkar et al., 2006). Also included in this table are the
goals of treatment that are hypothesized to overlap with these constructs. The treatment
group revealed effect sizes in all four domains whereas the control group demonstrated
change in only the adherence domain. However, it must be interpreted in light of the fact
that this group gained weight over the course of the study. When considering the impact
of treatment on these four constructs, it is not a stretch of the imagination to see that the
goals of treatment overlap with these domains. The cognitive-behavioral (CB)
intervention sessions were designed to not only achieve weight loss but also to maintain
the effects of weight loss, and to elicit changes in cognitive responses and behavioral
skills in personally relevant areas.
CB treatments conceivably help patients modify mechanisms that maintain the
target behavior (Cooper, Fairburn, & Hawker, 2003). In the present study, this involved,
among other things, improvement in identifying and moderating unrealistic goals;

Table 20
Comparison of Diabetes Care Profile Theoretical Constructs and CB Treatment Goals
Range of Effect Size
Control
Treatment
.20 -.27
None

DCP Constructs and Sample Questions
Patient Attitudes
-Positive Attitude Scale
•
I am able to keep my weight under control.
-Negative Attitude Scale
•
I find it hard to do all the things for my diabetes.

C-B Treatment Goals
- Identify and moderate unrealistic weight goals
- Problem Solving Training
- Identify and encourage changes in domains other than
eating
- Emphasize need for acceptance and change

Patient Beliefs
- Importance of Care Scale
• Jt is important to keep my weight under control.
- Long-term Benefits Scale
•
Taking the best possible care of diabetes will delay
or prevent kidney problems .
Adherence to Self-care
- Self-Care Adherence Scale
•
I do the things I need to do for my diabete s.
- Diet Adherence Scale
•
How often do you weigh or measure your food?

- Identify and moderate unrealistic weight goals
- Addressing obstacles to weight maintenance
- Educate about health risks of obesity
- Addressing beliefs about exercise and activity
-Cognitive aspects of eating

.22 - .35

None

- Identify and moderate unrealistic weight goals
- Establish monitoring of eating habits and of weight
changes
- Problem solving training
- Adherence to principles of health eating

.61 - .75

.35 - .62

Difficulties of Self-care
- Exercise Barriers Scale
•
How often do you have trouble getting enough
exercise because it takes to much effort?
- Monitoring Barriers Scale
•
When you don't test forsugar as often as
recommended, how often is it because you forgot?

- Identify and moderate bimiers to weight-loss
- Problem solving training
- Identify and moderate barriers to exercise
-Addre ssing beliefs about exercise and activity

.25 - .45

None

\0
Vl
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modifying attitudes about weight maintenance; addressing barriers to weight-loss; and
directly identifying and assessing patients' primary goals. Other studies using CB for
weight-loss have used similar strategies which have lead to changes in weight, shape and
eating concern (Diabetes Prevention Program , 2002; Nauta et al., 2001).
It appears that these goals of treatment may translate into improvements in other

areas of functioning. It is likely also that the social support received through the
individual sessions may contribute to the improvement in functioning as well. While the
loss of excess weight could lead to increases in physical functioning , it appears that
changes in beliefs about the self, goal-setting skills, addressing general problem-solving
strategies and experienci ng success in progressing toward a goal (weight loss), could be
related to increased functioning in work and social arenas.
It is interesting to note that while the DCP has demonstrated adequate reliability

and validity in measuring meaningful domains related to diabetes-specific quality of life
in other studies, no studies could be identified that used the DCP to measure change in
perceived quality of life (Bachman et al., 2003) . The DCP has been used in crosssectional studies and in studies assessing the reliability and validity of the DCP for use
with minorities (Cunningham et al., 2004). The lack of statistical significance in all
domains of the DCP in the present study could be due to the small sample size. Also, a
longer treatment period may be necessary to elicit change between baseline and followup. The results of this study may be an indication that the DCP is not a suitable
measurement tool for interventions aimed at psychosocial change. The creators of the
DCP suggest that the instrument should be suitable for intervention studies where
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outcome measures are needed to measure the impact of an intervention on patient
functioning (Fitzgerald, et al., 1996). Testa, (2000), however, expressed concern that
quality oflife measures must meet performance standards corresponding to the purpose of
analysis. "An evaluative analysis must employ scales that are responsive to changes and
differences in the underlying quality of life construct" (Testa, 2000). With no research
available showing the DCP's sensitivity to change, it is uncertain if this measures is
suitable for intervention studies.
A more likely explanation is that the intervention did not lead to significant
change in scores because the cognitive-behavioral intervention used was not focused on
changing diabetes-specific attitudes and behaviors as it was to change weight-relat ed
attitudes and behaviors. There is some overlap in these two domains and some of the
questions represented both diabetes and weight-loss behaviors. The scores on questions
regarding diet, exercise, problem solving, as well as topics regarding psychological issues
such as anxiety and depressive symptoms could have been impact ed through treatment.
Also , some of the diabetes-specific domains may have been impacted simply by
participating in the study where participants received increased social support and may
have become more motivated to improve diabetes-specific self-care behaviors. There
were diabetes-specific attitudes and behaviors that were not directly addressed in this
study. For example, no attention was given to whether or not participants were
measuring blood glucose as recommended and several questions within the DCP asked
about blood glucose monitoring and control.
Diet Adherence Scale change scores. As mentioned above, the Diet Adherence
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Scale in the Diabetes Care Profile represents an important construct in weight loss
behaviors. Both the treatment group and control group scores improved on this scale
(treatment= .675, control= .704). Improvement in scores for the control group may be
due to threats to internal validity including testing and a particular morale issue associated
with the control group. The testing threat may be due to the fact that participants
completed two questionnaires in which many of the questions inquired about dietary and
exercise behaviors. The expectation of improvement in these domains may have caused
the increase in scores for both groups . The improvement in scores may also be due to the
"care as usual " participants received from their health care professionals .
The researcher's subjective impression is that lower morale within the control
group may also have played a role in change scores. That is, several participants assigned
to the wait-list group expressed concern and even disappointment about waiting for
treatment. This disappointment may have translated into attempts to lose weight
irrespective of being assigned to the waitlist. Upon inspection of individual weight
changes in the control group, 30% had lost weight (~pounds).
Unrelated to specific threats to validity may be the fact that participants responded
to the call to participate in a weight-loss study because they were highly motivated to
make the necessary changes to lose weight. The changes that generally lead to at least
short-term weight loss are caloric restriction and increases in energy expenditure. These
can be easily implemented outside the confines of the research study, especially given that
the control group was not dissuaded to lose weight, but to simply wait to fully participate
in 12 weeks.
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It is noteworthy that while both the treatment and control group mean scores

improved on the DA variable, the treatment group mean BMI decreased (-1.16) while the
control group mean BMI increased (.20). This incongruence of outcomes lends itself to
the conclusion that the control group participants reported a significant change in
behavior, reflected in the DA subscale, but the BMI scores do not correlate with this
change. It might be speculated that there is perhaps a fundamental problem with the
validity of the Dietary Adherence selfreport measure i.e., obese individuals might
generally misreport or underreport eating behavior (Lara, et al., 2004).

Short Form 36. With many of the domains of the DCP measuring diabetesspecific attitudes and behavior another speculation of the present author was that the SF36, a general measure of quality of life, would be a qualitatively different and possibly
better measure of quality of life for this study. Unfortunately, none of the eight SF-36
scales demonstrated statistically significant differences between baseline and follow-up.
As was the case with the DCP, several of the SF-36 scales did show a notable magnitude
of change as reflected in effect sizes. As is the case with other discrepancies between the
absence of statistically significant results to absolute effect sizes, the present sample size
and thus the power to detect statistically significant change was inadequate for this study.
It is possible that the lack of effect of treatment on quality of life could be due, in

part, to the fact that this sample had lower scores an every scale of the SF-36 compared to
the normative sample listed in Table 8. These lowers scores could represent a selection
bias in which the participants either view themselves as, or are actually less able, to
perform the kinds of self-care behaviors which might elevate one's quality of life; this of
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course is considered to be a critical cornerstone of diabetes treatment (Sarkar et al., 2006).
This sample appears to suffer from lower levels of overall functioning which may be due
to comorbid disease states of type 2 diabetes and obesity (average BMI at baseline was
38.4). Support for this speculation comes from related studies . For example, Fontaine
(2002) and Kolotkin, Crosby, and Williams (2002) reported that, in general, obese
persons who seek treatment for their weight, repo1i greater impairment on health-related
quality of life.
The treatment group change scores do show improvement in certain other
dom ains of life functioning e.g., Role-Physical (R-P) , Social Functioning (SF) and RoleEmotional (R-E). The treatment group also demonstrat ed a small magnitude of chan ge in
both the Physical and Mental component summary scales . It is worth discussing the
similarities between these three subscales (where participants showed the most
improvement). These three scales (R-P, SF and R-E) all measure capacity of individuals
to participate in work, other , or social activities and impairment in these domains can be
due to physical or emotional problems. Mean change scores increased by as much as 18
points on a 100 point scale. It appears that, like the DCP results, the goals of the
cognitive-behavioral treatment and the social support may translate into improvements in
social, work and other areas of functioning.

Self-efficacy outcomes. Self-efficacy was an important outcome for which
treatment was expected to yield significant results, but did not. Specifically, it was
expected that diabetes-specific self-efficacy would improve due to the focus on changes
in cognition, improvement of behavioral skills and other personal factors related to health
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outcomes. It was thought that through actual successful performance of targeted
behaviors, confidence in the participants' ability to perform health behaviors would
increase and in tum would lead to increased likelihood to continue to perform targeted
behaviors (Bandura & Cervone, 1983) . It was speculated that this increase in confidence
would be reflected in scores in the Diabetes Empowerment Scale (DES).
While statistical significance was not reached, again effects sizes suggest the
possibility of some effect of treatment on the improvement of one scale of the DES ,
within this small sample . The scale "Managing Psychosocial Aspects of Diab etes
reflected a small effect size. This scale focuses on the ability to ask for help when needed
and the ability to moti vate and support the self in caring for diabetes. Ag ain, this dom ain
appears similar to the domains measured in the DCP and SF-36 regarding support and
social and personal factors that demonstrated change in scores in those measures. Other
studies have found an association between diabetes-specific self-efficacy, diet adherence
and other self-management behaviors (Sarkar et al., 2006) .
Also, development of a collaborative relationship in treatment could enhance selfefficacy . Instead of an expert giving advice to a passive recipient, the participant fully
participates in the development of the session agenda and leads in the discussion of the
monitoring records. It is hypothesized then that empowerment of the individual to
participate would provide experiences in new ways of behaving which could lead to
increased self-efficacy (Copper et al., 2004).

It appears the lack of significance cou ld be due to several factors. First, as with
the DCP, the Diabetes Empowerment Sca le (DES) focuses on change in attitude
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regarding diabetes-specific behaviors . Behaviors and cognitions targeted in this studied
were more focused on weight-loss than in changing diabetes-specific behaviors.
Anderson and colleagues (2000) stated that domain specific goals along with related
performance feedback are necessary to enhanced motivation. Also, for self-efficacy
scores to show effectiveness of treatment, items on the measure must be very specifically
related to the construct it is measuring. The DES contains diabetes-specific behaviors, but
this study did not provide specific goals or performance feedback tied to specified
behaviors measured by the DES. For example, the DES asks "In general, I can think of
ways to overcome barriers to my diabetes goals". Goals regarding weight-loss and related
topics were the focus of the study, but not specific barriers to diabetes goals per se.
Also, the iack of clear distinction between questions as well as lack of clarity of
intent of questions may have led to the lack of statistical significance. Sample questions
are listed in Table 21. During both baseline and follow--up assessments, some
participants expressed confusion about the meaning of questions on this measure.
Comments wen~ also made about the lack of differentiation between questions. Also, the
mean baseline scores for the treatment group were in the 2-point range which is
equivalent to agreement with the statement. The only way to improve scores on this
measure is to strongly agree (score of 1) with the statement. It appears this measure has a
ceiling effect and may not have the sensitivity to measure change in these three domains
(Gall, Borg, & Gall, 1996).
Finally, data were not collected from the control group upon completion of an
equivalent 12-week intervention. This was due to time constraints and high attrition in
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Table 21

DES Subscales and Sample Items
Subscale
Managing Psychosocial Aspects of
Diabetes

Sample Items
- In general, I believe that I can ask for
support for having and caring for my
diabetes when I need it.
- In general, I believe that I can support
myself in dealing with my diabetes .

Assessing Dissatisfaction and Readiness to
Change

- In general, I believe that I know what
part(s) of taking care of my diabetes that I
am dissatisfied with.
- In general, I believe I know what pari(s)
of taking care of my diabetes that I am
satisfied with.
- In general , I believe that I am able to think
of ways of overcoming barriers to my
diabetes goals works best for me.
- In general, I believe that I can decide
which way of overcoming barriers to my
diabetes goals works best for me.

Setting and Achieving Diabetes Goals

the control group. It is speculated that the high attrition rate in the control group is an
artifact of waning motivation from being placed on a wait list for treatment.

Threats to internal validity. As mentioned above , testing and morale problems
with the control group could be possible threats to the internal validity of the study
findings. Other potential threats to internal validity include experimental mortality and
imitation of treatment. Both the treatment and control groups experienced the same
attrition rates. However, it is not known why participants exited the study. It is possible
that those participants who ended treatment were unable or unwilling to complete
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treatment, whereas, participants who exited the wait-list group did not receive treatment
thus the characteristics of treatment did not affect their reasons for leaving the study.
Thus those participants who left treatment may have characteristics in common that if
they were to continue treatment, may change the findings of this study. Because thirty
percent of wait-list participants lost weight during the care-as-usual period, it is possible
that imitation of treatment was a factor that threatened the validity of the findings.
Also, the effects of social desirability may have been a variable in treatment
outcomes considering the treatment provider was also the researcher. Paiiicipants met
with the researcher weekly and were aware the treatment provider was also gathering data
for the research study. It is possible that participants tried harder in order to please the
researcher.
Generalizability of findings. It is important to note that this study utilized a
convenience sai11pleand not a representative sample. All participants were drawn from
the general geographical vicinity of Salt Lake City, Utah. All participants were patients
of University of Utah Community Clinic physicians and all had health insurance. The
lack of a representative sample decreases the generalizability of the findings, however,
the study was conducted in a naturalistic setting within the actual community clinics
where patients would likely attend treatment. Thus, it is difficult to precisely indentify
how generalizable the outcomes of the study are because factors weigh on both good and
poor generalizability.
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Implications and Limitations

The primary implication of this study is that a time-limited cognitive-behavioral
intervention for weight loss in adults diagnosed with type 2 diabetes can lead to initial
modest weight-loss of 3% of baseline body weight. When considering the current
outcomes reported in weight loss studies for adults with type 2 diabetes, this study's
findings are similar.
A longer intervention period in this study would likely lead to the desired 5-15%
weight loss that is associated with improved health outcomes (Klein et al., 2004;
Warn.kin, 2005) . Although a 12-week intervention is too short a time period to reach the
optimal 5-15% weight loss, maintenance of any weight loss is advantageous. Ideally, a
follow-up period of one year or more would provide a good measure of the success of
addressing ongoing weight maintenance . Other studies have concluded that a
maintenance period with ongoing support is required for sustaining weight lost (Cooper,
Fairburn, & Hawker, 2005).
Another implication is that this treatment, although it did induce weight loss in
participants, failed to yield changes in HbA 1c, Other studies have yielded reduced blood
glucose levels which correlated with a decrease in weight. However, treatment periods
were, on average, greater than twenty weeks (Norris et al., 2005). Longer treatment
periods then, with larger sample sizes would most likely yield more accurate results. A
large scale diabetes study found that tight blood pressure control was more predictive of
fewer microvascular incidents than was tight glucose control (Shaughnessy & Slawson,
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2003). Therefore, including blood pressure as an outcome may be as important as blood
glucose levels.
Secondary implications of this study included the lack of statistical significance in
the results from the quality of life and self-efficacy measures. It was expected the
measures would assess the impact of the treatment on these domains. In retrospect, a
reasonable speculation is that possible mismatch of measures to treatment goals existed in
the present study, which led to the failure to validly assess the effects of treatment.
However, because some scales of the measures did yield notable effect sizes , some
measures used in this study might have lacked sensitivity . If so, there may be a need to
develop more sensiti ve measures that can detect changes in quality of life and selfefficacy when intervention studies intending to measure change in these constructs are
employed. Also, an intervention study of this kind would have greater power to detect
effects with a larger sample size.
A limitation of this study is the impact of utilizing a control group that must wait
for treatment. Participants made remarks about their frustration over waiting for
treatment. As mentioned earlier, it must be considered that the desire and motivation to
participate in treatment may have led to participants engaging in weight loss activities. It
may be more appropriate to compare differential effects of two treatments rather than a
wait-list control group. When considering the main interest in this study was to
investigate weight maintenance outcomes, comparing treatments with and without a focus
on maintenance strategies would likely produce meaningful results.
Finally, a recognized limitation of this study is the possible conflict of interest and

107
bias inherent in a study when the researcher also provides the intervention as is the case
in this study. The findings must be considered in light of this potential bias. Some of the
conflicts possible include: patient's desire to please providers, researcher disappointment
with patient's level of participation, and introduction of data collection bias (Weber et al.,
1997).
This conflict is always a compelling topic for those who embrace the scientistpractitioner model. However, there is much need to translate basic science into clinical
benefit for patients and scientist-practitioners

can provide that bridge (Yanos & Ziedonis,

2006). Yanos and Ziedonis further stated that while non clinicians tend to have stronger
methodological skills, they may miss many real world issues that often inspire innovative
and relevant research. It is therefore necessary to be ever vigilant of ethical and practical
conflicts that may invariably arise because of these dual roles.

Recommendations

In order to evaluate the efficacy of this treatment intervention, it would need to be
duplicated with a larger sample size, a longer time for treatment and an extended follow
up period. A follow-up period of 1 year or more would provide the most substantial
findings of whether this type of treatment can affect change over time for the seemingly
intractable problem of obesity. Thus, one key recommendation for clinicians is that
application of a cognitive-behavioral intervention that follows the short time frame used
in the present study is not recommended.

The impact of treatment on quality of life is a

construct needing attention especially in populations with chronic diseases. Individuals
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with both type 2 diabetes and obesity have the symptoms and complications of these
chronic conditions to contend with and it is necessary to consider what impact that both
the act of undergoing treatment and the outcome of treatment have on quality of life.
When working with populations suffering with obesity and comorbid conditions it
is advisable that the formulation and provision of treatment may best be provided through
a team approach (Perri et al., 1992). A team that includes physicians, nutritionists,
exercise physiologists, psychologists and others could create a more comprehensive
approach to treating obesity. Given that obesity is correlated with many known disease
states , a comprehensive approach to treatment would be akin to prevention. Although
costs may be high initially , it is possible that paying now would likely cost less , in te1ms
of dollars and lives, than paying later.
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Appendix A:
Physician Presentation

Efficacy of certain strateg ies for weight loss in adults
with type 2 diabetes

Prindpal Inve stigator
Donald McCl 1ln M.O.
Director, Oivtalon of Endo crinology and M•taboliwn
Unlverwity of Utah Health $d1mcu

Student Researcher
KAthyWckelllNlm

Doctoral Student
Department of Pa~y

Utah Sta te Univer.ity

Diabetes
• The prevalence
of type 2 diabetes
among
Americans
of all ages is
increasing
at an ep idemic rate .
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Obesity
• Obesity is a primary risk factor for the
development
of and an impedance to the
treatment of Type 2 diabetes .
- An estimated 85% of adults with type 2
diabetes are overweight or obese.
- Weight loss improves insulin sensitivity and
glycemic control.
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Conclusion
• There is little research investigating
effective weight loss treatments and
weight loss maintenance
strategies for
people with type 2 diabetes .
- For those who do lose weight , research
indicates poor weight loss maintenance
outcomes for all overweight and obese
individuals who lose .weight.
• 95% regain lost weight within 5 years.

Cognitive Behavioral
Intervention
• Cognitive behavioral interventions hold the
most promise of effective weight loss
treatments and of subsequent
maintenance
strategies for sustaining the
lost weight .
- Typical weight loss of 5-15% of body weight is
usually achieved within 4-6 months (1-2
lbs/week).
- Focus on learning weight maintenance skills
during weight loss phase.
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Purpose of Study
• The purpose of this study is to investigate
the efficacy of certain interventions for
weight loss in adults with type 2 diabetes.
• Study characteristics
- Random assignment of 80 participants to 3
groups
• Cognitive behavioral intervention
• Self-monitor ing
• Comparison group/no treatment

- 12-week treatment

Physicianreferralto research
project
• Physician can directly refer patient to
project
• Physician permission to participate
- Diagnosis of Type 2 diabetes
-BMI ~27
- Health permits restriction of caloric intake to
about 1500 calories.
- Health permits increase in physical activity
•lncreas e number of daily steps taken
- Goal of 5 ,000-7 ,000 steps

•lncreas e intentional exerc ise

Main Treatment Protocol
• Two aspects to treatment
- Moderate Weight-Loss
• Cognitive and behavioral barriers to weight loss
- Address motivation
- Address adherence
- Acquire behavioral skills and cognitive responses
needed for effective weight control

- Maintenance
• Acceptance and change beliefs about weight
• Maintenance skills
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Measures and statistical
analyses
• BMI

•
•
•
•

HbA 1c
Diabetes Quality of Life Questionnaire
Diabetes Attitude Questionnaire
Weekly Summary of Self-Care Activities
Scale
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Appendix B:
Flyer placed in University of Utah Community Clinics
and Utah Diabetes Center

INVESTIGATING THE EFFECTIVENESS OF CERTAIN TREATMENT
OPTIONS FOR WEIGHT LOSS
To qualify for the study, participants must meet the following criteria:

1) Have a diagnosis of Type 2 Diabetes
2) Have a Body Mass Index Greater than 27 (approximately 20 pounds or more of
excess weight)
3) Have physician's permission to participate in the study
4) Have the ability to participate in a research study for 12 weeks
Possible Benefits:

1) No-cost weight loss treatment

Open enrollment until August 31, 2006
Study ends November, 2006
For more information or to enroll in the study
Please contact Kathy Wickersham
(801) 712-9904
or
(435) 882-8818
Study Location
University of Utah
Greenwood Health Center
7495 South State Street
Midvale, Utah
IRB # 15389
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Appendix C:
Radio Advertisement

Have you been diagnosed with type 2 diabetes and are you 20 pounds or more
overweight? The University of Utah is conducting a research study investigating the
effectiveness of certain treatments for weight-loss in adults with type 2 diabetes.
Permission to participate from your University of Utah clinic physician is required.
Research participants will receive no-cost weight-loss treatments.
The study will be conducted at the community clinics; will last 12 weeks and begins
September 1. To enroll, contact Kathy Wickersham at (801) 712-9904.
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Appendix D
12-week Treatment Module Outline

Week 1: Module I: Starting Treatment
• This is a preparatory session before weight loss is initiated.
• Assessment and orientation (Assessment checklist)
o Develop a collaborative working relationship
o Take a history of the weight problem
o Describe in outline the cognitive-behavioral perspective on weight control.
o Orient the patient to the f01m and style of treatment.
o Address motivation
o Address premature discontinuation of treatment
o Start self-monitoring of food and drink intake and calorie counting
o Forewarn regarding calorie restriction
o Start weekly weighing
Week 2: Module I: Session 2
• Weigh the patient and record weight
• Jointly review self-monit01ing records
• Set agenda for session collaboratively
• Work through agenda topics
• Introduce energy-restricted diet
• Educate about health risks associated with obesity
• Educate about unhealthy methods of weight control
• Educate about principles of health eating
• Agree on homework assignments
• Summarize the session
Week 3: Module II: Establishing and Maintaining Weight Loss
• Same activities as week 2
• Assess compliance with the energy restricted diet
• Education about weight regulation
• Address social eating
• Address activity level and exercise
• Develop problem-solving skills
Week 4: Module III: Addressing Barriers to Weight Loss
• Same activities as week 2
• Introduce Barriers to Weight Loss Checklist
Week 5: Module IV: Increasing Activity
• Same activities as week 2
• Introduce Increasing Overall Activity topic
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Week
•
•
•
•
•
Week
•
•
•
•
Week
•
•
Week
•
•
Week
•
•
•
•
•
•
•
•
•
•

Introduce monitoring physical activity
6: Module V : Addressing Body Image Concerns
Same activities as week 2
Introduce concept of body image as distinct from physical appearance
Assess and identify body image concerns
Introduce monitoring body image concerns
Introduce procedures for addressing problematic thoughts and beliefs
7: Module VI: Addressing Weight Goals
Same activities as week 2
Questioning the Desired Weight and modifying weight loss goals
Introduce topic of benefits of moderate weight loss
Emphasize need for acceptance and change
8: Module VII: Addressing Primary Goals
Same activities as week 2
Address goals, other than weight loss , that patients are hoping to achieve as a result of
losing weight
9: Module VIII: Healthy Eating
Same activities as week 2
Introduce general strategies to encourage healthy eating
10: Module IX: Weight Maintenance
Same activities as week 2
Prepare patients for weight maintenance
Define a target weight range and establish a weight monitoring system
Introduce topic of ling-term weight maintenance skills
Introduce topic of responding to changes in weight
Review Treatment
Phase out self-monitoring
Introduce topic of addressing weight change in the future
Address possible future attempts to lose weight
Prepare a personal weight maintenance plan
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Appendix E:
Phone Script for Data Collection

1st Contact:
Hello, my name is _____

_

I'm calling on behalf of the University of Utah and Dr. McClain and Utah State University and
Dr. Stein. We want to thank you for participating in our study of the relationship of weight-loss
strategies and type 2 diabetes. I'm calling today to get your total calories and total steps since

Collect data and then coordinate date for next phone call.

Ongoing phone contacts: (CB group)
Hello, this is -----I'm calling to record your calorie and step information since your last clinic visit.
(Collect data and thank them for the infom1ation. Coordinate the next date for you to call.)
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Appendix F
Treatment Participant Handouts

HANDOUT A

RECORDING YOUR EATING
The importance of recording can not be stressed too much. It is vital if treatment is to succeed.
Recording will help you identify exactly which aspects of your behavior you need to change, and it
will help you make these changes.
At this stage you need to record everything that you eat and drink. A simple description will
do. To do this, you will need to carry your records with you . The following instructions are to help
you complete the records .

•
•
•
•
•
•

Column 1 is for noting the exact time of day you ate or drank the items concerned . You
should write things down as soon as possible afterward.
Column 2 is for giving a simple description of what was eaten and drunk . You should record
absolutely everything consumed . Please identify meals with brackets .
Column 3 is for noting where you were at the time. If at home, please note the room .
An asterisk should be placed in column 4 beside anything you ate or drank that you viewed
as excessive. This should be your view not other people's.
Column 5 is for noting calories .
Column 6 is for noting other points of relevance (e.g., your thoughts or feelings, the
circumstance, or context in which they eating occurred). You should also note your weight in
this column each time that you weigh yourself.

Please remember to bring your records to each treatment session.
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HANDOUTB
A BLANK MONITORING RECORD
DATE:

DAY:
Time

Food and Drink
Consumed

Place

*

Calories

Comments
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A BLANK MONITORING RECORD
DATE:

DAY :
Time

Food and Drink
Consumed

Place

*

Calories

Comments
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A BLANK MONITORING RECORD
DATE:

DAY :
Time

Food and Drink
Consumed

Place

*

Calories

Comments
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HANDOUTE

ENERGY BALANCE

The key points
•

•
•
•
•
•

•

To have a stable weight, your energy intake (what you eat as food and drink) must equal
the energy you burn up (what you need to keep your body processes going and for
physical activity) .
Weight problems developed when your energy intake (calories) exceeds the energy you
are burning up over a sustained period of tirp.e.
This positive energy balance ( excess energy) is stored in the body mainly as fat.
Excess weight (fat) is only lost when you create a negative energy balance so that your
body draws on its energy (fat) stores.
A sustained reduction in your energy intake (as food and drink) is needed to produce
weight loss .
In principle your rate of weight loss could be accelerated by increas ing the energ y you
burn up as a result of physical activity, but in practice the additional benefits are not
great. On the other hand , regular physical activity does help weight maintenance .
Once you reach your target weight range, you will need to adjust your eating and activity
levels to stabilize your weight. This is an important skill that requires practice .

Why do some people develop weight problems?
•
•
•
•
•
•

•
•
•

There are two main reasons and often they both apply:
Eating too much ( energy intake too high)
Not being active enough (not burning enough energy)
Metabolic, hormonal or other medical problems are rarely relevant, although people vary
somewhat in the amount of energy their body needs to keep running.
Weight problems tend to run in families. This can be due to the family environment or to
genetic factors or both.
Genes have a definite influence on body weight, so if you come from a family in which
many people have significant weight problems, you are likely to be genetically vulnerable
to similar difficulties.
Psychological factors lead some people to overeat. Some people are worried in response
to stress or when they are unhappy or bored, whereas others find that their appetite is
diminished. Extreme dieting can also encourage overeating.
Poor eating habits can also be learned (at home, school or work, or do to another
circumstance). A particular problem in our society today is that most people eat too much
high-fat food, largely because it is readily available and tastes good.
As a society we are also much less active than we used to be. Many people have jobs that
involve little activity and people are much less active at home.
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HANDOUTF
REVIEW SESSIONS
Now that your appointments will be at 2-week intervals, it is important to have weekly between
session, appointments with yourself. This might seem odd but it can be extremely valuable. The
purpose of these review sessions is to ensure that you remain alert to your progress and any
problems that you might be having . They also help you maintain momentum between our
sess10ns.
These review sessions are important and should be given priority. It is best to schedule
them in advance like a treatment session. It is helpful if each session has the following structure:
•

•
•

Review of your progress based on your most recent monito1ing records and any
change in your weight. In doing this you should take account of the "homework" that
was agreed at our last session.
Identify everything that you have achieved over the last week. It is important to give
yourself credit for your achievements.
Set yourself one or two specific goals for the forthcoming week.

It is also very important to continue to weigh yourself at weekly intervals and record your
weight on your graph .
At each appointment we will discuss how you have managed with the review and the goals
that you set yourself.
Making a habit of assessing your progress in this way will prepare you for the future when
you will no longer be coming for treatment.
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HANDOUTG
SOCIAL EATING

Eating out or with other people can pose additional challenges when you're trying to control your
calorie intake. Planning ahead is important. In particular, it is helpful to ensure that you have
thought about how to deal with all the practical issues related to social eating and your attitude to
keep your calorie limit. Most situations can be successfully tackled if you have a plan for dealing
with them . On the other hand, if you're caught unawares you are at greater risk of experiencing
problems .
Here are some specific tips for dealing with eating out:

A. Practical Strategies
General
• Plan far enough in advance, as you may want to adjust your eating in the days before (and/or
after) the event to "bank" calories . You will also often need to plan a strategy to deal with the
specific situation (see below).
• Think about the difficulties you will encounter. Consider the following :
• The amounts and types of food that will be provided
• Social pressures to eat
• The availability of "extras" (e.g., pre meal appetizers, after-dinner chocolates)
• Alcohol
• It may be useful to think about how you have dealt with similar situations in the past.
In all the situations mentioned below it is helpful to plan in advance . This gives you time to
anticipate any difficulties that might arise and how to cope with them. Here are some practical tips
that may help. Note that not all will suit you or the situation.

Restaurants
• Participate in the choice of restaurants if possible; look at the menu in advance, or possibly
telephone the restaurants to ask about the availability of low fat or low calorie dishes.
• If possible, ask for food to be served without extra butter, and for dressing and sauces to be
served separately so you can control the amount you have. Consider asking for a smaller
portion of the main dish with extra vegetables or salad.
• Be wary of set menus. They may include dishes that are not choices for people who are
trying to lose weight, but are also difficult to resist when you have already paid for them.
• Try asking for fresh fruit as a dessert, or maybe share a dessert with somebody else.
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Buffets

• Look carefully at what is available before you actually put anything on your plate. Identify a

•

few foods that you would really enjoy (rather than trying a bit of everything) and choose
some low-calorie options such as salad or rice to fill you up.
Try using a side plate rather than a full-size dinner plate .
Handout G (Continued)

• Treat it as you would a sit-down meal. Visit the buffet table only once, and then when you
have eaten get rid of your plate as soon as possible.

• Alternatively, ask someone else to bring you some food, and tell them what you would like .
Entertaining In Your Own Home

• Consider whether you are obliged to provide a high-fat, high-calorie meal. Many people are

•
•
•

either watching their weight or being careful about their diet for health reasons . A lower-fat
meal is just as likely to be welcomed by guests and certainly does not indicate poor
hospitality.
Single-portion foods, such as individual chicken pieces, are often easier to manage and avoid
the difficulty of having tempting leftovers.
If you do have food left over, either give it to guests to take with them or freeze it
immediately.
If you tend to pick while preparing food, try immersing used dishes and utensils immediately
into soapy water or chewing gum while you cook.

Eating at Someone Else's House

•

•
•
•

•

If possible, try to find out in advance what will be served. If you know the host/hostess well,
consider contacting them in advance to explain your situation and ask if it would be possible
for him or her to help. You could perhaps find out what he or she is planning to serve so that
you can decide in advance what you will eat, and plan your day accordingly.
It may be possible to offer to take a dish with you, so that you know there will be at least one
low-calorie option.
Offer to help serve so that you can control your portion size, or ask for a small portion .
Fill your plate with salad or vegetables, and take only small amounts of high-calorie dishes .
This helps to control the calories and avoids drawing attention to your weight control efforts.
Asking for recipes may be a good (and socially acceptable) way of finding out what went into
a meal so as to calculate the calories you consumed.
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B. Other Issues

Pressured to Eat
If you tend to feel under pressure to eat more than you had planned, tried to work out exactly what
makes you feel this way. Are you concerned that people will be offended if you do not eat everything
you are offered, or that you will draw attention to yourself if you do not eat as much as everyone
else? See if you can work out precisely what the problem is, it will be easier to think of ways to cope.
For example, if you're concerned that your host will be offended if you do not eat much, you might
decide it would be helpful to practice saying "No" politely but firmly. You can test out whether
politely declining foods is likely to cause offense. You might do this by thinking about how you
would feel if you were the host and someone declined food in this way; or by watching carefully to
see if other people always eat large portions of everything available, and how others react if they do
not. If you are concerned about drawing attention to yourself by not doing what everyone else is
doing you might observe the reactions of others to people who, for example are not drinking alcohol,
perhaps because they are driving, or perhaps simply because it is their preference not to do so. Ask
yourself whether you think it would be reasonable to react negatively to such situations and whether
you would do so.

Feeling Deprived
Although planning ahead to make the most of your calories is helpful, it is not uncommon to feel that
social events revolve entirely around high calorie food and drink and to think that not being able to
eat or drink everything that you would like will make these events less enjoyable. You could test this
view to see whether you really enjoy occasions less if you limit your food and alcohol. Also, you
could try focusing on those nonfood aspects of social events that make them enjoyable (e.g., talking
to friends, and having time to relax, not having to wash the dishes) so that food and drink becomes
less important aspect of social events.

Coping with Unexpected Occasions
Sometimes invitations to eat arrive unexpectedly -someone drops in and suggests having lunch
together, or friends come around with take-out, or somebody suggests going for a meal after a movie.
It is helpful to take a few minutes to think clearly about how to handle the situation. You may
decide to join in on the meal, and cut down on calories later in the day or the next day. Alternatively,
if you have already planned what you're going to eat, you may need to respond differently: perhaps
by suggesting another time when you could have a meal together or explaining that you will just have
a small amount as you have already eaten. You may wish to experiment with different possibilities
and find out which one works best for you.
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PLANNING FOR VACATIONS
Vacations can pose additional challenges when you are trying to control your calorie intake. You
may be in unfamiliar surroundings where the food choices may be quite different from home, and
you may have less control than usual over the preparation of food.
Planning ahead is important. In particular, it is helpful to ensure that you have thought about
how to deal with both the practical issues related to eating, as well as how you might feel about
keeping a calorie limit. Most situations can be successfully tackled if you have a plan for dealing
with them. On the other hand, if you're caught unawares you are a greater risk of encountering
problems.

General
Vacations are a time to relax and enjoy yourself, and sometimes people see this as incompatible with
restricting their consumption of food and drink. It is worth considering how you can make the most
of your vacation without undoing all the hard work you have put into losing weight. The first task is
to decide on your goal over the vacation. Do you want to continue losing weight or to maintain your
current weight? If you intend to stick to your calorie goal with the aim of continuing to lose weight,
be clear and realistic about how you will achieve this goal. If you think that it is not realistic to stick
to your calorie goal, it may be best to work out a slightly higher calorie limits with your therapist for
the vacation, with the aim of maintaining your weight.
In making decisions about your goals, it may be helpful to consider what, besides being able
to drink and eat freely, will be enjoyable about the time away. A vacation may provide an ideal
opportunity to practice the new habits you have learned and experiment with the possibility that you
have an enjoyable time while still limiting your intake of food and alcohol.
Here are some specific practical issues to consider when planning ahead.

Monitoring Food and Weight

•
•

Will you monitor your food and weight while you are away? If so, how? Will scales be
available for weighing food and for checking your weight?
When will you do your weekly reviews? Can you set aside time with yourself? Would it be
helpful to send (fax or e-mail) your weekly review to your therapist while you are away?
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Arrangements for Travel
•

How long will your journey take from door to door? What meals would you normally eat
during this time? Will you be traveling over night or on a long haul flight? If so, how might
this affect your eating pattern?
• What food will be available? Is it worth taking your own to ensure you have control over
what you eat? Are you likely to be tempted by the availability of snack foods at gas stations,
airports, or trains? Will your food choices be determined by circumstance (e.g., food on an
airplane)? If so, would it be worthwhile ordering a special meal? .
• What time will it be when you arrive at your destination (and at home on your return
journey)? Can you arrange personal food to be available (e.g., by leaving a meal in the
freezer at home)?
• How can you make it easy to keep monitoring while you travel? Many people find it difficult
to resume monitoring after a break, so working out how to monitor through unusual
situations is worthwhile. Making sure you have your monitoring sheets handy is important,
and calculating in advance anything you take with you can make monitoring easier during the
Journey.

General Arrangements When Away

• We'll food be provided? Will you be eating out, preparing your own food, or a combination
•
•

of these? How will you cope with the particular arrangements? Do you anticipate any
difficulties? Planning ahead is likely to be helpful in these situations.
How will your requirements fit in with the rest of the party?
What types of food will be available?

Alcohol
•

Does your alcohol intake tend to increase when on vacation? How do you intend to manage
this?
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SPECIAL OCCASIONS
Controlling your calorie intake on special occasions (such as parties, birthdays, weddings, and other
celebrations) can be difficult. Such occasions provide a good opportunity to practice the new habits
you are learning and to experiment with the possibility of having an enjoyable time without eating
too much. This handout summarizes many of the strategies that we recommend for coping with
special occasions. It also suggests new and different ways to think about the role of food on special
occas10ns.

Goals
It is generally best to stick to your usual weekly calorie goal (as an average over the week). Be clear
and realistic about how you will achieve this. Eating nothing all day in anticipation of a party is
likely to lead to overeating later on. Instead, eating lightly the day before or after may be a better
plan. Completely avoiding food that you like may also be a mistake. It is usually a good idea to plan
to eat such food and incorporate it into your day's eating plan .

Plan Ahead
The single most important strategy for dealing with any special occasion is planning ahead. This is
especially important if there will be extra food around for over a period of several days, and ifthere
will be more than one special meal or party. High-calorie foods and alcohol drinks often seem to be
an integral part of these events, so it is especially important that you make plans to deal with these
challenges. It is generally helpful to make a plan for each day, and you may need to plan several days
in advance when celebrations go on for several days.

Monitor
It is very important to continue to monitor. This will keep you informed about how your strategies
are working and help you to adjust your plans as necessary. It will also help you to keep focused on
your goals.

Alcohol
It is especially important to have a plan for dealing with alcohol: not only does it add calories, but it
tends to weaken the resolve to eat moderately.

Focus on Other Pleasurable Aspects of Special Occasions
Although many social events may seem to center on high-calorie food and drinks, consider whether it
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is possible to celebrate without consuming these in large quantities. It may be helpful to think about
ways of making celebrations enjoyable that do not involve eating (or at least eating large quantities
of food) and trying these out. Try paying attention to the features of social occasions that make them
enjoyable. This may lead you to conclude that eating moderate quantities of food would not spoil
your enjoyment. Some people even discover that they enjoy occasions more when they eat and drink
less .

Dealing with Pressure to Eat
You may feel under pressure to eat more than you had planned. This can happen for many reasons :
the sheer abundance of food may attract you; you may feel people will be offended if you do not eat
much: or you may feel that you will be 'the odd one out' if you do not join others in eating and
drinking all that is offered. It is always easier to cope with such situations if you have made a plan in
advance. It also is helpful to practice refusing food lightly but firmly. You do not have to eat to
please others, and people rarely noticed what you are eating and drinking.

Gifts of Food
On special occasions people may buy chocol ates, sweets, cake, or other things for you. If this is
likely, would it be worth asking them to buy something else instead? If you feel you cannot make this
request yourself, perhaps your partner or a relative or friend can discreetly advise others that you
would prefer not to be given food. Also it would be helpful to consider how to cope if you receive
such food unexpectedly. Could you give it to someone else?

Snacks
Sometimes on special occasions there is a wide variety of snacks on display . Having bowls of nuts,
chocolates, and other high-calorie snacks is likely to be a temptation beyond most people's
endurance, so plan how best to cope with this situation . When such situations are under your control,
you may decide to do things differently.

If you are providing snacks:

• Plan the shopping carefully and limit the amount of extra food bought.
• Keep snacks in sealed containers, and only set out small quantities for specific occasions .
• Have alternative, lower-calorie snacks such as raw vegetables with low-calorie dip, fruit,
plain (unsweetened or unbuttered) popcorn, and breadsticks.

• The strategies suggested in Handout G on social eating are also relevant to many special
occas10ns.
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HANDOUTJ
PROBLEM SOLVING

As discussed in the session, effective problem solving involves six basic steps together with a final
review step. The six steps are as follows:
Step 1. Identify the problem as early as possible.
Step 2. Specify the problem accurately.
Step 3. Considered as many solutions as possible.
Step 4. Think through the implications of each solution.
Step 5. Choose the best solution or combination of solutions.
Step 6. Act on the solution.
Then, afterward, review the whole problem-solving process to see if you could have done it any
better. You will improve with practice.

HANDOUTK

BARRIERS TO WEIGHT LOSS CHECKLIST
Below is a list of commonly encountered barriers to weight loss. Please consider which (if any) apply to you, and place a check in the
relevant column.

No

To some
extent

Yes

Accuracy of recording:
Is absolutely everything written down?
Do you accurately measure you portions?
Do you carefully calculate calories?
Weighing and weekly reviews:
Are you weighing yourself once a week?
Are you holding weekly review sessions?
Your eating pattern (i.e., when you eat):
Do your eating habits vary greatly from day to day?
Do you eat regular meals and snacks through the
day?
Do you skip any meals?
Do you go for long periods without eating?
.......
+:>,

N

Do you tend to nibble or pick at food?
Are there particular times of day (or particular days)
when you are liable to overeat?
Do you have "binges" (large or small)?
Your portion size:
Are you portion sizes on the large side?
Do you take second helpings?
Do you always "clean your plate"?
Do you eat leftovers?
Your choice of foods and drink:
Are you prone to eat energy-rich (i.e., high-fat) foods?

......
+::,.

\.;.)
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HANDOUT K (CONTINUED)
Are you actively avoiding any foods?
How you eat:
Are you someone who eats very rapidly?
Do you eat in places other than the kitchen or dining
room?
Do you eat while driving or engaged in other
activities?
Is you eating planned in advance ?
Do you eat directly from packets or containers?
Other obstacles to weight loss:
Have you lost your motivation to lose weight ?
Are you prone to stress-related eating?
Are you liable to eat when bored?
Does thinking in black-and-white terms undermine
you attempts to lose weight ?
Are you facing other obstacles to losing weight?

......
.j:,..
.j:,..
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MONITORING YOUR LEVEL OF ACTIVITY
The first step in increasing your level of physical activity is to measure how active you are now. To
do this you need to measure the three forms of activity disused in treatment.
Inactivity
At the end of each day recall as accurately as you can how many hours you have spent sitting or lying
down. Do this for a 24-hour period (midnight to midnight) projecting forward for the few hours
remaining in the day. Then record the number in an "activity box" drawn on the back of the day's
monitoring record (see below). If you sit down at work, it may be best to keep a running total of the
time spent sitting in column 6 of your monitoring record.
Lifestyle Activity
This term refers to incidental physical activities that are part of day-to-day life. It includes walking,
standing, climbing stairs, household chores, light gardening, ordinary cycling, and gentle swimming.
With the exception of cycling and swimming, we recommend quantifying these activities in
an appropriate way (in terms of the number of steps taken) using a pedometer.
If you have pedometer, you should wear the pedometer at all times except when in bed and
engaging in formal exercise (see below). You should put it on first thing in the morning. To
remember to do this, attach it to something you use first thing in the morning (e.g., a comb or hair
brush) and return the reading to zero by pressing the reset button. Attach the pedometer to a belt for
article of clothing at the side of your hips. Then, last thing at night, note the number of steps recorded
in the day's activity box. Please note that you should ignore any calorie table that may come with the
pedometer as such figures are generally misleading .
Formal exercise
At the end of each day you should also record in the activity box the number of minutes spent
engaged in formal exercise. To be classed as formal exercise, the exercise should involve exertion to
the point that your pulse and breathing rates are increased. Such exercise includes jogging, moderateto-fast swimming, brisk walking, and fast cycling.
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HANDOUTLCONTINUED
Activity Box
The activity box summarizes your level of activity over the previous 24 hours. It should be
drawn on the back of the day's monitoring record and completed at the end of the day. It should
look like this:
Inactivity (hours)

8 hours in bed, 3 hours sitting

Lifestyle activity (steps)

3,860 steps

Formal exercise (minutes and type)

None today

HANDOUTM
THE BODY IMAGE CHECKLIST

Instructions: please answer these questions as they have applied to you over the PAST 4 WEEKS. Please place a check in the
appropriate column.

Over the past 4 weeks ...

Not at all

Sometimes

Frequently

Not
applicable

Questions about avoidance:
Have you avoided seeing yourself in mirrors (or
window reflections)?
Have you avoided weighing yourself?
Have you dressed in a way to disguise your
appearance?
Have you avoided your shape being seen by others
(e.g., swimming pools, communal changing rooms,
etc.)?
Have you avoided taking part in physical activities
because of your shape?
Have the avoided shopping for clothes?
Have you avoided being seen at home naked (e.g.,
when undressing or bathing)?
.......
.j:,.

-...l

Have you avoided wearing clothes that show the
shape of your body?

Have you avoided (or limited) close physical contact
because of your dislike of your shape (e.g., shaking
hands, sexual contact, hugging, kissing)?
Have you avoided wearing close that show your skin
(e.g ., short-sleeved shirts, shorts)?
Have you avoided social occasions because of your
shape?

Questions about checking :
Have you studied your overall appearance in the
mirror?
Have you weighed yourself?

Over the past 4 weeks .. .

Not at all

Sometimes

Frequently

Not
applicable

Have you measured parts of your body?
Have you assessed your size in other ways?
Have you pinched yourself to see how much fat
is there?

General questions :
,_.
~

00

Have you felt unhappy about your shape?
Have you worried about the size of particular
parts of your body?
HANDOUT M (CONTINUED)
Have you worried about your body wobbling?
Have you felt ashamed or embarrassed about
your body and public?
Have you felt that other people were noticing
your shape?
Have you felt that your body was disgusting?
Have you thought that other people were being
critical of you because of your shape?
Have you felt that you take up too much room
(e.g:, when sitting on a sofa or bus seat)?
Have you sought reassurance that your shape is
not as bad as you think it is?
Have people made critical comments about your
shape orappearance?

........

~
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A BLANK BODY IMAGE DIARY
Record on the body image diary times when : you were thinking negatively about your body; you avoided situations because of the way
you felt about your body; you were checking your body in an inappropriate way.
Situation

Feelings

Thoughts

Behavior

Consequences

Alternative Thoughts

.......
V,
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A COMPLETED BODY IMAGE DIARY - EXAMPLE 1: AVOIDANCE
Record on the body image diary times when: you were thinking negatively about your body; you avoided situations because of the way
you felt about your body; you were checking your body in an inappropriate way.
Situation

Feeling?

Thou_ghts

Behavior

Conse_quences

Alternative Thoughts

Being asked by my child
to accompany him on a
bike ride.

Anxious about what
to say, sad and
miserable about the
situation.

The whole street will
see
me
looking
ridiculous on a bicycle.
I will wobble. I cannot
ride my bike until my
body looks better. This
is another thing I
cannot do because of
the way I look.

Told my son that I
could not go. Made up
an excuse (lied).

Not able to do things with
my son, always putting
things off until I get
thinner.

It is me who thinks I will look
ridiculous and disgusting. I am
assuming everyone will think this; I
do not actually know what everyone
thinks.

In the past I have been surprised that
people have not always been thinking
what I thought they were-in this
case perhaps I could find out. If I saw
someone who was overweight riding
a bicycle I would not think they
looked ridiculous-I would think it
was healthy exercise .
So why do I have to wait until I lose
weight? Other people seem to be able
to do it who are even heavier than
me. Besides, I used to enjoy riding a
bicycle, and it is good exercise . By
. saying I cannot do it, I will deprive
myself of the opportunity of doing
exercise that might make me feel
better about myself. I should try to
ride and find out what happens.

>---'
V,

>---'
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A COMPLETED BODY IMAGE DIARY - EXAMPLE 2: REPEATED CHECKING
Record on the body image diary times when: you were thinking negatively about your body; you avoided situations because of the way you felt about
your body; you were checking your body in an inappropriate way.
Situation

Feelings

Thoughts

Behavior

Consequence s

Getting dressed in
the morning .

Really miserable,
disgusted and angry
with myself.

My hips and bottom
are so big, I do not
look nice in these
clothes-in
fact
nothing looks good on
me. I always look
terrible .

I try on several
outfits in the hope
that they will hide
my
hips
and
bottom. I check
myself in the mirror
several times and
from all angles to
see if I look any
better. I eventually
choose an outfit
that is slightly
better but not much.

Once again, I'm late Rationally, I know my shape
for work because it cannot really have changed
takes so long to dress, noticeably overnight. I felt OK
and I still spend all at work yesterday, so the fact
day worrying about that I feel low today is not
how
I
look.
I because I am fatter, but because
repeatedly go to the I am upset about something else.
restroom to check
I know . that anyone who
myself in the mirrorstill don ' t like what I scrutinizes themselves in a
see. When I buy mirror could find things about
clothes,
I
only · their appearance that they want
consider whether they to change . Constantly examining
will hide my hips and myself in the mirror just makes
me feel worse especially as I
bottom-I
don't
bother
considering
only look at the problem areas I
have-I don't bother about my
anything else .
hair and eyes , which are OK. So
I will try to stop doing that. I am
doing what I can to help
myself-I
have already lost
some weight, although it has
been slower than I would like .
Now I will just make the best of
where I am at the !moment. I may
try buying some new clothes that
I feel really good in.

Alternative Thoughts

>--'

Vl
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A COMPLETED BODY IMAGE DIARY-EXAMPLE

3: NEGATIVE THOUGHTS

Record on the body image diary times when: you were thinking negatively about your body; you avoided situations because of the way you felt about
your body ; you felt about your body; you were checking your body in an inappropriat e way.
Situation

Feelings

Thoughts

Behavior

Consequences

Alternative Thou_ghts

Sitting in dentist's
waiting room looking
at clothes in a fashion
magazine.

Envious of
models looking
good in great
clothes, miserable
and disgusted
with my body.

I never looked good
in clothes. I cannot
fit into any decent
clothes anyway. It
is not fair, the
women in those
magazines are so
thin an attractive,
and my body is so
fat and ugly.

Felt so bad I bought
a bar of chocolate
on the way home to
console myself.

Felt even worse later
because
eating
chocolate will make
me even fatter and
make the situation
worse.

Just because I am not thin and
perfect like a model does not
mean that I am unattractive. I
know people whom I regard as
attractive and they don't look
like models . I am comparing
myself to an ideal no one can
attain-photographs
of models
are touched up to remove
imperfections.
I always compare myself to
people whom I think are more
attractive than I am, and not to
those who are Jess attractive. If
someone else did that, I would
think they were being unfair.
Perhaps I am being unduly hard
on myself because I never think
of the things I'm good at. I
know that society's ideals for
shape are narrow, and I admire
people who are not so influenced
by them . Thinking the way I do
is not helpful, because it resul ts
in my eating the wrong things,
which only makes things worse.
>-'

Vl
u-)
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YOUR WEIGHT GOALS
We have begun to discuss your weight goals. As "homework" we would like you to set aside
some time before the next session to consider the issues listed below . We suggest you write
out your answers (perhaps in note form).
You will remember that we discussed your "desired" weight , the weight that you
think that you really ought to achieve. Please answer the following questions with reference
to your desired weight. Please answer them in this order:
1. Origins of your desired weight:
• Why do you want to be this specific weight?
• Is there anything particularly special about this weight?
2. Other weight goals in the past:
• Have you had other weight goals in the past?
• Why were they different from your present goal ?
3. Achievability of the your desired weight:
• When were you last at your desired weight?
• How hard do you think it would be to stay at this we ight?
4. Important of reaching your desired weight:
• How important to you is reaching your desired weight?
• If it is important, why is it important?
5. Consequences of reaching your desired weight:
• How would your life differ if you reached your desired weight ?
• What could you do that you cannot do now?
Or, if you have previously been this weight , how was your life different when you were at
this weight?
When answering the two parts of question 5 consider the following eight aspects of
daily life:
Attractiveness (to yourself and other)
Clothes size and choice
Leisure activities (e.g., sports)
Health and fitness
Work
Social life
Self-esteem and self-confidence
Personal relationships
6. Consequences of not reaching your desired weight
• How would you feel if you do not reach your desired weight?
• What effect would it have on your daily life?
PLEASE REMEMBER TO BRING YOUR ANSWERS TO YOUR NEXT SESSION.
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HANDOUTS
ACCEPTANCE AND CHANGE - VERSION 1

•
•
•
•
•

•
•
•

Some aspects of the problem of being overweight can be changed; some cannot.
A good treatment should help people change what can be changed and accept what cannot.
Body weight is somewhat genetically determined, and it is therefore only partly under one's
control.
It is possible to make fairly dramatic short-term changes in weight by severe ly cutting down food
intake , but a great deal of research has shown that such changes cannot be sustained in the long
te1m.
There is currently no treatment for being overweight (other than gastrointestinal surgery) that
results in the weight loss of more than 10-15% of the initial body weight, and the weight loss is
generally regained. Typically a third of the lost weight is regained within one year and almost all
of it is regained within five years. This is true of all nonsurgical treatments (e.g., dietary
treatments, very-low-calorie diets, behavior modification , and appetite suppres sant drugs) as well
as combinations of these treatments.
If you lost 10-15 % of your starting weight, you would weigh ______
_
For most people, their desired weight is far lower than the weight a 10-15% loss would be. As a
result they view the treatment (and/or themselves) as ha ving failed , whereas it is really an
achievement to lose this amount of weight and keep it off.
The benefits of a 10-15% weight loss can include the following:
• Improved appearance and decreased waist size (and ther efore clothing size)
• Enhanced sense of general well-being and self-e steem
11
Decrease in many of the negative effects on health association with obesity (e.g., high blood
pressure, high blood lipids , high blood sugar) as well as the risk of developing these problems
• Improved sense of physical well-being
• Simultaneously treatment can address other personal goals, and generally this has very
positive effects on quality of life.

Implications for You

•
•

•

You can change your weight to an important extent (10-15% weight loss), although the
weight loss may well not be as great as you would wish .
You can directly address other personal goals, but it is essential that you accept what cannot
be changed (your weight range, your overall shape).
If you do not succeed in accepting what cannot be changed, you are going to be at risk of the
following:
• Undervaluing what you have achieved in treatment
• Believing that you cannot control your weight at all
• Not being fully committed to keeping off the weight that you have lost, a major cause of
weight regain

BOTH ACCEPTANCE AND CHANGE ARE ESSENTIAL FOR SUCCESSFUL
WEIGHT CONTROL.
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ACCEPTANCE AND CHANGE - VERSION 2
•
•
•
•

•

•

•

Some aspects of the problem of being overweight can be changed; some cannot.
A good treatment should help people change what can be changed and except what
cannot.
Body weight is, to an important extent, genetically determined, and it is therefore only
partly under one's control.
It is possible to make fairly dramatic short-term changes in weight by severely cutting
down food intake, but a great deal of research has shown that such changes cannot be
sustained in the long term.
There is currently no treatment for being overweight (other than gastrointestinal surgery)
that results in the weight loss of more than 10-15% of the initial body weight, and the
weight lost is generally regained . Typically a third of the lost weight is regained within
one year and almost all of it is regained within five years. This is true of all nonsurgical
treatments (e.g., dietary treatments, very-low-calorie diets, behavior modification, and
appetite suppressant drugs) as well as combinat ions of these treatments.
Many people who try to lose weight do not lose as much weight as they would like . As a
result they view the treatment (and/or themselves) as having failed. In reality it is an
achievement to maintain any weight loss, however small. For people who have been
gaining weight, to stop gaining weight is in itself an achievement.
The benefits of a 10-15% weight loss can include the following:
• Improved appearance and decreased waist size (and therefore clothing size)
• Enhanced sense of general well-being and self-esteem
• Decrease in many of the negative effects on health associated with obesity (e.g., high
blood pressure , high blood lipids, high blood sugar) as well as the risk of developing
these problems
• Improved sense of physical well-being
• Simultaneously treatment can address other personal goals, and generally this has
very positive effects on quality of life.

Implications for You
•
•
•

•

Although your weight loss may well not be as great as you would wish, you should see it
as a team that you have stopped gaining weight, and have lost a certain amount of weight.
You should be aware of any other positive changes that you have made during the course
of this treatment, such as addressing other personal goals.
It is essential that you accept what cannot be changed (your weight range, your overall
shape) .
If you do not succeed in accepting what cannot be changed , you are going to be at risk of
the following:
• Undervaluing what you have achieved in treatment

157
•
•

Believing that you cannot control your weight at all
Not being fully committed to keeping off the weight that you have lost, a major cause
of weight regain

BOTH ACCEPTANCE AND CHANGE ARE ESSENTIAL FOR SUCCESSFUL
WEIGHT CONTROL.

158
HANDOUTU

RESPONDING TO CHANGES IN WEIGHT
Each week you should inspect your weight maintenance graph, focusing on the past 4
weeks' readings. This will constitute your weekly review. This review involves:
• Weighing yourself,
• Plotting your latest weight on your weight maintenance graph, and
• Carefully appraising the data
If there has been a change in your weight, you need to do the following:
1. Identifying and evaluate the change in your weight.
Questions to ask:
• Is it a sudden leap or gradual trend?
• Is your body weight now outside the "tramlines"?
Action to take:
• Inspect your weight graph, focusing on the past four readings.
2. Identify the explanation for any change in your weight (In terms of energy intake and
expenditure).
Questions to ask:
• Is it due to changes in eating?
• Is it due to change an activity?
• Is ill health, pregnancy or medication contributing?
Action to take:
• To collect information, you should carefully monitor your energy intake (food
and drink). Often it is wise to resume calorie counting (and, therefore weighing
food) for a while. Common causes of weight gain include an insidious increase
in proportion size (which often goes undetected), picking up the , a change in
food choice (with increased energy intake of energy-dense foods), and stressrelated eating.
• You should also consider the possible role of physical activity. Have you given
up certain lifestyle activities (e.g., going for walks, playing sports, and going
swimming)?
3. Identify the background cause(s) of any change in behavior.
Questions to ask:
• Is there an obvious explanation for the change?
• Is it due to slipping into "bad habits"?
Action to take:
• You should consider what factors in your life might be contributing to the change
in your behavior. These are generally readily identified ifthere has been a recent
change. More gradual changes can be more difficult to pinpoint.
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4. Devise and implement a plan for addressing weight gain.
You should devise a plan for correcting the weight gain. There will need to be two
phases.

HADNOUT U (CONTINUED)
•

•

First, you will need to establish an energy deficit to bring you weight back into
the middle of the tramlines. This will usually involve restricting you food intake
for some weeks (to, say, 1,500 calories).
Second, once the increase has been corrected, you will need to make further
adjustments to stabilize your weight. Generally these will involve changes in
both energy intake and physical activity following the guidelines which have
been provided. You will also need to discontinue monitoring your food intake.
You will need to continue regularly monitor your weight.

5. Devise and implement a plan for dealing with the background cause(s) of the change
in behavior.
You will also need to address the background columns. This is best done using the
formal problem-solving approach . As with the changes in eating and activity, you will
need to regularly evaluate your progress and adjust your plans accordingly.
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HANDOUTV
DRAFT MAINTENANCE PLAN
Make some notes under the following headings .
1. Reasons I do not want to regain weight:
a.
b.
C.

d.

2. Good habits to keep up ( eating) :
a.
b.
C.

d.
3. Good habits to keep up (activity) :

a.
b.
C.

d.
4. Danger areas to be aware of:

a.
b.
C.
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Useful Websites

The following table has been adapted from a similar table published in a chapter titled
"Obesity and the Internet" by K.R. Fontaine and D . B. Allison from Fairburn and Brownell
(2002).

Website

Description

American Diabetic Association
(\vww .eatri ght.org)

Provides infonnation
weight control.

American Obesity Society
(w\vw.obe sity.org)

Provides education for general public and
health professionals and advocates for rights
of obese persons.

International Obesity Task Force
(www .iotf.org)

Provides education and advocacy for obesity
to be viewed as a world wide epidemic.

National Association to Advance Fat
Acceptance (www.naafa.org)

Advocates on behalf of obese persons to
improve quality of life and reduce
discrimination.
Provides resources for health professionals
and the general public.

National Heart, Lung and Blood Institute
(www.nh1bi.nih.gov)

on nutrition

and

National Institute of Diabetes and Digestive
and Kidney Diseases (www.niddk.nih.gov)

Provides information on weight loss and
control for health professionals and the
general public. Includes information about
physical activity for overweight people.

North American Association for the Study
of Obesity (www.naaso.org)

Interdisciplinary society that develops,
extends, and disseminates knowledge in the
field of obesity.
Provides general information on weight
control and physical activity.

Shape Up America! (www.shapeup.org)
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Principles of Healthy Eating
1. Temporal Pattern of Eating
a. Eat at regular intervals throughout the day
i. 3 meals a day and one or more planned snacks
ii. Without "nibbling" outside these planned times
iii. A pattern of regular eating helps to reduce the risk of overeating.
b. Evening snacks can be especially important
1. Minimize feelings of deprivation
11. Make the snack appetizing-even a highlight of the day's eating

2. Food Choice
a. Eating a broad range of food
i. Protects against binge eating
ii. Improves overall health
b. Less food but good food
c. Which foods contribute most to calorie intake
d. Energy dense foods
1. Fat has 9 calories per gram
11. Carbohydrate and protein has 4 calories per gram
3. Eating
a.
b.
c.

Style
Whenever possible, plan eating
Eat in a set place at home and sitting down
Savor food

4. Cognitive Aspects of Eating
a. Rigid dieting may lead to extreme reaction to breaking any of own rules
b. Flexible dieting with guidelines rather than rules
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Appendix G
Diabetes Care Profile
ID#

---------

Name

---------

Today's Date

---------

Diabetes Care Profile
Michigan Diabetes
Research and Training Center
DCP2.0
© 1998 The University of Michigan
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Section I - Demographics
Please answer each of the following questions by filling in the blanks with the correct answers or
by choosing the single best answer .

Note:

For this survey, a Health Care Provider refers to a doctor, nurse practitioner,
or physician assistant.

Q 1.

Age:

Q2 .

Birth date: ------ /
/
(Month / Day I Year)

Q3 .

Zip Code: ____

Q4.

Sex:

Q5.

What year were you first told you had diabetes? (Please enter the year) ____

Q6 .

What is your marital status? (check one box)

D1
D2
D3
D4
Q7.

__

years old

_

D1Male

D2Female

Never married
Married
Separated/Divorced
Widowed

What is your ethnic origin/race? (check one box)

D1
D2
D3
D4
Ds
D6
D1

White
Black
Hispanic
Native American
Asian or Pacific Islander
Arabic
Other

_
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Q8.

Where do you live most of the year? (check one box)

D1
D2
D3
D4
Ds
D6
D1
Q9.

Senior citizen apartment/condo
Home of a relative/friend
Retirement home
Adult foster care
Nursing home
Other

How many people live with you? (check one box)

Do
D1
D2
DJ
D4
Ds
QlO.

Your home, apartment or condo

I live alone
1 person
2 people
3 people
4 people
5 or more

How much schooling have you had? (Years of formal schooling completed)
(check one box)

D1
D2

Some high school

03

High school graduate or GED

D4

Some college or technical school

Os

College graduate (bachelor's degree)

D6

Graduate degree

8 grades or less

166
Q 11.

Which of the following best describes your current employment status? (check one box)

D Working full-time, 35 hours or more a week
D 2 Working part-time, less than 35 hours a week
1

0 3 Unemployed or laid off and looking for work
0 4 Unemplo yed and not looking for work

Os Homemaker
D6In school

D1Retired
OsDisabled , not able to work
0 9 Something
Q12 .

else ? (Please specify) :

How would you describe the insurance plan(s) you have had in the past 12 months ?
(check all that apply)

01
02

An individual plan - the member pays for the plan premium
A group plan through an employer , union , etc. - the employer pays all or part
of the plan premium

03

U.S. Governmental Health Plan (e.g., Military , CHAMPUS , VA)

D4
Os

Medicaid
Medicare

06

I have not had an insurance plan in the past 12 months

167
Q13 .

What type(s) of insurance plans have you had in the past 12 months?
(check all that apply)

0

1

Indemnity or fee-for-service plan (i.e., you choose which health care provider you
see for care without financial penalty)

02

Health Maintenance Organization (HMO) (i.e., you must have a primary care
provider who must refer you to specialty care if needed)
Prefen-ed Provider Organization (PPO) (i.e., you have lower co-payments when
you see a preferred provider within the network , but you can see a provider
out-of-network for a higher co-payment)

04

Point of Service (POS) (i.e., you must have a primary care provider; you have the
option to self-refer to an in-network specialist , or you can see an out-of-network
specialist with a higher co-payment)

Os
06

Other (please specify) : ______

_

I have not had an insurance plan in the past 12 month s.
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Ql4.

Do you test your blood sugar? (check one box)

D1No D2Yes

j

Q 14a. How many days a week do you test your
blood sugar?
__

(days / week)

i
Ql4b.

On days that you test, how many times
do you test
your blood sugar?
__

(times I day)

i

Q14c. Do you keep a record of your blood
sugar test
results? (check one box)

01 No D2Yes
0 3 Only Unusual Values
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Section II - Health Status SF-36

QI.

In general, would you say your health is: (check one box)
D1

Os
Excellent

Q2.

Very Good

Good

Fair

Compared to one year ago, how would you rate your health in general now?
(check one box)
D1

Much better now than 1 year ago

D2

Somewhat better now than 1 year ago

D3

About the same

D4

Somewhat worse now than 1 year ago

Os

Much worse now than 1 year ago

Poor
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Q3.

The following questions are about activities you might do during a typical day.
Does your health now limit you in these activities? If so, how much?
(circle one answer on each line)

Yes,
Yes,
No, Not
Limited ALimited A Limited
Lot
Little
At All
A. Vigorous activities, such as running, lifting heavy
objects, participating in strenuous sports?

1

2

3

B. Moderate activities, such as moving a table, pushing a
vacuum cleaner, bowling , or playing golf?

1

2

3

C. Lifting or carrying groceries?

1

2

3

D. Climbing several flights of stairs?

1

2

E. Climbing one flight of stairs?

1

2

F. Bending, kneeling, or stooping?

1

2

,,
.)

3

3

-- - ----

-

G. Walking more than a mile?

1

2

3

H. Walking several blocks?

1

2

3

I. Walking one block?

1

2

3

J. Bathing or dressing yourself?

1

2

3
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Q4.

During the past 4 weeks, have you had any of the following problems with your work
or other regular daily activities as a result of your physical health ?
(circle one answer on each line)

Yes
A.

Cut down the amount of time you spent on work or other

No

1

2

Activities
B.

Accom_Qlished less than you would like

1

2

C.

Were limited in the kind of work or other activities

1

2

D.

Had difficulty performing the work or other

1

2

activities (for example, it took extra effort)
During the past 4 weeks, have you had any of the following problems with your work
or other regular daily activities as a result of any emotional problems (such as feeling
depressed or anxious)? (circle one answer on each line)

QS.

A.

Cut down the amount of time you spent on

Yes

No

1

2

work or other activities
B.

Accom12lished less than you would like

1

2

C.

Didn't do work or other activities as carefully

1

2

as usual

Q6.

During the past 4 weeks, to what extent has your physical health or emotional problems
interfered with your normal social activities with family, friends, neighbors, or groups?
(check one box)

Os
Not at all

Q7.

Slightly

Moderately

Quite a bit

Extremely

How much bodily pain have you had during the past 4 weeks? (check one box)

Os
None

Very Mild

Mild

Moderate

Severe

Very Severe
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Q8 .

During the past 4 weeks, how much did pain interfere with your normal work (including
both work outside the home and housework)? (check one box)

Ds
Not at all

A little bit

Moderately

Extremely

Quite a bit

These questions are about how you feel and how things have been with you during the
past 4 weeks. For each question please give the one answer that comes closest to the
way you have been feeling.

Q9.

How much of the time during the past 4 weeks: (circle one answer on each line)

A Good Some A Little None
Bit of the of the of the of the
Time
Time Time Time
4
5
6
3

All
of the
Time
1

Most
of the
Time

1

2

3

4

5

6

1

2

3

4

5

6

1

2

3

4

5

6

E. Did you have a lot of energy?

1

2

3

4

5

6

F.

1

2

3

4

5

6

G. Did you feel worn out?

1

2

3

4

5

6

H. Have you been a happy
person?

1

2

3

4

5

6

I.

1

2

3

4

5

6

A. Did you feel full of pep?

B. Have you been a very nervous
person?

---- ----

-

C. Have you felt so down in the
dumps that nothing could
cheer you up?
D. Have you felt calm and
peaceful?

Have you felt do\\rnhearted
and blue?

Did you feel tired?

2
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QlO.

During the past 4 weeks, how much of the time has your physical health or emotional
problems interfered with your social activities (like visiting with friends, relatives, etc.)?
(check one box)

D1All of the time
D2Most of the time
DJ Some of the time
D4A little of the time
Os None of the time
Q 11.

Please choose the answer that best describes how true or false each of the following
statements is for you. (circle one answer on eac h line)

Definitely Mostly
True
True

Not
Sure

Mostly Definitely
False
False

A. I seem to get sick a little easier
than other people.

1

2

3

4

5

B. I am as healthy as anybody I know.

1

2

3

4

5

C. I expect my health to get worse.

1

2

3

4

5

D. My health is excellent.

1

2

3

4

5

Ql2a.

Which are you? (check one box)

D1Male
D2Female
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Q12b. How old were you on your last birthday? (check one box)
D1 Less than 35
D2 35-44
D3 45-54

D455-64
Os65-74
D675-84
D 1 85 and older

Q 13.

Have you ever filled out this form before? (check one box)
D1Yes
D 2No
D3 Don 't remember
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Section III - Education / Advice Received
Q 1.

Has your health care provider or nurse ever told you to take special care of your feet?
(check one box)

0 3 Not Sure
Q2.

Has your health care provider or nurse ever told you to follow an exercise program ?
(check one box)
03 Not Sure

Q3.

Has your health care provider or nurse ever told you to follow a meal plan or diet?

(check one box)

0 3 Not Sure
Q4.

Have you ever received diabetes education? (for example: attended a series of classes or
series of meetings with a diabetes educator) (check one box)
D 3 Not Sure
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Section IV - Understanding

Ql. How do you rate your

Excellent

Good

Poor

understanding of: (circle one
answer for each line)

1

2

3

4

5

b) coping with stress

1

2

3

4

5

c)

diet for blood sugar control

1

2

3

4

5

d) the role of exercise in diabetes
care

1

2

3

4

5

e)

medications you are taking

1

2

3

4

5

f)

how to use the results of blood
sugar monitoring

1

2

3

4

5

g) how diet, exercise, and
medicines affect blood sugar
levels

1

2

3

4

5

h) prevention and treatment of
high blood sugar

1

2

3

4

5

i)

prevention and treatment of
low blood sugar

1

2

3

4

5

j)

prevention of long-term
complications of diabetes

1

2

3

4

5

k)

foot care

1

2

3

4

5

1) benefits of improving blood
sugar control

1

2

3

4

5

m) pregnancy and diabetes

1

2

3

4

5

a)

overall diabetes care
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Section V - Support
Ql.

I want a lot of help and support from my family or friends in :
(circle one answer for each line)

Strongl
y

Somewha
Somewha
t
Neutral
t
Disagree
Agree

Strongl
y
Agree

Does
Not
Apply

Disagre
e
a)

following my
meal plan.

1

2

3

4

5

NIA

b)

taking my
medicine.

1

2

3

4

5

NIA

c)

taking care of
my feet.

1

2

3

4

5

NIA

d)

getting enough
physical activity.

1

2

3

4

5

NIA

e)

testing my
sugar.

1

2

3

4

5

NIA

handlin g my
feelings about
diabetes.

1

2

3

4

5

NIA

~

f)

Q2.My family or friends help and support me a lot to:
(circle one answer for each line)

Neutral

Strongl
y
Agree

2

3

4

5

NIA

1

!

2

3

4

5

NIA

1

2

3

4

5

NIA

1

2

3

4

5

NIA

Somewh
at
Disagree

1

b) take my medicine.
c)

a)

follow my meal
plan.

take care of my
feet.

d) get enough
physical activity.

Does
Not
Apply

Somewh
at
Agree

Strongly
Disagree
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e)

test my sugar.

2

3

4

5

NIA

f)

handle my feelings
about diabetes.

2

3

4

5

NIA

Q3 .My family or friends: (circle one answer for each line)

Strongly
Disagree

Somewhat

Somewha
t
Disagree

Neutral
Agree

Strongl
y
Agree

a)

accept me and my diabetes.

1

2

3

4

5

b)

feel uncomfortable about
me because of my diabetes .

1

2

3

4

5

c)

encourage or reassure me
about my diabetes.

1

2

3

4

5

d) discourage or upset me
abou t my diabetes .

1

2

3

4

5

e)

listen to me when I want to
talk about my diabetes .

1

2

3

4

5

f)

nag me about diabetes .

1

2

3

4

5

Q4.

Who helps you the most in caring for your diabetes? (check only one box)

D1Spouse
D2 Other family members
0 Friends
D4Paid helper
Os Doctor
D6Nurse
3

07 Case manager

Os Other

health care professional

0 9 No one
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Section VI - Control Problems Scale
For the following questions , please check the appropriate response.

QI.How many times in the last month have you had a low blood sugar (glucose) reaction
with symptoms such as sweating, weakness, anxiety, trembling, hunger or headache?

D10 times
D21-3 times
D34-6 times
D47-12 times
Os More than 12 times
D6Don't know

Q2.How many times in the last year have you had severe low blood sugar reactions such as
passing out or needing help to treat the reaction?

D10 times
D21-3 times
D34-6 times
D47-12 times
OsMore than 12 times
D6Don't know
Q3,How many days in the last month have you had high blood sugar with symptoms such
as thirst , dry mouth and skin, increased sugar in the urine, less appetite, nausea , or
fatigue?

D10 days
D21-3 days
D34-6 days
D47-12 days
Os More than 12 days
D6Don't know
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Q4.How many days in the last month have you had ketones in your urine?
01 0 days
02

1-3 days

0 3 4-6 days

04 7-12 days

OsMore
06 Don't

than 12 days
test

Q5. During the past year, how often did
your blood sugar become too high
because: (circle one answer for each
line)
a)

you were sick or had an
infection?

Ofte
n

Sometime
s

Neve
r

Don't
Know

l

2

3

4

5

DK

b)

you were upset or angry?

1

2

3

4

.J

<::

DK

c)

you took the wrong amount of
medicine?

1

2

3

4

5

DK

d)

you ate the wrong types of
food?

1

2

3

4

5

DK

e)

you ate too much food?

1

2

3

4

5

DK

f)

you had less physical activity
than usual?

1

2

3

4

5

DK

g)

you were feeling stressed?

1

2

3

4

5

DK
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Q6. During the past year, how often did
your blood sugar become too low
because: ( circle one answer for each
line)
a)

you were sick or had an
infection?

Neve
r

Sometime
s

Ofte
n

Don't
Know

1

2

3

4

5

DK

b)

you were upset or angry?

1

2

3

4

5

DK

c)

you took the wrong amount of
medicine?

1

2

3

4

5

DK

d)

you ate the wrong types of
food?

1

2

3

4

5

DK

e)

you ate too little food?

1

2

3

4

5

DK

f)

you had more physical activity
than usual?

1

2

3

4

5

DK

g)

you v,aited too long to eat or
skipped a meal?

1

2

3

4

5

DK

h)

you were feeling stressed?

1

2

3

4

5

DK
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Section VII - Social and Personal Factors Scale
For the following questions, please circle the appropriate response.

Never

Don't
Kno

Often

Sometimes

w

Q 1. How often has your diabetes kept you
from doing your normal daily activities
during the past year (e.g., couldn't: go
to work, work around the house, go to
school, visit friends)?

Q2. My diabetes and its treatment
keep me from: (circle one answer
for each line)

2

Strongly
Disagree

Disagree

3

DK

5

4

Neutral

Agree

Strongly
Agree

a)

having enough money.

1

2

3

4

5

b)

meeting school, work,
household, and other
responsibilities.

1

2

3

4

5

c)

going out or traveling as
much as I want.

1

2

3

4

5

d)

being as active as I want.

1

2

3

4

5

e)

eating foods that I like.

1

2

3

4

5

f)

eating as much as I want.

1

2

3

4

5

g)

having good
relationships with people.

1

2

3

4

5

h)

keeping a schedule I like
(e.g., eating or sleep ing late).

1

2

3

4

5

i)

spending time with my
friends.

1

2

3

4

5

j)

having enough time
alone.

1

2

3

4

5
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Strongly
Disagree Disagree
Q3 . Paying for my diabetes treatment
and supplies is a problem.

2

Strongly
Disagree Disagree
Q4 . Having diabetes makes my life
difficult.

2

Neutral

Agree

Strongly
Agree

3

4

5

Neutral

Agree

Strongly
Agree

3

4

5
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Section VIII - Attitudes Toward Diabetes Scales

(Positive Attitude, Negative Attitude, Care Ability,
Importance of Care, and Self-Care Adherence)
For the following questions, please circle the appropriate response.
(circle one answer for each line)

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Ql.

I am afraid of my diabetes.

1

2

3

4

5

Q2.

I find it hard to believe
that I really have diabetes.

1

2

3

4

5

Q3.

I feel unhappy and
depressed because of my
diabetes.

1

2

3

4

5

Q4.

I feel satisfied with my
life.

1

2

3

4

5

QS.

I feel I'm not as good as
others because of my
diabetes.

1

2

3

4

5

Q6.

I can do just about
anything I set out to do.

1

2

3

4

5

Q7.

I find it hard to do all the
things I have to do for my
diabetes.

1

2

3

4

5

Q8 .

Diabetes doesn't affect my
life at all.

1

2

3

4

5

Q9.

I am pretty well off, all
things considered.

1

2

3

4

5

Things are going very well
for me right now.

1

2

3

4

5

QlO.
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Ql 1.

I am able to: (circle one answer
for each line)

Disagree

Neutral

Agree

Strongly
Agree

a)

keep my blood sugar in good
control.

1

2

3

4

5

b)

keep my weight under
control.

1

2

3

4

5

c)

do the things I need to do for
my diabetes ( diet, medicine,
exercise, etc.).

1

2

3

4

5

1

2

3

4

5

d) handle my feelings (fear,
worry, anger) about my
diabetes.

Ql2 .

Strongly
Disagree

I think it is important for me to:
(circle one answer for each line)

Strongly
Disagree

Disagree

Neutral
,.,

Agree

Strongly
Agree

.)

4

5

a)

keep my blood sugar in good
control.

1

'

2

b)

keep my weight under
control.

1

2

3

4

5

c)

do the things I need to do for
my diabetes (diet, medicine,
exercise, etc.).

1

2

3

4

5

d)

handle my feelings (fear,
worry, anger) about my
diabetes.

1

2

3

4

5
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Q13.

I keep my blood sugar in
good control.

Alway
s

Sometime
s

Never

2

3

4

5

Sometimes

Never

Don't
Know

DK

Always

Q14.

I keep my weight under control.

1

2

3

4

5

Q15.

I do the things I need to do for my
diabetes (diet, medicine, exercise,
etc.).

1

2

3

4

5

Q16.

I feel dissatisfied with life because
of my diabetes .

1

2

3

4

5

1

2

3

4

5

Ql 7. I handle the feelings (fear, worry,
anger) about my diabetes fairly
well.
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Section IX - Diet Adherence Scale
Q 1.

Has any health care provider or nurse
told you to follow a meal plan or diet?

Q2. How often do you follow a meal plan or
diet?

2

1

Always

Sometimes

Never

4

3

5

Q3.

Have you been told to follow a schedule for
your meals and snacks?

D

1 No

Q4.

Have you been told to weigh or measure
your food?

D1No

D2 Yes

QS.

Have you been told to use exchange lists or
food group lists to plan your meals?

D1No

D 2 Yes

D2 Yes

Sometimes

Never

Always

Q6 .

How often do you follow the schedule
for your meals and snacks?

1

2

3

4

5

Q7.

How often do you weigh or measure
your food?

1

2

3

4

5

Q8.

How often do you (or the person who
cooks your food) use the exchange lists
or food group lists to plan your meals?

1

2

3

4

5
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Section X - Long-Term Care Benefits Scale
For the following questions, please circle the appropriate response.
( circle one answer for each line)

Strong!
Agre y Agree
e

Strong!
y
Disagre
e

Disagre
e

Neutra
I

eye problems

1

2

3

4

5

b) kidney problems

1

2

3

4

5

c) foot problems

1

2

3

4

5

d) hardening of the arteries

1

2

3

4

5

e)

1

2

3

4

5

Q 1. Taking the best possible care
of diabetes will delay or
prevent:

a)

heart disease
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Section XI - Exercise Barriers Scale
For the following questions, please circle the appropriate response.
(circle one answer for each line)

Ql.

How often do you have trouble
getting enough exercise because:

Sometime
s

Rarely

Often

a) it takes too much effort?

1

2

3

4

5

b) you don't believe it is useful?

1

2

3

4

5

c) you don't like to do it?

1

2

3

4

5

d) you have a health problem?

1

2

3

4

5

e) it makes your diabetes more
difficult to control?

1

2

3

4

5
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Section XII - Monitoring Barriers and Understanding Management Practice Scales
Q 1.

How many days a week have you been told to test:
a)

urine sugar?

__

(days per week)

b)

blood sugar?

__

(days per week)

D
D

9

Not told to test

9

Not told to test

If you do not test for sugar, skip Question No. 2.

For the following questions, please circle the appropriate response.
(circle one answer for each line)
Q2. When you don't test for sugar as often
as you have been told, how often is it
because:

Rarely

Often

Sometime
s
- ·- ·

--

-

-

a)

you forgot?

1

2

3

4

5

b)

you don't believe it is useful?

1

2

3

4

5

c)

the time or place wasn't right?

1

2

3

4

5

d) you don't like to do it?

I

2

3

4

5

e)

you ran out of test materials?

I

2

3

4

5

f)

it costs too much?

1

2

3

4

5

g)

it's too much trouble?

I

2

3

4

5

h)

it's hard to read the test results?

1

2

3

4

5

i)

you can't do it by yourself?

1

2

3

4

5

j)

your levels don't change very

1

2

3

4

5

1

2

3

4

5

often?
k)

it hurts to prick your finger?

-
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Q3.

D

Have you ever received diabetes education?

1

No

If No , skip Question No. 4
For the following questions, please circle the appropriate response.
( circle one answer for each line)

Q4 .

How do you rate your understanding of:
Good

Poor

Excellent

a) diet and blood sugar control

1

2

3

4

5

b) weight management

1

2

3

4

5

c)

1

2

3

4

5

d) use of insulin/pills

1

2

3

4

5

e) sugar testing

1

2

3

4

5

f)

foot care

1

2

3

4

5

g)

complications of diabetes

1

2

3

4

5

1

2

3

4

5

exercise

h) eye care

,

i)

combining diabetes medication with
other medications

1

2

3

4

5

j)

alcohol use and diabetes

1

2

3

4

5
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Addition to Section I (Demographics) - Income Question
Q 15.

Which of the categories best describes your total annual combined household income from
all sources? (check one box)

Doi

Less than $5,000

Do2

$5,000 to $9,999

Do3

$10,000 to $14,999

Do4

$15,000 to $19,999

Dos

$20,000 to $29,999

Do6

$30,000 to $39,999

Do1

$40,000 to $49,999

Dos

$50,000 to $59,999

Do9

$60,000 to $69,999

D10

$70,000 and over
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Appendix H
Diabetes Empowerment Scale

University of Michigan Diabetes Research and Training Center
DIABETES ATTITUDE QUESTIONNAIRE

PLEASE ANSWER THE FOLLOWING QUESTIONS

BACKGROUND:
1. Sex:

Male

D

D

Female

2. H ow old are you? _ __

years old

3. How long ago were you told by a doctor that you had di abete s?

__

years

4. Which type of diabetes did your doctor say that you have?

D

insulin-dependent diabetes , also called juvenile or type 1 diabetes

D

non insulin-dependent diabetes, also called adult onset or type 2
diabetes (some people with non insulin-dependent diabetes
take insulin)

5. How often does your diabetes prevent you from doing your normal daily activities
(could not work or go to school)? Circle one number.
Frequently

Never
2

3

4

5

6

7

6. Have you ever attended a diabetes patient education program (a series of classes)?

D

No

D

Yes (If "Yes", how many years ago?

7. How would you rate your understanding of diabetes and its treatment? Circle one number.
Excellent

Poor
1

2

3

4

5.

6

7
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8. How much schooling have you completed?

D

8th grade or less
graduate

D

some high school
college or
school

D
D

9. Are you now taking diabetes pills?
10. Are you now taking insulin?

D

Yes

D

No

D

Yes

D

No

D

11. Have you always treated your diabetes with insulin?
12. What is your height?

__

feet

13. How much do you weigh?

highschool

D

Yes

some
technical

No

inches

___

pounds

14. Please circle the number that indicates how able you are to fit diabete s into your life in
a positive manner.

Very
Able

Not At
All Able
2

5

4

3

7

6

15. Please circle the number that indicates how comfortable you feel asking your doctor
questions about diabetes.

Very
Comfortable

Not At All
Comfortable
2

3

4

5

6

7
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Attitudes Toward Diabetes - DES
Agree

Neutral

Disagree

)

(

)

(

)

(

)

Strongly
Disagree
( )

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

In general, I believe that I:

Strongly
Agree

1. ... lmow what part(s) of

(

taking care of my diabetes
that I am satisfied with .
2.

...lmow what part(s) of
taking care of my diabetes
that I am dissatisfied with .

3.

...lmow what part(s) of taking
care of my diabetes that I am
ready to change.

4.

... lmow what part(s) of taking
care of my diabetes that I am
not ready to change .

(

)

(

)

(

)

(

)

(

)

5.

...can choose realistic
diabetes goals.

(

)

(

)

(

)

(

)

(

)

6.

...lmow which of my
diabetes goals are most
important to me .

(

)

(

)

(

)

(

)

(

)

7.

.. .lmow the things about
myself that either help or
prevent me from reaching
my diabetes goals.

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

8. ...can come up with good
ideas to help me reach my
goals .
9. ... am able to tum my
diabetes goals into a
workable plan.

196

Agree

Neutral

Disagree

Strongly
Disagree

In general, I believe that I:

Strongly
Agree

10. ...can reach my diabetes goals
once I make up my mind .

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

13. ...can try out different ways
of overcoming barriers
to my diabetes goals .

(

)

(

)

(

)

(

)

(

)

14. ...am able to dec ide which
way of overcoming barriers
to my diabetes goals works
best for me .

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

17. ...know the ways that
having diabetes causes
stress in my life .

(

)

(

)

(

)

(

)

(

)

18. ...know the positive ways
I cope with diabetes-related
stress .

(

)

(

)

( )

(

)

(

)

(

)

(

)

(

(

)

(

)

11. ...know which barriers
make reaching my diabetes
goals more difficult.
12. ...can think of different
ways to overcome barriers to
my diabetes goals

15. ...can tell how I'm feeling
about having diabetes .
16. ...can tell how I'm feeling
about caring for my
diabetes

19. ...know the negative ways
I cope with diabetes-related
stress

)
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Strongly
Agree

Agree

Neutral

Disagree

Strongly
Disagree

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

22 . ...can ask for support for
having and caring for my
diabetes when I need it.

(

)

(

)

(

)

( )

(

)

23. ...can support myself in
dealing with my diabetes.

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

(

)

In general, I believe that I:

20 . ...can cope well with diabetesrelated stress .
21. .. .know where I can get
support for having and
caring for my diabetes .

24 . ...know what helps
me stay motivated to
care for my diabetes .
25. ..can moti·1ate myself
to care for my diabetes.
26 . .. .know enough about
diabetes to make self-care
choices that are right for me.
27. ...know enough about my-

self as a person to make
diabetes care choices that
are right for me .
28 . ...am able to figure out if it
is worth my while to change
how I take care of my
diabetes.
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Appendix I
Physician Referral/Permission to Participate

University of Utah Diabetes/Weight-loss Study
Referral /permission to participate in research study to evaluate certain weight-loss
treatments
Name --------------------Address -------------------Mo /yr Type 2 Diabetes Diagnosed ------Any restrictions regarding caloric restriction (restrict to approximately 1500 kcal /day)

If none , please initial here for medical clearance to restrict calories -------Any restrictions regarding exercise __________________

_

If none, please initial here for medical clearance to exercise / increase activity
Diabetes Medications -----None --------Oral glucose-lowering agent(s) _________
_
Insulin regimen ____________
___
_
Other relevant meds
-------------Any weight-loss inducing agents _________
_
Lab Data
Date oflast Al C -------AlC ---------Comments
----------------------------Date --------

Physician signature _____________
Address ------------------City, State, Zip ______________
Telephone number ______________
Fax number ----------------Please mail form to:
Kathy Wickersham
245 International A venue
Tooele, UT 84074

_

_
_
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Appendix J
Letter of Support

..,.:
~}, ,

,J

Tl-It •,,:_•. •

~~-

lJ NJ VER $1 TY
OF UTAH

Jaouury

3, 2005

Dear Kathy.
t:he
I am writing to confinn the fact that I am wi llin g to cooperate in your study: " In vestigating
Effec tiveness of Certai n Treat m en t Options for Weight Loss. " As Director of the Division of
E ndocrinology
and bead of the U tah Diabetes Center at the Un iversity of Utah, I will ass ist you
in patient recruitment from our Diabetes C lini c and provide space a t the Center for you to pur s ue
you r in te rview s and interventions,
pe n di n g approval of the st udy by the lnsti utiona l Review
Boards at our respective l Jniversitics . r an1 looki ng forward to working with you.
Sincerely
.,

,
1 4 ,,

:) v"V\. //1/l

'.{Z-L~

Don McClain MD,
Betillyon Professor
Associate
Director,
Director, Division

PhD
of Medicine,
Gene ra l Cl inical Research Cen ter
of Endocri no logy and Metabolism

Division

of Endocrinology,

Metabolism,

and Diabetes

Dcpurtmcnt of Imctnill M<!dicinc
School of Medidrie
30 N. 2030 East
Salt Lake Ciry, Uuh 84132
(801} 5S1-77S5 • FAX (l>0i) 585-0956
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Physician Referral/Permission to Participate

University of Utah Diabetes/Weight-loss Study
Referral /permission to participate in research study to evaluate certain weight-loss
treatments
_

Name ___________________
Address ___________________

_

Mo/yr Type 2 Diabetes Diagnosed ______

_

Any restrictions regarding caloric restriction (restrict to approximately 1500 kcal/day)

If none, plea se initial here for medical clearance to restrict calories _______
Any restrictions regarding exercise __________________

_
_

If none, please initial here for medical clearance to exercise/ increase activity

None ________
Diabetes Medications _____
_
Oral glucose-lowering agent(s) _________
_
Insulin regimen _______________
_
Other relevant meds _____________
_
Any weight-loss inducing agents _________
_
Lab Data
Date of last AlC _______
_ AlC ________
Comments ____________________________
Date ______

_

_

_
_

Physician signature _____________

_

Address __________________
City, State, Zip ______________
Telephone number _____________
Fax number ________________

_
_
_

Please mail form to:
Kathy Wickersham
245 International A venue
Tooele, UT 84074

_

